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Scientic Abstract
This thesis may be divided into two related parts. The rst of which considers a popu-
lation balance approach to modelling a population of cells, with particular emphasis on
how the cells pass between the G1 and S phases of the cell cycle. In the second part of
the thesis a model is described which combines a cell cycle model with a simple Phar-
macokinetic/Pharmacodynamic (PKPD) drug model. This model is then discussed in
detail.
Knowledge of how a population of cancerous cells progress through the cell cycle is vital if
the population is to be treated eectively, as treatment outcome is dependent on the phase
distributions of the population. Estimates on the phase distribution may be obtained
experimentally however the errors present in these estimates may eect treatment ecacy
and planning. In this thesis mathematical models are used to explore the factors that
eect the phase distributions of the population.
In this thesis it is shown that two dierent transition rates at the G1-S checkpoint provide
a good t to a growth curve obtained experimentally. However, the dierent transition
functions predict a dierent phase distribution for the population, but both lying within
the bounds of experimental error. Since treatment outcome is eected by the phase
distribution of the population this dierence may be critical in treatment planning.
Using an age-structured population balance approach the cell cycle is modelled with par-
ticular emphasis on the G1-S checkpoint. By considering the probability of cells trans-
itioning at the G1-S checkpoint, dierent transition functions are obtained. A suitable
nite dierence scheme for the numerical simulation of the model is derived and shown to
be stable. The model is then tted using the dierent probability transition functions to
experimental data and the eects of the dierent probability transition functions on the
model's results are discussed.
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In contrast to the population balance approach a more simplistic compartmental model
is also considered. This model results in a system of linear ordinary dierential equations
which, under specic circumstances may be solved analytically. It is shown that whilst
not as accurate as the population balance model this model provides an adequate t to
experimental data with the results for the total cell population lying within the bounds
of experimental error.
The ODE compartment model is combined with a simple PKPD model to allow a detailed
analysis of the equations for this combined model to be undertaken for dierent drug-cell
interactions. These results are then discussed.
As a tumour grows many of the cells receive oxygen and nutrients from blood vessels
formed within the tumour, these provide a less than ideal supply, resulting in areas that are
well perfused, hypoxic and necrotic. In hypoxic regions the lack of oxygen and nutrients
limit the cells' growth by increasing their cycle time and also reducing the eects of
radiation and chemotherapy. In the conclusion of this thesis the idea of separating a
tumour into three regions, normoxic, hypoxic and necrotic is discussed. Each of these
regions may then be modelled using three coupled compartments, each of which contain
a cell cycle model, modelled using a set of ordinary dierential equations. Additionally,
the interaction of a simple (PKPD) drug model with these populations of cells may be
considered.
Keywords and AMS Classication Codes: Cell Cycle, phase distribution, age structured
mathematical model, mathematical modelling, 35Q92, 92C37
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Lay Summary
Cancer tumours are comprised of a heterogeneous population of cells diering in age, size
and DNA content. Such populations may be modelled mathematically using a population
balance framework giving a set of partial dierential equations for the cell population
density. Such a model may then be modied to account for external factors aecting the
population such as nutrient deprivation, radiation treatment or cytotoxic drugs allowing
for a greater understanding of how the carcinogenesis process may be controlled.
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Chapter 1
Introduction
Cancer tumours are comprised of a heterogeneous population of cells diering in age, size
and DNA content. The vulnerability of cells to dierent treatments varies according to
their position in the cell cycle, therefore knowledge of how a population of cells progress
through the various phases of the cycle is vital if the population is to be treated eectively.
Estimates on the phase distribution may be obtained experimentally however the errors
present in these estimates may eect treatment ecacy and planning. If mathematical
models are to be used to make accurate, quantitative predictions concerning treatments,
whose ecacy is phase dependent, knowledge of the phase distribution is crucial.
1.1 The Cell Cycle
The cell cycle is an ordered set of events that a cell undergoes from its birth until it
divides into two daughter cells [1] as depicted in Figure 1.1. In eukaryotic cells1 the cell
cycle may be broken down into four distinct phases, namely G1, S, G2 and M . After
birth, a cell enters the longest of the phases, the G1 (Gap 1) phase, during which the cell
takes on nutrients needed to complete the rest of the cycle. Once the cell has absorbed
enough nutrients it may proceed round the cell cycle leaving the G1 phase and entering
the S (Synthesis) phase. Not all cells leave the G1 phase to enter the S phase, a number
of cells enter a quiescent period where they remain viable but leave the cell cycle for a
short time, these cells enter the G0 (Gap 0) phase. During the S phase a cell replicates its
1cells with a nucleus which contains the majority of the DNA.
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DNA, at the end of which they have eectively doubled their DNA content. Once DNA
synthesis is completed the cell enters the G2 (Gap 2) phase. During the G2 a cell grows
in size and prepares for mitosis. Upon leaving G2 the nal phase M (Mitosis) is entered.
It is during the mitotic phase that the cell divides, producing two daughter cells. Due
to the processes involved in cell division, cells in the M phase are especially vulnerable
to radiotherapy. It should be noted that the M phase may be broken down further into
several sub phases, however this is of no consequence for the cell cycle models discussed
in this thesis. The actual length of the cell cycle is variable, this variability mainly occurs
in the length of time cells spend in the G1 phase which is governed by the way in which
cells `transition' from the G1 phase to the S phase [59]. Once a cell commits itself to
DNA synthesis (i.e. enters the S phase) it must continue the cell cycle until division is
complete, the `transition' from the G1 phase to the S phase is irreversible. Chemotherapy
drugs can be divided into several types, each of which target a specic process within the
cell cycle such as RNA synthesis or cell division. Hence the ecacy of many chemotherapy
drugs (e.g. [11], [40] and [50]) is dependent on the cell cycle phase. The radiosensitivity of
cells is also phase dependent (e.g. [13], [43] and [64]) with cells in the M (mitotic) phase
having their chromosomes arranged in a line prior to separation making them particularly
sensitive to ionising radiation. Due to the phase dependent nature of chemotherapy drugs
and radiotherapy knowledge of how the cells progress through the dierent phases is
crucial.
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Figure 1.1: Illustration of a Cell Cycle Model.
1.2 Overview
There have been numerous mathematical models developed that describe how populations
of cells progress round the cell cycle. Such models vary greatly in complexity from a
single ordinary dierential equation (ODE) modelling the growth of an entire population2
to sophisticated multi-scale models that account for intercellular biochemical processes of
individual cells and the eect of external factors on the population as a whole [53].
2As early as 1798 Thomas Malthus described the exponential growth of a population. By the early
twentieth century this concept was being applied to populations of cells.
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The outline of this thesis is as follows
1.2.1 Chapter 2 : Cell Cycle Models
In Chapter 2 a detailed literature review of existing cell cycle models is undertaken.
Section 2.1 starts with considering a simple ODE model in which the entire population of
cells is assumed to be homogeneous. Steel's formulae, which allows information about the
age structure of the population to be inferred from a simple ODE model is derived. This
derivation is undertaken so that it is clear where the formulae is valid and under what
circumstances it may not yield correct results. Structured models, resulting in systems
of coupled ODEs are then discussed with a brief review of some existing models that use
this approach. Section 2.1 concludes with a review of molecular ODE models, it is then
explained why this approach is not considered further.
To account for the intraphase heterogeneity of the population it is necessary to model the
population using partial dierential equations (PDEs). Whilst there are several dierent
approaches for modelling a population of cells using PDEs the most popular approach is
to use a population balance framework. In Section 2.2.1 a detailed review is undertaken
of models that use such a framework, resulting in a system of PDEs which describe some
of the intrinsic properties of the population such as age or DNA distribution. Chapter
2 concludes with a brief discussion of the existing models highlighting limitations and
possible areas for improvement.
1.2.2 Chapter 3 : Validation and Comparison of New Ordinary Dierential
Equation and Partial Dierential Equation Models
In Chapter 3 new ODE and PDE models are formulated. A new PDE model, based upon
the CelCyMUS model ( [22], [23] and [57]), is formulated and veried. This new PDE
model is then compared against the ODE modelling approach.
In Section 3.1 a new structured ODE model is constructed. This model consists of four
compartments, each corresponding to a dierent phase of the cell cycle. The rate con-
stants, which dene the rates at which cells pass between these compartments are chosen
to all be unity allowing an analytic solution to be obtained. This model gives an al-
ternative to Steel's formulae for calculating the percentage of cells in each phase, and a
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detailed comparison between this result and Steel's formulae is undertaken. The ODE
model presented also allows for a good comparison of ODE and PDE models and forms
a general framework which is extended in Chapter 6.
Section 3.2 starts with a brief discussion of simplications which may be made to the
CelCyMUS model, details of which may be found in Section 2.2.1. Using the CelCyMUS
model as a starting point a new three compartment, age-structured PDE model is presen-
ted.
In Section 3.3 two dierent approaches for deriving the transition function which de-
scribes how cells transition from the G1 phase to S phase are detailed. Constant, quad-
ratic and sigmoidal functions from the literature [6], [22], [23] and [57] are discussed in
detail, with respective aws highlighted. A new, sigmoidal transition function is then
presented together with an appropriate non-dimensionalisation consistent with the non-
dimensionalisation given in Section 3.2 for the new simplied age-structured model.
A numerical scheme for the new simplied age-structured model is derived in Section 3.4,
together with a proof of the scheme's stability.
Section 3.5 sees the simplied age-structured model with dierent transition functions
compared with experimental data. In Section 3.6 the ODE model framework discussed
in Section 3.1 is modied to allow direct comparison with the PDE model described in
Section 3.2. The ODE model is then tted to the same experimental data as that used
in Section 3.5 and the ODE and PDE results are compared.
Some of the work in this chapter, in particular Section 3.3 has been published jointly with
A. Skeldon, D. Lloyd and N. Kirkby [16].
1.2.3 Chapter 4 : Integral Equations for an Age Structured Population Bal-
ance Model
In Chapter 4 the construction of integral equations which may be used for the analysis
of the cell population is considered. A four compartment age-structured model, similar
to that discussed in Section 3.4, is constructed. Two new functions, Mptq and P ptq,
representing the number of cells dividing and the total number of cells in the population
are introduced. The system is then expressed in terms of integral equations for these
two new functions. Once Mptq and P ptq have been found the integral equations for the
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population densities are readily derived. It should be noted in this chapter the integral
equations are derived and no analysis of the resulting system is undertaken. The integral
equation approach has been included to indicate alternative methods for the modelling of
the cell population are available.
1.2.4 Chapter 5 : Pharmacokinetic and Pharmacodynamic Models
Pharmacokinetics (PK) and pharmacodynamics (PD) are the branches of pharmacology
which are concerned with how a drug interacts with a biological environment. Pharma-
cokinetic/pharmacodynamic (PKPD) modelling is an attempt to model the interaction of
a drug with a particular biological environment. Chapter 5 starts by giving a brief over-
view of how PKPD may be modelled. In the case of pharmacodynamics the way in which
this may be incorporated directly into a cell cycle model is discussed. A brief introduc-
tion to widely used pharmacokinetic modelling is then undertaken. Drugs administered
by intravenous infusion and also extravascularly are considered and simple compartment
models described. The idea of multiple periodic doses resulting in an iterative map of
ODEs is discussed, but not solved. It is explained how the eects of bioavailability may be
included and what eect this would have on the resulting solution. Chapter 5 concludes
with a brief discussion of the type of PKPD model which will be used in conjunction with
cell cycle models in Chapter 6.
1.2.5 Chapter 6 : A Cell Cycle Model with Drug Interaction
In Chapter 6 a model for a population of cells eected by drugs is developed. This model
enables a semi-analytical solution to be obtained. The solution may be used to gain a
qualitative understanding of the way in which dierent types of drug-cell interactions eect
a given population. Since only a qualitative understanding of the system is sought the
ODE model described in Section 3.1 and a simple PKPD model similar to that described
in Section 5.1.1 are combined.
Chemotherapy drugs eect a population of cells in two dierent ways, namely cytostasis
and cytotoxicity, therefore it seems sensible to consider two separate models. In Section
6.2 the cell cycle model is modied to include the eects of a cytotoxic drug on the
population of cells. The modied system of ODEs are presented and non-dimensionalised.
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It is observed that the model may be divided into three categories dependent on the order
of one of the parameters of the system, each of these is then analysed.
Section 6.3 follows a similar format to Section 6.2 with the model now modied to include
the eects of a cytostatic drug on the population of cells. As this scenario is worked
through a number of similarities between the cytotoxic and cytostatic model are noted. In
Section 6.4 the cytotoxic and cytostatic models are compared with the chapter concluding
with a summary of the ndings.
The majority of the work in this chapter is currently being prepared for publication with
A. Skeldon, D. Lloyd and N. Kirkby.
1.2.6 Chapter 7 : Conclusion and Further Work
The thesis concludes by summarising the main results found, and discussing possible ways
in which this work could be extended.
Chapter 2
Cell Cycle Models
There have been a number of mathematical models developed that describe how popula-
tions of cells progress round the cell cycle. The simplest of these models consist of ODEs
that model the growth kinetics of populations of cells and these are detailed in Section 2.1.
Section 2.1 starts with considering a simple ODE model in which the entire population
of cells is assumed to be homogeneous. It is shown that by utilising Steel's Formulae it is
possible to obtain some information concerning the proportion of cells in each of the cell
cycle phases from such a model. The idea of structured ODEs is then discussed with a
brief review of some existing models that use this approach. Section 2.1 concludes with a
review of molecular ODE models, it is then explained why this approach is not considered
further.
Whilst it is possible to construct a model which provides a good representation of the
cell population as a whole using ODEs this approach does not consider the intraphase
heterogeneity of the population. For this it is necessary to model the population using
a PDE model. In Section 2.2.1 a detailed review is undertaken of models that use a
population balance framework, resulting in a system of PDEs that describe some of the
intrinsic properties of the population such as age or DNA distribution. It should be noted
that the models described in this chapter relate to a closed population of cells. This type
of closed in-vitro system where there is no ow in or out of the system, for a xed duration,
is often referred to as a batch experiment. This chapter concludes with a brief discussion
of the existing models highlighting limitations and possible areas for improvement.
13
14 2.1 Ordinary Dierential Equation Models
2.1 Ordinary Dierential Equation Models
The simplest models for the growth of a population of cells consider the population as
homogeneous where all individuals have the same intermitotic time TC . If the only variable
of interest is the total number of cells then the total number of cells N is governed by the
rst order ODE
dNptq
dt
 Nptq and Np0q  NI ; (2.1)
where NI is the number of cells at time t  0 and  is the growth constant. Equation
(2.1) has the solution
Nptq  NIet: (2.2)
If the population at t  0 is given by NI then at time t  TC all cells will have undergone
exactly one division, thus the population will now be NI . Therefore
NI  NIeTC ; (2.3)
or
  ln
TC
: (2.4)
2.1.1 Steel's Formulae
From a single ODE model for the cell cycle it is possible to obtain further information
such as the proportion of cells in each of the phases. This information is useful not only in
validating structured ODE models such as that described in Section 3.1 but is also used
to obtain parameters for some PDE models such as [3]. Specically, in [60] it is shown
that if the relative phase lengths are known then it is possible to calculate the proportion
of cells in each phase of the cell cycle. The results presented in [60] are now reproduced as
they provide a useful insight into how further information may be obtained from dierent
ODE models.
Consider an individual cell. If when it divides there are  daughter cells then there is an
increase of 1 cells to the population. Therefore, the fraction of cells produced, at time
t, Nptq, which are additional, Nptqp  1q, is given by
Nptqp  1q
Nptq 
  1

: (2.5)
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The growth rate is the fraction of new cells, that are additional, multiplied by the rate at
which cells begin a new cycle, K. Since the growth rate is given by Nptq it follows that
 1

K  Nptq: (2.6)
Thus, the rate at which cells begin a new cycle is given by
K  
  1Nptq: (2.7)
Assuming there is no death part way round the cycle the number of cells (the cell density)
of age P r;    q is given by 
1Npt q , this is the rate at which cells start a new
cycle at time t  . However, from Equation (2.2),
Npt q  NIeptq;
 NIete ;
 Nptqe : (2.8)
Therefore the number of cells whose age is P r;    q is given by 
1Nptqe .
Upon normalising the cell density, the probability density function for cells in terms of
their age P pq, is obtained
P pq  
  1e
 : (2.9)
In order to obtain information about the age structure of the population it is necessary to
divide the cell cycle into two parts  and  whose durations are T and T respectively,
such that T   T  TC , then the proportion of cells in the  section is given by
P  
  1
» T T 
T
ed;
 
  1
 
eT  epT T q( ;
 
  1
 
eT  eTC( : (2.10)
From Equation (2.4)  may be expressed in terms of  and Tc as   eTC . Using this
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together with the fact that T   T  TC means Equation (2.10) may be re-written as
P  
  1
"
eT 

 1

*
;
 1
  1
 
eT  1( : (2.11)
By employing Equation (2.11) it is now possible to determine the proportion of cells in
the  part of the cycle if the duration, T , is known.
It should be noted that it is often dicult to determine experimentally the dierence
between cells in the G2 and M phases thus these two phases are often grouped together,
and denoted as G2M . Let the  section of the cycle contain the G1 and S phases, with
the G2 and M phases being contained in  then
PG2M  1  1
 
eTG2M  1( : (2.12)
If at the end of the cell cycle every cell divides exactly into two daughter cells then   2.
By setting   2 and substituting for  from Equation (2.4) this expression becomes
PG2M  e
TG2M
TC
ln 2  1;
 2
TG2M
TC  1: (2.13)
Equation (2.13) may be re-arranged to make the duration of G2M , TG2M the subject, i.e.
ln pPG2M   1q  TG2MTC ln 2;
TG2M  TC ln pPG2M   1qln 2 : (2.14)
To calculate a similar expression for the G1 phase it is necessary to redene  and  such
that the  section only contains the G1 phase and the rest of the cycle is contained in  .
This gives
PS G2M  1 1
 
eTS G2M  1( ;
 eln 2
TS G2M
TC  1;
 2
TS G2M
TC  1: (2.15)
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Proceeding as before yields
TS G2M  TC ln pPS G2M   1qln 2 : (2.16)
From Equations (2.13) and (2.15) it follows that the proportion of cells in the S phase,
PS, is given by
PS  PS G2M  PG2M ;
 2
TS G2M
TC  2
TG2M
TC : (2.17)
In a similar manner if the duration of the S phase is required and the proportions of cells
in the phases are known then Equations (2.14) and (2.16) lead to
TS  TS G2M  TG2M ;
 TC ln pPS G2M   1q
ln 2
 TC ln pPG2M   1q
ln 2
;
 TC
ln 2
tln pPS G2M   1q  ln pPG2M   1qu : (2.18)
Clearly,
PG1  1 PS  PG2M ; (2.19)
and
TG1  TC  TS  TG2M : (2.20)
Thus, if the durations of the phases G1, S and G2M are known and the population is
assumed to be progressing through the cell cycle at a uniform rate then it is possible
to obtain the proportion of cells in each phase by using Equations (2.13), (2.17) and
(2.19). Conversely, if the proportions are known then the durations for the phases may be
obtained using Equations (2.14), (2.18) and (2.20). These results are referred to hereafter
as `Steel's formulae' [60] and are used in Section 3.1 and [3].
2.1.2 Structured ODE Models
By considering dierent properties of the population of cells it is possible to create a
simple, structured model which includes some of the cellular properties. Early examples
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of this type of structured model may be found in [54] and [62], both of which contain
a good overview of early structured ODE models. In both [54] and [62] the population
of cells is considered as a `biomass' comprising of two distinct mass compartments, one
relating to the nucleic acids and the other the rest of the active biomass, i.e. mainly
proteins. In addition to the biomass the substrate and an inhibitor to growth are also
modelled using ODEs. By using a compartmental approach for the biomass, external
interactions with the population on a `compartment' specic basis, such as the eect
of limited nutrient availability on cell progression,1 may be included. This is a major
advantage over the simple unstructured model described by Equation (2.1). Both [54]
and [62] introduce a bottleneck to take into account the growth limiting aects of limited
nutrient availability.
The idea of a structured compartment model is extended in [52] where a ve compartment
model is presented. Each of the ve compartments in this model represents a phase in the
cell cycle with an additional quiescent phase G0 being appended to the main four cycling
phases, G1, S, G2 and M . In this model it is assumed that cells may enter the quiescent
G0 phase from the G1 phase if a cell attaches to a regulatory molecule. This molecule
may in turn be released from the cell allowing the cell to return to the active G1 phase.
This regulatory molecule is assumed to be excreted by all cells; the concentration and
degradation of these molecules in the substrate is also accounted for within the model.
This model also considers a linear loss of cells from each of the compartments. The
resulting system of ODEs is then studied both analytically and with the aid of numerical
simulations. A number of equilibrium scenarios are found for diering parameter values.
Piantadosi et al. then postulate the possible eects of specic external agents, specically
oncology treatments, on the model, however no analysis of this is undertaken.
Motivated by the idea of a structured ODE approach a new four compartment model,
where each compartment represents one of the active cell cycle phases, is detailed in
Section 3.1.
1The eects of which may be more pronounced in a particular part of the cycle.
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2.1.3 Molecular ODE Models
An alternative approach to modelling the population of cells using compartmental models
such as those described in Section 2.1.2 is to consider an individual cell and model the
internal biochemical processes [46]. This type of model is based upon modelling the key
processes within the regulatory network of the cell, particularly proteins (such as cyclin)
and enzymes (such as Cdc2) concerned with cell maturity.
Even a simplistic model of this type requires a system of nonlinear ODEs with a large
number of parameters2. This type of modelling may be extended to include further detail
on the regulatory network [47], [48] and [49]. It is possible to obtain some information from
these models using analytical techniques [48], however to fully study the complex systems
of nonlinear ODEs governing the internal processes numerical techniques are required.
Such models have been eectively used to gain an understanding of the eects of external
factors on the cell cycle [49].
Powathil et al. [53] use a multi-scale hybrid modelling approach to combine a molecular
ODE model with a cellular automaton approach to simulate a population of cancerous
cells and the eects of chemotherapy treatments on this population. The time dependent
nature of phase specic drugs is considered and the resulting eectiveness of treatments
is discussed.
Whilst being able to eectively model the internal biochemical processes of a cell is valu-
able, if a population of cells is to be considered the resulting multi-scale model can only
eectively be studied using numerical techniques. The large number of parameters present
allow for over tting of a model to experimental data, limiting the model's ability to pre-
dict further scenarios. Also, the size of the population of cells that can be modelled using
this technique is limited due to computational resources. For a large population (e.g. 107
cells) it is not a viable approach. Smaller scale simulations may provide valuable inform-
ation about the population dynamics but it is not possible to gain much insight into the
model from studying the complex system of governing equations, as such this modelling
approach has not been used in this thesis.
2For the model presented in [46] there are nine ODEs containing 18 parameters.
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2.2 Partial Dierential Equation Models
Whilst it is possible to construct a model which provides a good representation of the
cell population as a whole using ODEs this approach does not consider the intraphase
heterogeneity of the population. For all populations of cells there is some degree of hetero-
geneity, this is even more pronounced for populations of cancerous cells [37]. To accurately
represent the population there would need to be an innite number of compartments as no
two cells will be in exactly the same place in their cycle. Thus it is necessary to formulate
a model using a dierent approach.
There are a number of dierent approaches for modelling cell population dynamics such as
Markov chains [65], but the most common approach is to use a population balance frame-
work, modelled using partial dierential equations, to take into account the continuous
variability of the cell properties.
The remainder of this section is concerned with population balance models. A brief
introduction of the population balance framework is given together with an overview
of the most common types of structuring used for a population of cells. The concept of
partition functions for mass and DNA structured population balance models is introduced.
The lack of the need for a partition function for an age structured model is also discussed.
DNA, mass and multi variable models are then reviewed with both a single, generation
type approach and a multi cell phase approach being considered. Particular emphasis is
placed on the DNA structured framework presented by Basse et al. in [3]. Age structured
models are then reviewed with a comprehensive review of the CelCyMUS (Cell Cycle
Model University of Surrey) age structured model, which will form the basis of a new
PDE model to be discussed in Chapter 3.
2.2.1 Population Balance Models
Many of the partial dierential equation models share the same fundamental population
balance structure as detailed in [20], [24] and [25]. These models may broadly be grouped
in terms of which cellular property is used to structure the model, the main properties
used being DNA ( [3], [4], [5], [33] and [39]), age ( [6], [17], [22], [23], [38], and [57]) and
mass ( [17], [38] and [41]).
There are advantages of using a DNA or mass structured model in as much as these
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quantities may be easily determined experimentally, however such a model contains no
information about the age of a particular cell. Consequently, it is possible for cells to
remain in one phase of the cycle for an innite amount of time. By use of an age-
structured model it is possible to control the length of time a cell may remain in the
cell cycle. This is of particular importance for cells in the G1 phase as this is the phase
with the largest variability in length, due to the diering availability of nutrients for cells
within the population. Another advantage of age structuring is that, if growth rates and
nutrient uptake rates for a given cell line are known, it is possible to determine the mass
and DNA content of a cell from its age. In contrast, when given the cells DNA content
or mass it is not possible to determine a cell's age as there is not a one-to-one mapping
between age and DNA or mass.
Analysis has been undertaken to determine the existence and stability of steady size/age
distributions [10] which may occur under specic circumstances using an age-structured
model. Population balance models have been used not only on healthy, unperturbed cell
lines but also to model the eects of various treatments to cancer cell populations [4], [6],
[12] and [33].
Partition Functions
For population balance models which do not use the age variable for structuring it is
necessary to introduce the concept of a partition function P . When a cell divides into
two daughter cells the mass and DNA content of the two new cells is not exactly equal.
If the structuring variable for the model is denoted by x then let P px; x1q x denote the
probability of a cell with property x1 producing a daughter cell with the property lying
P rx; x  xq. Since the continuity of most cellular properties such as mass is preserved
at cell division it follows P px; x1q x  P px1  x; x1q x, i.e. the partition function is
symmetric about x  x1
2
. Dierent distributions are possible for the partition function
but it has been suggested that a symmetric beta distribution is a sensible choice [30]
and [41]. In the case of multiple variables being used for the structuring of the model this
idea may be extended where x is now a vector. If age is being used as the variable for
structuring the model then since all cells have an age of zero at division/birth a partition
function is not required, thus slightly simplifying the equations governing the model.
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DNA, Mass and Multi Variable Structured Models
There are a number of dierent models that consider a population balance framework
using DNA ( [3], [4], [5], [33] and [39]) and mass ( [10], [17], [38] and [41]) as the structuring
variable.
In [38] a population of cells is modelled by considering successive generations of cells. It
is assumed that cells in the pk  1qth generation are ospring of cells in the kth generation
only. The general integro-partial dierential equation for cells in the kth generation was
shown to be
Bnkpx; tq
Bt  rx 

9Xpxqnkpx; tq

 2
»
 px1qP px;x1qnk1px1; tqdx1   pxqnkpx; tq: (2.21)
Where nk is the number of cells in the k
th generation, x is the state vector (i.e. the
variable(s) which is being used to structure the model), 9X is the rate of change of the
state vector, P is the partition function and   is the division rate function. For an age
structured model the analytic solution was presented, together with analytic solutions
for a mass-structured model, with specic growth functions. A simple multi-dimensional
model structured using both age and mass was also discussed. The growth dynamics of
a synchronised population was simulated using both age and mass structured approaches
with both showing that any synchronicity diminishes with time. This model was con-
structed using a single term for the total number of cells within each generation nk, thus
despite accounting for the heterogeneity of the population no knowledge about the phase
distributions could be easily inferred.
A similar mass-structured, single compartment model was considered in [41]. In this work
the population's growth was linked to the availability of a substrate. Dierent partition
functions and growth rates were analysed and the system was shown to exhibit periodic
solutions in certain cases and reach a steady-state in others. Further analysis of the type
of solutions which may occur may be found in [17] where overcrowding and mortality are
considered. Once again periodic and steady state solutions were found.
A thorough study of dierent steady size/mass distributions is undertaken in [7], [8], [9]
and [10]. Begg et al. discuss, in detail, the existence of steady distributions for both an
age structured and an age-size structured model. It is shown that for an age structured
model with periodic birth and death coecients that when a strictly positive periodic
solution exists it is a global attractor. Conditions sucient for the existence of such a
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periodic solution are also presented. A multi compartment age structured model is also
considered, but purely from a theoretical view and no attempt is made to validate the
model against experimental data. The work also touches on extending this approach to
a multi compartment age-size structured model.
DNA Structured Model
A DNA structured framework has been used to study both healthy, unperturbed cell
lines but also to model the eects of various treatments on populations of cancer cells
( [4], [6], [12] and [33]). Since DNA structuring is one of the more common population
balance frameworks used for modelling cell populations this is now considered in more
detail. The majority of the models using a DNA framework share the same general
properties, so only the model presented by [3] will be considered.
This model is described fully by Basse et al. in [3]. The cell cycle is modelled using the
four phases, G1, S, G2 and M , as compartments. The transition between the G1 to S
phases, G2 to M phases and M to G1 phases are assumed to occur at constant rates
denoted by k1, k2, and b respectively. Modelling these transitions in this way assumes
cells can be in the phases G1, G2 and M for an innite amount of time, i.e. these phases
do not have a maximum duration.
During the S phase the cells' DNA content increases by, on average, a factor of two [3].
In [3] the increase is assumed to be linear and occurs at a constant rate g. An additional
term accounts for the relative DNA content dispersing slightly. It is argued this dispersion
is caused by the observational error in measuring the DNA content, whilst this error should
not be ignored inclusion in the model at this stage is not ideal. Regardless of the rationale
it is important that some small dispersive term is present as the relative DNA content of
cells does not always double exactly [37]. Unlike the other phases the S phase is assumed
to be of xed duration. The model is structured using the relative DNA content x; this
is used to infer the phases of the cells within the population. Relative DNA content is a
popular choice for the structuring of the population balance framework as it may easily be
measured using ow cytometry. It is assumed that cells in the G1 phase have an average
relative DNA content of one, cells in the G2 and M phases have an average relative DNA
content of two and cells in the S phase have an average relative DNA content between
one and two.
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The equations governing the movement of cells round this model are given by
BG1px; tq
Bt  2
2bMp2x; tq  pk1   G1qG1px; tq; (2.22)
BSpx; tq
Bt  D
B2Spx; tq
Bx2  SSpx; tq  g
BSpx; tq
Bx   k1G1px; tq  Ipx; t;TSq; (2.23)
BG2px; tq
Bt  Ipx; t;Tsq  pk2   G2qG2px; tq; (2.24)
BMpx; tq
Bt  k2G2px; tq  bMpx; tq  MMpx; tq: (2.25)
The rst of these equations, Equation (2.22) describes the change in cell density in the
G1 phase of the cycle. The 2
2 is present as all cells whose DNA content is P r2x; 2x 2xs
(i.e. cells leaving the M phase) are doubled and mapped to a domain half this size, i.e.
rx; x   xs (cells entering G1 phase). The rate at which cells divide, i.e. the birth rate
is denoted by b. The death rate of cells in the G1 phase is given by G1 and the rate at
which cells transition to the S phase is k1.
Equation (2.23) describes the change in the cell population density for the S phase of the
cycle. Since the cellular DNA does not double exactly during the S phase a dispersion
term, D B
2Spx;tq
Bx2 , is included. The rate of cells dying in the S phase is given by S and
the cells leaving the S phase after TS hours are represented by the Ipx; t;TSq term. The
g BSBx px; tq term is necessary to account for the linear increase in the average DNA content
for cells whilst they are in the S phase. The Ipx; t;TSq term is chosen to ensure that cells
exit the S phase after a xed duration TS. Basse et al. show that Ipx; t; q satises
BIpx; t; q
B  D
B2Ipx; t; q
Bx2  SIpx; t; q  g
BIpx; t; q
Bx ; 0   x   8 and t ¡  ¡ 0;
(2.26)
with the conditions
Ipx; t; 0q  k1G1px; t TSq; 0   x   8 and t ¥ 0; (2.27)
and
D
BI
Bxp0; t; q  gIp0; t; q  0; t ¥  ¥ 0: (2.28)
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Equations (2.24) and (2.25) describe the change in cell densities in the G2 and M phases
respectively. Where k2 is the rate cells transition between the G2 and M phases and G2
and M represent the cell death rates in the two corresponding phases.
To complete the description of the cell population it is necessary to also include the initial
conditions for the system. These are given by
Spx; 0q  0; 0   x   8; (2.29)
G2px; 0q  0; 0   x   8; (2.30)
Mpx; 0q  0; 0   x   8; (2.31)
G1px; 0q  a0a
220
exppx 1q
2
220
; 0   x   8: (2.32)
The initial conditions given by Equations (2.29)-(2.31) state no cells start in the S, G2
and M phases. These initial conditions may arise when modelling an in-vitro population
of cells which has been subject to some form of synchronisation which results in all the
cells in the population being in the same phase. Further details of this type of blocking
process may be found in [23] and [31]. However, in reality, the whole population will not
be synchronised. Equation (2.32) gives the DNA content for cells starting in the G1 phase
as a Gaussian distribution with relative mean of one, the variance of the distribution is
denoted by 20 and the height of the starting distribution is a0. To ensure the proportion
of the Gaussian distribution with x   0 is insignicant 20 is chosen to be very small. It
follows from Equations (2.29)-(2.32) that the initial number of cells is given by» 8
0
G1px; 0qdx  a0
2

1  erf
"
1?
20
*

: (2.33)
An additional boundary condition is required to ensure cells always have a positive DNA
content. i.e. the dispersion multiplied by the change in DNA is equal to the growth in
DNA for cells with zero DNA content. This is represented mathematically as
D
BS
Bx p0; tq  gSp0; tq  0; t ¡ 0: (2.34)
Equations (2.22)-(2.34) fully describe the system. A graphical representation of the model
is shown in Figure 2.1.
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Figure 2.1: Illustration of the Cell Cycle Model Described in [3].
In [61] it is shown that for a population with all phases of innite length and with constant
transition rates that once the population has attained a steady DNA distribution (i.e. for
a population which is undergoing exponential growth) the average time cells spend in
each phase is linked to the transition rate parameters by the formulae
TG1  1k1   G1 ; (2.35)
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TS  1
g   S ; (2.36)
TG2  1k2   G2 ; (2.37)
TM  1
b  M : (2.38)
These relationships only hold for when all phases are of innite length with a constant
transition rate. For the model described by Equations (2.22)-(2.34) this is not the case,
as the S phase is of xed duration. Both Equations (2.35)-(2.38) and Steel's formulae,
detailed in Section 2.1.1, are used in [3]. Basse et al. estimated the time cells spent in
each phase by measuring the percentage of cells in each phase experimentally then using
Steel's formulae. The values obtained for the time the cells spent in each phase were then
used in Equations (2.35)-(2.38) to obtain an estimate for the parameters k1, g, k2 and b.
There appears to be some discrepancy between the use of these two sets of equations as
the values for the time spent in each phase that are used to obtain parameter estimates
from Equations (2.35)-(2.38) do not agree with the values for the time spent in each phase
obtained when the cell phase distribution is placed into Steel's formulae. The source for
this discrepancy is the use of Steel's formulae with a xed duration S phase; this aects
the k2 parameter.
Age Structured Models
As discussed in Section 2.2.1 a single compartment, age-structured model of a population
of cells was considered in [38] using a successive generations approach. The formulation
of the model and solutions are similar to those previous discussed in Section 2.2.1 for the
mass structured approach. Further analysis of this type of model and the form of the
solutions which may occur may be found in [17] where overcrowding and mortality are
considered. Once again periodic and steady state solutions were found.
Both a healthy population of cells and a population of cells exposed to a variety of cancer
treatments, in particular the chemotherapy drug pacitaxel, was modelled using an age
structured population balance framework in [6]. The approach for obtaining a solution to
the equations for the model is similar to that discussed in Chapter 4.
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In [6] it is noted that the most convenient way of validating the model and the resulting
cell populations was to compare the model with experimental DNA proles obtained using
ow cytometry. In order to do this DNA proles must be inferred from the information
contained in the model regarding the ages of cells within the population. This was done by
assuming the DNA content of cells in the P phase where P P tG1; G2;Mu ts a Gaussian
distribution given by
FP px; tq  NP ptqa
22P
exp

px P q2
22P

; (2.39)
where x is the relative DNA content, P is the mean DNA content for a cell in the P
phase and 2P is the variance for the distribution. For the S phase the DNA prole is
given by
FSpx; tq 
» 8
0
NSpt; Sqa
22SpSq
exp

px SpSqq2
22SpSq

ds: (2.40)
It should be noted that for the S phase the mean and variance of the population are age
dependent.
Whilst this work provides a good general framework for the solution of a multi compart-
ment, age structured model it is assumed that the rates that cells transition between the
phases is constant and independent of their age. Although this simplies the problem it
has not been examined in depth. Since the transition between the G1 and S phases is
independent of age, cells are assumed to be viable for entering the S phase immediately
upon starting the G1 phase, as mentioned in Section 2.2.1, this is biologically unrealistic.
These issues are addressed in the remainder of Section 2.2.1.
CelCyMUS Age Structured Model
In [22], [23] and [57] an age structured model, known as CelCyMUS, developed at the
University of Surrey is discussed. This model consists of six compartments, the G1 phase
is divided into two parts G1a and G1b, the other compartments being the S, G2 and
M phases and an additional G' phase. The initial G' phase is introduced so that the
model may accurately represent in-vitro experiments where the cell population has been
partially synchronised with a chemical block. It is from this phase cells initially enter
the cell cycle. The G1 phase is subdivided into two parts G1a and G1b. This is done to
address the issue of cells being able to transition from the G1 to S phase before they have
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had time to grow and acquire the minimum amount of nutrients required for successful
completion of the cycle. The G1a compartment is of a xed time duration, representing
the minimum amount of time a cell must be in the G1 phase before being able to progress
to the S phase. During G1b cells `transition' to the S phase via a probability distribution
function which may be dependent on age, nutrient levels or other growth limiting factors.
This `transition' of cells between G1b and the S phase is discussed in detail in Section 3.3.
Cells who have not left G1b after a certain time are assumed to enter a death compartment
D where they are no longer viable. Once in the death compartment D, the cells leave
(i.e. break down) at a rate which is related to the concentration of ammonia in the
media; the ammonia is a by-product of the viable cells consuming glutamine. The death
compartment is not discussed further but is merely described here for completeness.
Age is a natural choice for the independent variable to use for the population balance
framework, as this allows the model to incorporate the age dependent nature of the
transition from theG1b phase to the S phase. A graphical representation of the CelCyMUS
model is shown in Figure 2.2. In addition to the equations governing the cell populations in
the various phases the model also considers the concentration of growth limiting nutrients.
In [23] the model is validated using experimental data presented in [31] and concerns a
batch experiment which was conducted using a mouse-mouse hybridoma cell line (mm321).
In this model glutamine is considered as the sole growth limiting nutrient, however this
may easily be extended to include other growth limiting factors.
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Figure 2.2: Illustration of the CelCyMUS Cell Cycle Model.
Equations governing the model
Since the CelCyMUS model is used as motivation for the construction of a new simplied
model in Section 3.2, a full derivation of the equations governing the CelCyMUS model
is necessary.
Nutrient Equation
If the glutamine concentrations in the media surrounding the cells, the ow stream of
media into the region of interest and the glutamine within a cell are denoted by CGLUT ,
CQGLUT and CCGLUT respectively, then
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dCGLUT ptq
dt
pCQGLUT ptq  CGLUT ptqqQptq
V ptq
RGLUT
» TG1a
0
nG1apt; G1aqdG1a  
» TG1b
0
nG1bpt; G1bqdG1b


; (2.41)
where Qptq is the ow rate of the media into the region of interest, V ptq is the volume of
the media in the region of interest and RGLUT
2
is the rate that cells in both G1a and G1b
absorb glutamine i.e.
RGLUT
2
 BCCGLUT pt; G1bqBt 
BCCGLUT pt; G1aq
Bt : (2.42)
It should be noted that the rate cells absorb glutamine is given by RGLUT
2
so that full
derivative along the characteristics t     constant is given by RGLUT . Furthermore,
RGLUT is assumed to be a Heaviside function of CGLUT such that RGLUT is constant if
CGLUT ¡ 0 and zero otherwise.
Since [23] uses experimental batch data Qptq  0, thus Equation (2.41) simplies to
dCGLUT ptq
dt
 RGLUT
» TG1a
0
nG1apt; G1aqdG1a  
» TG1b
0
nG1bpt; G1bqdG1b


: (2.43)
G1a Phase Equation
To derive the population balance equation for the cells in the G1a portion of the G1 phase
it is useful to rst describe the parts of the equation in words. Thus,
Change in number of cells, Cells owing out (washout)
whose age P r;    q;   
in the time interval rt; t  tq Cells leaving due to ageing
 
Cells joining due to ageing
 
Cells leaving or joining due
to transition rules. (2.44)
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Each of the parts of this equation are now considered in turn.
The number of the cells is given by the volume of the system V ptq multiplied by the cell
density. The change in the number of cells in the time interval rt; t  tq is the dierence
between the number at time t and time t   t. Hence, the left hand side of Equation
(2.44) may be expressed as
Change in number of cells
whose age P r;    q 
»  

pV pt  tqnG1apt  t; q  V ptqnG1apt; qq d;
in the time interval rt; t  tq (2.45)
where nG1apt; q is the cell density in the G1a phase. Using integration by parts and the
product rule, the integrand in Equation (2.45) may itself be written in terms of an integral
as
pV pt  tqnG1apt  t; q  V ptqnG1apt; qq 
» t t
t
B
BstV psqnG1aps; qu ds

» t t
t
dV psq
ds
nG1aps; q   V psq BBstnG1aps; qu ds:
(2.46)
Hence, Equation (2.45) may be rewritten as
Change in number of cells
whose age P r;    q 
» t t
t
»  

dV psq
ds
nG1aps; q   V psq BBstnG1aps; qu dds:
in the time interval rt; t  tq (2.47)
It is assumed that there is no ow of cells into the region of interest so the only ow is cells
leaving due to washout. Washout from the region of interest may represent cells leaving
in the blood stream in-vivo or from an exit stream of an in-vitro continuous stirred-tank
reactor (CSTR) experiment. The change in the number of cells whose age is P r;    q
due to washout is the ow rate out Qoutptq multiplied by the change in cell density over
the time interval rt; t   tq, summed over the biological age period of interest. Thus, for
cells whose age is P r;    q the term related to cell washout may be written as

» t t
t
»  

QoutpsqnG1aps; q dds: (2.48)
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The second term on the right hand side of Equation (2.44) represents cells who leave due
to ageing; their total number is given by the volume of the system V ptq multiplied by the
cell density summed over the time interval rt; t  tq. As we are only concerned with the
oldest cells in the age interval r;    q leaving there is no summation over  so this
term can be expressed as

» t t
t
V psqnG1aps;    q ds: (2.49)
In the same manner, cells entering the age interval r;  q due to ageing may be written
as » t t
t
V psqnG1aps; q ds: (2.50)
Using both integration by parts and the product rule the sum of Equations (2.49) and
(2.50) may now be written as

» t t
t
»  

V psq BBnG1aps; q dds: (2.51)
The nal term in Equation (2.44) concerns the cells that leave or join due to the transition
rates RG1a , which depends on the number of cells available for transitioning at a given
time and may also depend on a number of dierent variables, including cell age  , nutrient
concentrations and time. The change in number of cells is given by the volume of cells
V ptq multiplied by the transition rate (units are number per volume per time i.e. cell
density per time), summed over the biological age and time intervals of interest. Thus for
cells of age P r;    q over the time interval rt; t   tq the number of cells leaving due
to transition is given by

» t t
t
»  

V psqRG1apxq dds; (2.52)
where x denotes the variables upon which the transition rate depends.
Using Equations (2.47), (2.48), (2.51), and (2.52), Equation (2.44) may now be rewritten
as » t t
t
»  

dV psq
ds
nG1aps; q   V psq BBstnG1aps; qu dds 

» t t
t
»  

QoutpsqnG1aps; q   V psq BBnG1aps; q   V psqRpnG1aq dds: (2.53)
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The change in the volume of the system at time t is given by the ow rate in Qptq minus
the ow rate out Qoutptq. Thus, the ow rate into the region of interest Qptq is given by
Qptq  dV ptq
dt
 Qoutptq. Using this Equation (2.53) may be simplied to
» t t
t
»  

V psq
" B
BsnG1aps; q 
Qpsq
V psqnG1aps; q  
B
BnG1aps; q  Rpxq
*
dds  0:
(2.54)
Since V psq ¡ 0 @ s P R;@ t it follows that" B
BsnG1aps; q 
Qpsq
V psqnG1aps; q  
B
BnG1aps; q  Rpxq
*
 0; (2.55)
i.e. " B
BtnG1apt; G1aq 
Qptq
V ptqnG1apt; G1aq  
B
BG1a nG1apt; G1aq  Rpxq
*
 0: (2.56)
This is the population balance equation presented in [23] where
R1G1apnG1apt; G1aq; G1aq  pG1a  TG1aqnG1apt; G1aq (2.57)
is the transition rate dened such that cells cannot leave the G1a part of the G1 phase
until they have reached a certain age.
G1a Phase Boundary Conditions
To account for new cells entering theG1 phase the following boundary condition is required
nG1apt; 0q 
#
2nMpt; TMq for CGLUT ptq ¡ 0;
0 for CGLUT ptq  0;
(2.58)
where TM is the maximum age of cells in the M phase of the cycle. It should be noted
that cells at the end of the M phase are only able to divide and produce daughter cells if
there are nutrients available, otherwise no daughter cells are produced. This discontinuous
boundary condition may be modied to account for limited nutrients.
The derivation of the equations governing cells in the other phases follows in a similar
fashion to the derivation of the equations for the G1a phase. This leads to the following
set of equations
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G1b Phase Equation
Let nG1bpt; G1bq denote the density of cells of age G1b in the G1b phase at time t then
B
BtnG1bpt; G1bq 
Qptq
V ptqnG1bpt; G1bq  
B
BG1b
nG1bpt; G1bq
 R1G1bpnG1bpt; G1bq; G1bq  R2G1bpnG1bpt; G1bq; G1bq  0; (2.59)
where
R1G1bpnG1bpt; G1bq; G1bq  pG1b  TG1bqnG1bpt; G1bq (2.60)
and
R2G1bpnG1bpt; G1bq; G1bq 
2nG1bpt; G1bq
SMAX  CCGLUT pt; G1bq
BCCGLUT pt; G1bq
Bt ; (2.61)
where SMAX represents the total amount of glutamine a cell may consume before it is
forced to leave the G1b phase and enter the S phase.
R2G1bpnG1bpt; G1bq; G1bq represents the transition from the G1b to the S phase. This
transition function is used in [23] however it may be replaced with any suitable transition
function as discussed in Section 3.3.
G1b Phase Boundary Conditions
nG1bpt; 0q  nG1apt; TG1aq   nG11pt; TG11q: (2.62)
S Phase Equation
Let nSpt; Sq denote the density of cells of age S in the S phase at time t then
B
BtnSpt; Sq 
Qptq
V ptqnSpt; Sq  
B
BS nSpt; Sq  R1SpnSpt; Sq; Sq  0; (2.63)
where
R1SpnSpt; Sq; Sq  pS  TSqnSpt; Sq (2.64)
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S Phase Boundary Conditions
The number of cells entering the S phase at time t is given by the total number of cells,
of all ages, who leave the G1b phase via the R2G1b transition function, dened as
nSpt; 0q 
» TG1b
0
2nG1bpt; G1bq
SMAX  CCGLUT pt; G1bq
BCCGLUT pt; G1bq
Bt dG1b : (2.65)
G2 Phase Equation
Let nG2pt; G2q denote the density of cells of age G2 in the G2 phase at time t then
B
BtnG2pt; G2q 
Qptq
V ptqnG2pt; G2q  
B
BG2 nG2pt; G2q  R1G2pnG2pt; G2q; G2q  0; (2.66)
where
R1G2pnG2pt; G2q; G2q  pG2  TG2qnG2pt; G2q (2.67)
G2 Phase Boundary Conditions
nG2pt; 0q  nSpt; TSq: (2.68)
M Phase Equation
Let nMpt; Mq denote the density of cells of age M in the M phase at time t then
B
BtnMpt; Mq 
Qptq
V ptqnMpt; Mq  
B
BM nMpt; Mq  R1MpnMpt; Mq; Mq  0; (2.69)
where
R1MpnMpt; Mq; Mq  pM  TMqnMpt; Mq (2.70)
M Phase Boundary Conditions
nMpt; 0q  nG2pt; TG2q: (2.71)
G' Phase
The G' phase represents an initial quiescent phase which may occur in an in-vitro setting
where some form of cell blocking technique has been used. There are no equations for this
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phase as cells are only in this phase at the start so this may be thought of as an `initial'
phase with the initial cells of varying age. Therefore at t  0, 0 ¤ 
G'   TG'.
The model outlined by Equations (2.41-2.71) form the basis of the CelCyMUS model
presented in [23] and [22].
2.3 Summary of Existing Cell Cycle Models
In this chapter a number of existing cell cycle models have been considered. Some of
the approaches utilising ODEs to model a population of cells were discussed in Section
2.1. Using Steel's formulae, which were derived in Section 2.1.1, it was shown that it is
possible to obtain the proportion of cells in each of the phases from a single unstructured
ODE model. The idea of structured ODE models was also introduced and a number of
existing structured ODE models briey discussed. In Section 2.1.3 some Molecular ODE
models were reviewed. Whilst appreciating the importance of these models, this type of
model was not considered further as it is not possible to gain much insight into the model
from studying the complex system of governing equations.
Whilst it is possible to construct a model which provides a good representation of the
cell population as a whole using ODEs this approach does not consider the intraphase
heterogeneity of the population. For this it is necessary to model the population using
a PDE model. There are a number of dierent approaches for modelling cell population
dynamics such as Markov chains [65], but the most common approach is to use partial
dierential equations, to take into account the continuous variability of the cell properties.
A comprehensive review of existing population balance models was given in Section 2.2.1.
Section 2.2 began with a brief introduction of the population balance framework, as
detailed in [20], [25] and [24], together with an overview of the most common types of
structuring used for a population of cells. The concept of partition functions for mass
and DNA structured population balance models was introduced and the advantage of not
needing a partition function for an age structured model was also discussed. DNA, mass
and multi variable models were reviewed with both a single, generation type approach
and a multi-cell phase approach being considered.
A detailed review of the DNA structured framework presented by Basse et al. in [3]
was undertaken. Whilst such models may easily be veried by direct comparison with
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observed DNA content there are also a number of shortcomings to the model given in [3],
namely
 The observational error in measuring relative DNA content caused by diering ori-
entations of the nucleus when passing through the ow cytometer is included directly
into the model. Whilst this is important this should be applied as an additional
transformation to the data at the end of the model.
 Cells are assumed to be viable for entering the S phase immediately upon starting
the G1 phase, this is unrealistic as there is a minimum time cells must remain in G1,
as certain specic processes such as mass accumulation and protein synthesis must
be at least partially completed, before progressing further round the cycle [45]. This
issue could be addressed by dividing the G1 phase into two parts, one of which, like
the S phase, would be of xed duration. This would ensure cells remain in the G1
phase for a minimum period of time before progressing through the cycle.
 Even if cell death during the cycle is assumed to be zero (i.e. @ i P tG1; S;G2;Mu;  
0) there are still a number of parameters (k1, g, k2, , b and a0) which need to be
tted. Although estimates on most of these can be obtained from experimental data
the parameters still need to be optimised for best t.
In Section 2.2.1 age structured PDEs are considered. The structure used in [6] was
discussed and whilst this work provides a good general framework for the solution of
a multi compartment, age structured model it is assumed that the rates that the cells
transition between the phases is constant and independent of their age. Because the
transition between the G1 and S phases in this model is independent of age, cells were
assumed to be viable for entering the S phase immediately upon starting the G1 phase,
this is biologically unrealistic. These issues are addressed by the CelCyMUS model given
by [22], [23] and [57]. In Section 2.2.1 the age structured PDE model, CelCyMUS, was
reviewed in depth. This work consists of a detailed and accurate model, which was veried
against experimental data, and has since been extended to consider external factors such
as radiation [35]. Despite this model providing a good t to experimental data there
are issues concerning the validity of the transition functions used in [23] and [57], this
is discussed further in Section 3.3. A number of simplications may be made without
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compromising the model's ability to accurately simulate and t experimental data. These
simplications and a new simplied age structured population balance model are presented
in Chapter 3.
In conclusion, it is possible to obtain some information on a population of cells using a
structured ODE model. However, if the heterogeneity of the population is to be accounted
for then a PDE model must be used. Most PDE models have a population balance
framework with a variety of variables being used to structure the model. By using an
age structured model it is possible to control the length of time that cells may remain in
the cell cycle and infer the mass and DNA distributions. Since there is not a one-to-one
mapping between age and DNA or mass the converse is not true. Age structured models
have the additional benet that there is no need for a partition function. As detailed in
Section 2.2.1 there are a number of existing age structured PDE models, but these models
have their limitations and may be unnecessarily over complicated.
Chapter 3
Validation and Comparison of New
Ordinary Dierential Equation and
Partial Dierential Equation Models
In this Chapter new ODE and PDE models are formulated. The new ODE model gives
an alternative method for calculating the percentage of cells in each phase from Steel's
formulae. Whilst Steel's formulae infers information from the relative phase lengths the
new ODE model allows the percentage of cells in each phase to be obtained directly from
the ODE model. The ODE model presented also allows for a good comparison of ODE
and PDE models and forms a general framework which is extended in Chapter 6. The
PDE model presented is compared against the CelCyMUS model ( [22], [23] and [57])
upon which it is based and, once veried, the new PDE model is compared against the
ODE modelling approach.
In Section 3.1 the new structured ODE model is constructed. This model consists of
four compartments, each corresponding to a dierent phase of the cell cycle. The rate
constants, which dene the rates at which cells pass between these compartments are
chosen to all be unity allowing an analytic solution to be obtained. The model is then used
to predict the phase distribution of the population and these results are then compared
to Steel's formulae.
Section 3.2 starts with a brief discussion of simplications which may be made to the
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CelCyMUS model, discussed in Section 2.2.1. Using the CelCyMUS model as a starting
point a new three compartment, age-structured PDE model is presented. The review
given in Chapter 2 highlights the fact that cells only progress from the G1 to S phase of
the cycle after they have grown suciently and taken on enough nutrients to complete the
cycle. In Section 3.3 two dierent approaches for deriving the transition function which
describes how cells transition from the G1 phase to S phase are detailed. A constant
transition function of the form used in [6] is then briey discussed. The quadratic and
sigmoidal functions used in [22], [23] and [57] are then discussed in detail, with respective
aws highlighted. A new, sigmoidal transition function is then presented together with
an appropriate non-dimensionalisation consistent with the non-dimensionalisation given
in Section 3.2 for the new age-structured model.
In Section 3.4 a numerical scheme for the new age-structured model is presented, together
with a discussion on the scheme's stability. Section 3.5 sees this new age structured model
with dierent transition functions compared with experimental data. The experimental
data concerns a batch experiment which was conducted using a mouse-mouse hybridoma
cell line (mm321) [31].
In Section 3.6 the ODE model framework discussed in Section 3.1 is modied to allow
direct comparison with the PDE model described in Section 3.2. The ODE model is then
tted to the same experimental data as that used in Section 3.5 and the ODE and PDE
results are compared.
The chapter concludes with a brief summary of the ndings.
3.1 Structured Ordinary Dierential Equation Model
By considering the dierent phases within the cell cycle it is possible to create a simple,
structured model which includes some information on the cells' progression through the
cell cycle. In this Section an approach is used where there are a number of compartments
each containing a portion of the cell cycle, i.e. four compartments each containing one
of the four phases, G1, S, G2 and M . This type of model provides a better description
on the population of cells being modelled than those of [54] and [62] discussed in Section
2.1.2, and is of a similar form to the model presented in [52]. This type of compartmental
model has been chosen as it may be used to obtain qualitative information about the
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growth kinetics of the population. The model that is detailed in this section is similar
to that discussed in [52], in as much as each compartment represents a phase of the cell
cycle however the quiescent G0 phase is omitted. As the population of cells which are
to be modelled excludes any quiescent G0 phase the population is assumed to be closed,
i.e. no net ow of cells into or out of the population. The population may be represented
as four compartments each of which contain one phase, as shown in Figure 3.1, where
ki; i P t1; 2; 3; 4u represents the rate cells pass between the dierent phases.

	
I
M
G2 G1
S
k4
k3 k2
2
R
2k1
k1
R
Figure 3.1: Compartmental Representation of the Cell Cycle.
Unlike the model detailed in [52], there is no regulatory molecule included as the G0 phase
has been omitted, this simplies the resulting ODEs governing the population kinetics.
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Furthermore, no cell death is included at this stage, however this is considered in Chapter
6, where the non linear eects of chemotherapy drugs are included.
If the rate constants ki are assumed to be constant then this compartment model may be
represented mathematically by four linear rst order ODEs, one for each compartment
dNG1ptq
dt
 2k1NMptq  k2NG1ptq; (3.1a)
dNSptq
dt
 k2NG1ptq  k3NSptq; (3.1b)
dNG2ptq
dt
 k3NSptq  k4NG2ptq; (3.1c)
dNMptq
dt
 k4NG2ptq  k1NMptq; (3.1d)
where NG1ptq; NSptq; NG2ptq and NMptq are the number of cells in the four compartments
at time t. Equations (3.1) may be solved analytically to give
NG1ptq 
4¸
j1
Cje
Rjt;
NSptq  1
2k1k3k4

4¸
j1
CjR
3
je
Rjt

  k1   k2   k4
2k1k3k4

4¸
j1
CjR
2
je
Rjt

  k1k2   k1k4   k2k4
2k1k3k4

4¸
j1
CjRje
Rjt

  k1k2k4
2k1k3k4

4¸
j1
Cje
Rjt

;
 1
2k1k3k4

4¸
j1
CjpRj   k1qpRj   k2qpRj   k4qeRjt

;
NG2ptq  12k1k4

4¸
j1
CjR
2
je
Rjt

  k1   k2
2k1k4
4¸
j1
CjRje
Rjt   k2
2k4
4¸
j1
Cje
Rjt;
 1
2k1k4
4¸
j1
Cj pRj   k1q pRj   k2q eRjt;
NMptq  1
2k1
4¸
j1
Cj pRj   k2q eRjt;
(3.2)
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where Rj; j P t1; 2; 3; 4u are the roots of the characteristic polynomial
R4  

4¸
i1
ki

R3  

3¸
i1
4¸
ji 1
kikj

R2  

2¸
i1
3¸
ji 1
4¸
mj 1
kikjkm

R 
4¹
i1
ki  0; (3.3)
and Cj; j P t1; 2; 3; 4u are constants which may be determined from the initial conditions.
Note Equation (3.3) may be rewritten as
4¹
i1
pR   kiq  2
4¹
i1
ki; (3.4)
this result is required later in the simplication of Equation (3.8). From Equations (3.2)
for t " 1
NG1ptq  CeRt;
NSptq  1
2k1k3k4

CpR   k1qpR   k2qpR   k4qeRt
	
;
NG2ptq  12k1k4C
 pR   k1q pR   k2q eRt;
NMptq  1
2k1
C pR   k2q eRt;
(3.5)
where R  max tRpRiq i P t1; 2; 3; 4uu and C is the corresponding constant. For the
special case where there is a pair of complex conjugate roots with largest real part then
C  °Cj @j such that Rj  max tRpRiq i P t1; 2; 3; 4uu. Should repeated roots Ra  Rb
occur then each Cb is be replaced with Cbt in Equations (3.2). If in this case Ra  Rb  R
then all of the expressions on the right hand side of Equations (3.5) are multiplied by t.
The fraction of the total population in phase q P tG1; S; G2; Mu at time T is given by
PqpT q  NqpT q
NG1pT q  NSpT q  NG2pT q  NMpT q q P tG1; S; G2; Mu: (3.6)
Thus, using Equations (3.5) and (3.6), for suciently large t the fraction of the population
in the G1 phase at time t is estimated by
PG1pT q  C
eRT

; (3.7)
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where
 CeRT   1
2k1k3k4

CpR   k1qpR   k2qpR   k4qeRT
	
  1
2k1k4
C pR   k1q pR   k2q eRT   1
2k1
C pR   k2q eRT :
Equation (3.7) may be simplied to give
PG1pT q  2k1k3k4pR   k1qpR   k2qpR   k4q   pR   k1qpR   k2qk3   pR   k2qk3k4   2k1k3k4 :
(3.8)
By using Equation (3.4) it is possible to rearrange Equation (3.8) to give
PG1pT q  pR
   k1qpR   k3qpR   k4q
pR   k1qpR   k3qpR   k4q   pR   k1qpR   k4qk2   pR   k1qk2k3   k2k3k4 ;
(3.9)
it is this form that will be used for comparison with the results obtained using Steel's
formulae.
Similar expressions may be obtained for the other phases, S, G2 and M .
3.1.1 Comparison of Results Obtained Using Steel's Formulae and the Four
Compartment ODE Model
Consider the special case where ki  1; i P t1; 2; 3; 4u and the initial conditions given by
NG1p0q  N0; (3.10a)
NSp0q  0; (3.10b)
NG2p0q  0; (3.10c)
NMp0q  0: (3.10d)
As previously discussed in Section 2.2.1 these initial conditions may arise when modelling
an in-vitro population of cells which has been subject to some form of synchronisation
which results in all the cells in the population being in the same phase. Further details
of this type of blocking process may be found in [23] and [31].
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The characteristic polynomial given by Equation (3.4) is now
pR   1q4  2: (3.11)
The roots of Equation (3.11) are
Rj  ij2 14  1; j P t1; 2; 3; 4u: (3.12)
Let R  max tRpRiq i P t1; 2; 3; 4uu  2 14  1. Using this value of R and ki  1; i P
t1; 2; 3; 4u in Equation (3.9) gives
PG1ptq  2
3
4
2
3
4   2 12   2 14   1 ;
 2
3
4
2
1
2   1
	
2
1
4   1
	 ;

2
3
4

2
1
4  1
	

2
1
2   1
	
2
1
4   1
	
2
1
4  1
	 ;
 2 2 34 ;
(3.13)
for suciently large t.
As can be be seen in Figure 3.2, initially the number of cells in the G1 compartment drops
as there are cells leaving but none entering. The number of cells in the S compartment
increases from zero, followed by the G2 and M compartments respectively. Once the
number of cells in theM compartment is half that of theG1 compartment then the number
of cells in G1 also starts to increase. Intuitively this seems to be the correct response but
is easily veried by considering the stationary point of Equation (3.1a). To compare
this result to that of Steel's formulae it is necessary to obtain an estimate of the average
time cells spend in a compartment. Equations (2.35-2.38) state that if there is no cell
death (i  0 @ i P tG1; S;G2;Mu) then the average time a cell spends in a compartment
is the reciprocal of the rate they leave that compartment. Since ki  1 @i P t1; 2; 3; 4u
the corresponding average time a cell spends in each of the compartments is also all one.
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Figure 3.2: Growth Curves for the Number of Cells in Dierent Phases as a Function of
Time when ki  1, i P t1; 2; 3; 4u and N0  106.
Figure 3.3: Fraction of the Total Population of Cells in Dierent Phases as a Function of
Time when ki  1, i P t1; 2; 3; 4u and N0  106.
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From Equations (2.13), (2.17) and (2.19) Steel's formulae predicts the fractions to be
PG2M  2 12  1;
PS  2 34  2 12 ;
PG1  1 PS  PG2M ;
 1

2
3
4  2 12
	


2
1
2  1
	
;
 2 2 34 ;
(3.14)
which agrees exactly with the values given by the ODEmodel prediction given by Equation
(3.13). It should be noted that the predicted values from the ODE model only agree
exactly with Steel's formulae for very specic cases of ki. To nd the maximum dierence
between the predicted values from the ODE models and Steel's formula the dierence was
maximised using Matlab's [44] minimising function fmincon. To maximise the function
using fmincon, the function gpkiq  dierence was minimised. The constraints placed
on the parameter space were ki P r0:05; 2s @i P t1; 2; 3; 4u, which from Equations (2.35-
2.38) correspond to average phase lengths of between 30 minutes and 20 hours. A range
of starting values for the parameters was used ensuring the maximum obtained was the
global maximum within the parameter space. The maximum dierence in the predicted
value for the percentage of cells in the G1 phase between the ODE model and Steel's
formulae was found to be 3.7 %. The dierence between the two methods being due in
part to only the dominating R value of the characteristic polynomial being considered in
the ODE model and the use of Equations (2.35-2.38) to obtain an estimate of the average
time cells spend in a compartment.
Thus, the ODEmodel described may be adequate if the information required only concerns
the number of cells in each phase. However, to adequately model heterogeneity of the
the cells' age, mass or DNA distribution within each phase a system of partial dierential
equations is needed.
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3.2 A Simplied Age Structured Partial Dierential Equation Model
In this section a new simplied age structured population balance model is presented. The
purpose of this new model is twofold. Firstly it is to demonstrate that a simple model is
sucient to t experimental data. Secondly by using a simpler model than those detailed
in [22], [23] and [57] it is easier to gain insight into the model's behaviour, particularly
the transition of cells between the G1 and S phases, this is considered in detail in Section
3.3.
The new age structured model is based upon the CelCyMUS model discussed in Section
2.2.1. The CelCyMUS model may be simplied considerably by making several assump-
tions. These assumptions are
 No ow
The system now being considered is closed such that no cells or nutrients enter or
leave the system for t ¡ 0, hence the ow rate Qptq is set to zero.
 Constant glutamine uptake
If BCCGLUT pt;qBt  BCCGLUT pt;qB  RGLUT2 a direct comparison can now be made with [22]
and [23] who use dCCGLUT ptq
dt
 RGLUT along characteristic curves.
 Reduction in number of transition rules
All of the end of phase transition rules, for example Equation (2.57) are removed
and now included in the relevant boundary conditions.
 Reduction in the number of phase/compartments
Phases S, G2 and M are all of xed length and during these phases the cells do
not absorb glutamine or leave via death so these three phases are combined into
one compartment called `MAIN'. By combining the S, G2 and M phases the model
is simplied from ve partial dierential equations to three. However, information
about the distribution of the cells in these dierent phases is lost and as such must
be inferred by the relative time length of these phases. It is also now more dicult
to perturb the system by an amount dependent on cell phase.
In this model the cell cycle is divided into three, age structured compartments, G1a, G1b
and MAIN . The MAIN compartment contains cells in the S, G2 and M phases of the
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cell cycle, division occurs at the end of this compartment. As this is an age-structured
model the mechanisms and location of DNA replication are not important, however this is
assumed to occur at the start of theMAIN compartment. The G1a compartment contains
cells which have just undergone division, i.e. new cells. Cells that are inG1a are not able to
progress further round the cell cycle until a xed time period has elapsed, this represents
the minimum age a cell can start replicating its DNA. This is biologically realistic as new
cells are normally unable to immediately start replicating their DNA. Once cells have
progressed to the G1b compartment they undergo transition to the MAIN compartment
via some transition function R2G1bpvq which is often a function of how long the cell has
spent in the G1b compartment. It may also be a function of other factors which eect a
cell's progression round the cell cycle such as nutrient levels, the presence of certain drugs
and temperature. The MAIN compartment is of xed duration and can be thought of as
merely a time delay from cells leaving the G1b compartment until cell division occurs and
the new cells enter into the G1a compartment. All compartments within this model are
of a limited duration, the MAIN and G1a compartments are of a xed duration and the
duration of G1b varies from zero to some maximum value, TG1b . Any cells remaining in
the G1b compartment at the end of this period have not successfully undergone transition
and are assumed to progress to a death phase, not modelled here, where the cells are
no longer viable. In some cell lines cells may enter a quiescent phase where they remain
viable but leave the cycle for a period of time, this may apply to cells who are still in the
G1b compartment after a given time. These cells may be able to rejoin the cycle at a later
time, this scenario is not included in this model.
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Figure 3.4: Illustration of a Simplied Cell Cycle Model.
Equations for the Simplied Model
The equations governing the cell populations in each of the compartments are now given
by
G1a Compartment Equation
B
BtnG1apt; G1aq  
B
B nG1apt; G1aq  0: (3.15)
G1a Compartment Initial Conditions
nG1apt; 0q 
#
2nMAINpt; TMAINq for CGLUT ptq ¡ 0;
0 for CGLUT ptq  0:
(3.16)
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G1b Compartment Equation
B
BtnG1bpt; G1bq  
B
B nG1bpt; G1bq  R2G1bpnG1bpt; G1bq; G1bq  0; (3.17)
where
R2G1bpnG1bpt; G1bq; G1bq 
# RGLUTnG1b pt;G1b q
SMAXCCGLUT pt;G1b q for CGLUT ptq ¡ 0;
0 for CGLUT ptq  0:
(3.18)
It should be noted that the transition function R2G1bpnG1bpt; G1bq; G1bq given by Equation
(3.18) is the same as that used in [22] and [23]. The factor of two being omitted because
of the assumption BCCGLUT pt;qBt  BCCGLUT pt;qB  RGLUT2 .
G1b Compartment Initial Conditions
nG1bpt; 0q  nG1apt; TG1aq   nG'pt; TG'q: (3.19)
MAIN Compartment Equation
B
BtnMAINpt; MAINq  
B
B nMAINpt; MAINq  0: (3.20)
MAIN Phase Initial Conditions
nMAINpt; 0q 
# ³TG1b
0
RGLUTnG1b pt;G1b q
SMAXCCGLUT pt;G1bqdG1b for CGLUT ptq ¡ 0;
0 for CGLUT ptq  0:
(3.21)
Glutamine Equations
dCGLUT ptq
dt
 RGLUT
» TG1a
0
nG1apt; G1aqdG1a  
» TG1b
0
nG1bpt; G1bqdG1b


; (3.22)
where
dCCGLUT pt; G1bq
dt
 dCCGLUT pt; G1aq
dt

#
RGLUT for CGLUT ptq ¡ 0;
0 for CGLUT ptq  0:
(3.23)
It should be noted that the derivatives in Equation (3.23) are full derivatives not partial
derivatives for the reasons previously discussed in Section 2.2.1.
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Non-Dimensionalisation of the Equations
In order to remove any potential numerical problems caused by very large and very small
scales the system may be non-dimensionalised. By non-dimensionalising the system of
equations it may be possible to reduce the number of dependent parameters making the
system more tractable.
The rst step in the non-dimensionalisation process is to introduce new, dimensionless
variables ~t, ~
G', ~G1a , ~G1b , ~MAIN , ~nG'p~t; ~G'q, ~nG1ap~t; ~G1aq, ~nG1bp~t; ~G1bq, ~nMAINp~t; ~MAINq,
~Cp~t; ~G1bq and ~CGLUT p~tq. Since time and age progress at the same rate and have the same
units (units of time) it seems sensible to scale all the ages and time by the same amount.
It also seems sensible to scale the cell densities in the dierent compartments by the same
rate. If this is not done this may lead to misleading phase distributions. CCGLUT pt; G1bq
and CGLUT ptq are not scaled by the same amount as these refer to the intracellular and
intercellular glutamine levels which will normally dier by several orders of magnitude.
Hence we let
~t  t
b
; (3.24a)
~
G' 

G'
b
; (3.24b)
~G1a  G1ab ; (3.24c)
~G1b 
G1b
b
; (3.24d)
~MAIN  MAIN
b
; (3.24e)
~n
G'p~t; ~G'q 
n
G'pt; G'q
a
; (3.24f)
~nG1ap~t; ~G1aq  nG1apt; G1aqa ; (3.24g)
~nG1bp~t; ~G1bq 
nG1bpt; G1bq
a
; (3.24h)
54 3.2 A Simplied Age Structured Partial Dierential Equation Model
~nMAINp~t; ~MAINq  nMAINpt; MAINq
a
; (3.24i)
~Cp~t; ~G1bq 
CCGLUT pt; G1bq
c
; (3.24j)
~CGLUT p~tq  CGLUT ptq
g
: (3.24k)
Substituting the non-dimensional variables into Equations (3.15-3.23) gives
G1a Compartment Equations
a
b
B
B~t ~nG1ap~t; ~G1aq  
a
b
B
B~ ~nG1ap~t; ~G1aq  0: (3.25)
G1a Compartment Initial Conditions
a~nG1ap~t; 0q 
#
2a~nMAINp~t; ~TMAINq for g ~CGLUT p~tq ¡ 0;
0 for g ~CGLUT p~tq  0:
(3.26)
G1b Compartment Equations
a
b
B
B~t ~nG1bp~t; ~G1bq  
a
b
B
B~ ~nG1bpt; G1bq  R2G1bp~nG1bp~t; ~G1bq; ~G1bq  0; (3.27)
where
R2G1bpa~nG1bp~t; ~G1bq; b~G1bq 
$&%
aRGLUT ~nG1b p~t;~G1b q
SMAXc ~Cp~t;~G1b q
for g ~CGLUT p~tq ¡ 0;
0 for g ~CGLUT p~tq  0:
(3.28)
Let ~R2G1bp~nG1bp~t; ~G1bq; ~G1bq be dened as
~R2G1bp~nG1bp~t; ~G1bq; ~G1bq  R2G1bpa~nG1bp~t; ~G1bq; b~G1bq: (3.29)
Therefore
~R2G1bp~nG1bp~t; ~G1bq; ~G1bq 
$&%
aRGLUT ~nG1b p~t;~G1b q
SMAXc ~Cp~t;~G1b q
for g ~CGLUT p~tq ¡ 0;
0 for g ~CGLUT p~tq  0:
(3.30)
G1b Compartment Initial Conditions
a~nG1bp~t; 0q  a~nG1ap~t; ~TG1aq   a~nG'p~t; ~TG'q: (3.31)
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MAIN Compartment Equations
a
b
B
B~t ~nMAINp~t; ~MAINq  
a
b
B
B~ ~nMAINp~t; ~MAINq  0: (3.32)
MAIN Compartment Initial Conditions
a~nMAINp~t; 0q 
$&%
³ ~TG1b
0
abRGLUT ~nG1b p~t;~G1b q
SMAXc ~Cp~t;~G1b q
d~G1b for g
~CGLUT p~tq ¡ 0;
0 for g ~CGLUT p~tq  0:
(3.33)
Equations (3.25-3.33) may be simplied by choosing c  SMAX and b  SMAXRGLUT . Note a
may be chosen arbitrarily, so to normalise the total cell count it is chosen to equal the
starting number of cells, a  ³TG'0 nG'p0; qd . Equations (3.25-3.33) now become
G1a Compartment Equations
B
B~t ~nG1ap~t; ~G1aq  
B
B~ ~nG1ap~t; ~G1aq  0: (3.34)
G1a Compartment Initial Conditions
~nG1ap~t; 0q 
#
2~nMAINp~t; ~TMAINq for g ~CGLUT p~tq ¡ 0;
0 for g ~CGLUT p~tq  0:
(3.35)
G1b Compartment Equations
B
B~t ~nG1bp~t; ~G1bq  
B
B~ ~nG1bpt; G1bq   R^2G1bp~nG1bp~t; ~G1bq; ~G1bq  0; (3.36)
where
R^2G1bp~nG1bp~t; ~G1bq; ~G1bq 
$&%
~nG1b p~t;~G1b q
1 ~Cp~t;~G1b q
for g ~CGLUT p~tq ¡ 0;
0 for g ~CGLUT p~tq  0:
(3.37)
G1b Compartment Initial Conditions
~nG1bp~t; 0q  ~nG1ap~t; ~TG1aq   ~nG'p~t; ~TG'q: (3.38)
MAIN Compartment Equations
B
B~t ~nMAINp~t; ~MAINq  
B
B~ ~nMAINp~t; ~MAINq  0: (3.39)
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MAIN Compartment Initial Conditions
~nMAINp~t; 0q 
$''''&''''%
» ~TG1b
0
~nG1b p~t;~G1b q
1 ~Cp~t;~G1b q
d~G1b for g
~CGLUT p~tq ¡ 0;
0 for g ~CGLUT p~tq  0:
(3.40)
In order to choose g the equation for the intercellular glutamine given by Equation (3.22)
is changed into a non dimensional form. Using the substitutions given in Equations (3.24a,
3.24c, 3.24d, 3.24g, 3.24h and 3.24k) into Equation (3.22) gives
g
b
d ~CGLUT p~tq
d~t
 aRGLUT
» ~TG1a
0
~nG1ap~t; ~G1aqd~G1a  
» ~TG1b
0
~nG1bp~t; ~G1bqd~G1b

; (3.41)
i.e.
d ~CGLUT p~tq
d~t
 ab
g
RGLUT
» ~TG1a
0
~nG1ap~t; ~G1aqd~G1a  
» ~TG1b
0
~nG1bp~t; ~G1bqd~G1b

: (3.42)
It should be noted the constant RGLUT dened in Equation (3.23) is not rescaled. A
natural choice for g is therefore g  abRGLUT  SMAX
³T
G'
0 nG'p0; qd .
The non-dimensionalisation that has been described in this section forms the basis for any
non-dimensionalisation which will be used. It is clear from the non dimensionalisation
that the form of the transition function plays an important role in the choice of the
appropriate scaling constants. As such a specic non-dimensionalisation will be briey
outlined for the new transition function detailed in Section 3.3.
3.3 Transition Functions
In the literature there are a number of dierent functions describing the transition of cells
between the G1 and S phases of the cell cycle ( [6], [22], [23] and [57]). In this section two
dierent approaches for deriving the transition function are detailed. A constant transition
function of the form used in [6] is then briey discussed. The quadratic and sigmoidal
functions used in ( [22], [23] and [57]) are then discussed in detail, with respective aws
highlighted. A new, sigmoidal transition function is then presented together with the
appropriate non-dimensionalisation of the system.
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3.3.1 Derivation of Transition Functions
The probability of a cell leaving the G1b phase and entering the S phase via the transition
rule is given by some probability distribution function fpxq where x is the variable that
determines how likely cells are to undergo transition, for example, age, mass or concentra-
tion of some nutrient. Figure 3.5 gives a graphical representation of a typical biologically
reasonable probability distribution function with phase age G1b acting as the variable
controlling the transition probability. Figure 3.5 shows that the probability of transition
is low for cells that have only recently joined the G1b phase, as they have not had the
time to acquire the nutrients needed to successfully complete the cycle. The probability
then peaks for a range of G1b and tails o for cells which have been in the G1b phase
for a long period of time. Note that phase age is the length of time a cell spends in a
particular phase. For the rest of this derivation the subscripts have been removed from
the age variable for ease. If  varies by a small amount,  , then the probability of cells
Figure 3.5: Probability Distribution of Transition, fpq Showing the Probability that a
Cell of Age  has not yet Transitioned (Shaded Region) and the Probability a Cell of Age
 will Transition in the Time Interval  to     (Dark Region).
whose age is in r;    q transitioning can be approximated by fpq . Assuming all
cells are capable of transitioning given enough nutrients, the total area under the prob-
ability distribution curve is one. Therefore the probability that a cell of age  has not
yet transitioned is given by 1  ³
0
fp 1qd 1. So the fraction of cells, who have not gone
through transition, who go through transition when their age changes from  to     is
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given by
fpq
1 ³
0
fp 1qd 1 : (3.43)
Another way of considering the number of cells going through transition is via a transition
rate hpq. The fraction of cells who leave in the time period rt; t  tq is given by rate
cells leave  time i.e hpqt, then by denition this must be equal to Equation (3.43).
Therefore,
hpq  fpq
1 ³
0
fp 1qd 1

t
; (3.44)
which, in the limit tÑ 0, becomes
hpq  fpq
1 ³
0
fp 1qd 1
d
dt
: (3.45)
Since a cell ages at the same rate as time passes ptq  tc where c is a constant therefore
d
dt
 1 hence Equation (3.45) simplies to
hpq  fpq
1 ³
0
fp 1qd 1 : (3.46)
If the cumulative probability of cells transitioning, F pq, is considered instead of the
probability distribution, fpq, then Equation (3.46) may be expressed as
hpq  F
1pq
1 F pq ; (3.47)
where the dash notation denotes the derivative with respect to  . It is this form of the
transition rate which is most frequently used and will be used herein.
An alternative approach for deriving the transition rate is detailed in [32]. The material
leaving in the time period rt; t  tq is equal to the ow rate Qptq multiplied by the time
interval t multiplied by the age distribution of the exit stream Eptq. Clearly this must
be equal to the volume V multiplied by the age distribution of the material which has
not left prior to time t, Ipq  1 ³
0
fp 1qd 1 multiplied by the fraction which will leave
over the time period t i.e. pqt. Thus,
Flow Rate time interval age distribution of exit stream

Volume age distribution of population fraction that will leave over t;
(3.48)
3.3 Transition Functions 59
or, using the same notation as [32],
Qptq  Epq  t  V  Ipq  pqt: (3.49)
In this notation pq can be thought of as the transition rate for material of age  . Also,
if the ow is constant and normalised such that Q
V
 1 Equation (3.49) simplies to
pq  Epq
Ipq ; (3.50)
where Epq corresponds to the probability distribution fpq. Since Ipq  1 ³
0
fp 1qd 1
Equations (3.47) and (3.50) are equivalent.
3.3.2 Constant Transition Function
In [6] a constant transition function, h  c, is used at the G1  S phase checkpoint.
Such a transition function is therefore independent of the time spent in the G1b phase
and is therefore not biologically realistic as it implies all cells in the G1b phase have
an equal probability of progressing to the S phase regardless of how long they have
spent acquiring nutrients and preparing for DNA synthesis. However, the use of such a
transition function may be justied and the eects of using a constant transition function
are discussed further in Section 3.5.1 To obtain the cumulative probability distribution
F pq for a constant transition function it is necessary to substitute h  c into Equation
(3.47) which gives
c  F
1pq
1 F pq : (3.51)
Assuming that the cumulative probability is zero at a phase age of zero this dierential
equation for F pq may readily be solved to give
F pq  1 ec : (3.52)
3.3.3 Quadratic Transition Function
In [22] the rate of transition is given as the derivative of a function dened as the fraction
of cells whose phase age was 0 at time tG1b that still remain in G1b at time t (note these
cells now have a cell age of G1b). This is given as a function of intracellular glutamine
Cc1G1bpt; G1bq. The expression for this function is dened as
nG1bpt; G1bq
nG1bpt G1b ; 0q
 pCc1G1bpt; G1bq  SMaxq
2
S2Max
; (3.53)
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where SMax is the maximum glutamine content a cell may have before being forced to
go through transition. From Equation (3.53) it follows that the cumulative probability of
transition, F pt; G1bq, is given by
F pt; G1bq  1 pCc1G1bpt; G1bq  SMaxq
2
S2Max
: (3.54)
A plot of this cumulative probability function for an arbitrary t is shown in Figure 3.6.
From Equation (3.54) it follows
Figure 3.6: Sketch of a Quadratic Cumulative Probability Distribution Function for an
Arbitrary Time for the Transition Function Presented in [22].
BF
BG1b
 2pCc1G1bpt; G1bq  SMaxq
S2Max
BCc1G1bpt; G1bq
BG1b
: (3.55)
Substituting Equations (3.54) and (3.55) into Equation (3.47) yields
hpt; G1bq   2pCc1G1b pt;G1bqSMaxqpCc1G1b pt;G1b qSMaxq2
BCc1G1b pG1b q
BG1b ;
 2
SMaxCc1G1b pt;G1b q
BCc1G1bpt;G1b q
BG1b :
(3.56)
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This diers by a minus sign from the expression in [22] however, it can be seen that this
version is correct since hpt; G1bq is now ¥ 0 for all Cc1G1bpt; G1bq. It is assumed that the
intracellular glutamine never decreases, hence
BCc1G1b pt;G1b q
BG1b is always ¥ 0. It is worth
noting that if the glutamine in the extra cellular medium is suciently abundant the
uptake rate will be constant, and as such the intracellular glutamine and transition rate
will now only be functions of cell age.
This transition rule has the major aw that when Cc1G1bpt; G1bq  SMax, which is a
biologically realistic possibility, it is undened, this problem was mentioned in [57], who
proposed an alternative transition function.
To obtain the transition rule given in [22] it is possible to work backwards, allowing the cor-
responding cumulative probability distribution to be found. By substituting hpt; G1bq 
2
Cc1G1b pt;G1b qSMax into Equation (3.47) then solving the corresponding dierential equation
for F pt; G1bq gives a cumulative probability distribution of
F pt; G1bq  1
S2Max
pSMax  Cc1G1bpt; G1bqq2
: (3.57)
Figure 3.7 shows a plot of this function. Since the cumulative probability distribution
must always be positive and monotonically increasing this function is incorrect.
3.3.4 Sigmoidal Transition Function
The problems arising from the quadratic transition function tending to innity as
Cc1G1bpt; G1bq Ñ SMax were addressed by [57] who proposed a sigmoidal shaped cumu-
lative probability function for the transition of cells between the G1 and S phases of the
cycle.
In [57] the rate of transition is given as the derivative of a function dened as the fraction
of cells whose phase age was 0 at time t  G1b that still remain in G1b at time t. The
expression for this function is dened as
nG1bpt; G1bq
nG1bpt G1b ; 0q
 1 1
1  eG1b rSdG1bs ; (3.58)
where G1b and dG1b are parameters. It is not stated explicitly in [57] but it is implied
that S used in [57] is the same as Cc used in [22], this is the intracellular glutamine
and corresponds to Cc and CCGLUT used in Section 2.2.1. As such, it is assumed S is
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Figure 3.7: Sketch of the Quadratic Cumulative Probability Distribution Function for an
Arbitrary Time Presented in [22].
dependent on cell phase age G1b and possibly time, although this is not in the formula
given in [57]. If S is meant to be constant this will make the cumulative fraction of cells
transitioning constant and hence the transition rate will be zero. For clarity Ccpt; G1bq
will replace Spt; G1bq and the glucose concentration in the medium will be denoted by
CMedptq.
In [57] the right hand side of Equation (3.58) is used as the cumulative probability distri-
bution function F . However the left hand side of this equation relates to the fraction of
cells of age G1b remaining in the G1b phase, 1  F . This can easily be shown by setting
G1b and Ccpt; G1bq to zero in Equation (3.58) giving
nG1bpt; 0q
nG1bpt; 0q
 1 1
1  eG1bdG1b ; (3.59)
clearly the left hand side is one, for all values of G1b and dG1b used in [57] these are
both strictly non zero and positive hence for Equation (3.59), LHS  RHS. It is therefore
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assumed Equation (3.58) should read
nG1bpt; G1bq
nG1bpt G1b ; 0q
 1  e
G1bdG1b
1  eG1brCcpt;G1b qdG1bs
; (3.60)
giving the cumulative probability of transition as
F pt; G1bq  1
1  eG1bdG1b
1  eG1brCcpt;G1b qdG1bs
: (3.61)
The transition function, hpt; G1bq, is readily obtained by substituting (3.61) and its de-
rivative into Equation (3.47) to give
hpt; G1bq 
G1be
G1brCcpt;G1b qdG1bs

1 eG1brCcpt;G1b qdG1bs
2

1 eG1brCcpt;G1b qdG1bs
1 BCcpt;G1b qBG1b ;
 G1be
G1brCcpt;G1b qdG1bs
1 eG1brCcpt;G1b qdG1bs
BCcpt;G1b q
BG1b :
(3.62)
Upon careful scrutiny of the FORTRAN code for the model presented in [57] it can be seen
that this is not the function actually used. Instead,
Tr  hpt; G1bq  1
1
1  eG1brCcpt;G1b qdG1bs
; (3.63)
this is the function used as F pt; G1bq in the main body of the text. To check the validity
of the transition function hpt; G1bq used in the FORTRAN code it is necessary to rearrange
the formulae
Tr  1 1
1 eG1brCcpt;G1b qdG1bs ;
 eG1brCcpt;G1b qdG1bs
1 eG1brCcpt;G1b qdG1bs ;
(3.64)
which diers from Equation (3.62) only by a factor of 
BCcpt;G1b q
BG1b . Because it only diers
by a factor this may still be a valid transition rule. To check the validity of this rule it
is necessary to specify Ccpt; G1bq. It is reasonable to assume that Ccpt; G1bq takes the
same form as described in Equation (2.42), i.e. Ccpt; G1bq  RG1b where R is a constant.
Making this assumption simplies Equation (3.63) to
hpG1bq  1
1
1  eG1brRG1bdG1bs
: (3.65)
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Figure 3.8: A Plot of F pG1bq as Dened in Equation (3.61) with Ccpt; G1bq  RG1b
Where R is a Constant for R  0:1, dG1b  1 and G1b  5.
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Figure 3.9: A Plot of F pG1bq as Dened in Equation (3.67) for R  0:1, dG1b  1 and
G1b  5.
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Substituting for hpG1bq from Equation (3.65) into Equation (3.47) and rearranging gives
the dierential equation
dF pG1bq
dG1b
 p1 F pG1bqq

1 1
1  eG1brRG1bdG1bs


: (3.66)
Solving Equation (3.66) together with the initial condition F p0q  0 yields
F pG1bq  1
"
1  eG1bdG1b
1  eG1brRG1bdG1bs
* 1
RG1b
: (3.67)
The function F pG1bq now goes from zero to one and is therefore a valid cumulative
distribution. Thus, despite the inconsistency between the FORTRAN code and the main
body of text [57] uses a valid transition function. Plots of F pG1bq as dened in Equation
(3.61) with Ccpt; G1bq  RG1b where R is a constant and F pG1bq as dened in Equation
(3.67) are shown in Figures 3.8 and Figures 3.9 for the same parameter values.
3.3.5 New Sigmoidal Transition Function
The sigmoidal form of the transition rule seems biologically reasonable as it is sensible to
assume the probability of cells progressing to the S phase immediately after entering the
G1b portion of the G1 phase is low due to the limited amount of nutrients they have taken
up. Once the amount of nutrients taken up reaches some critical value then the probabil-
ity of transition is likely to increase considerably, however there will always be a few cells
which do not progress to the S phase regardless of nutrient uptake. Furthermore, a sig-
moidal cumulative probability function is in keeping with the phase transition seen in cell
populations which have been modelled using the kinetics and chemical processes within
the cell [49] and [53]. A new sigmoidal transition rule is therefore proposed which, unlike
the one considered in [57], may be non-dimensionalised so there is only one independent
parameter which needs to be tted, making the problem more tractable.
Consider a cumulative distribution function given by
F pt; G1bq  1
1  e 2
1  e

Ccpt;G1b q
S
 1
2

 ; (3.68)
where  and S are parameters which need to be tted. Substituting Equation (3.68) into
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Equation (3.47) gives
hpt; G1bq 

S
BCcpt; G1bq
BG1b
e


Ccpt;G1b q
S
 1
2


1  e

Ccpt;G1b q
S
 1
2

 : (3.69)
As with the other transition rules discussed previously it is reasonable to assume that the
rate of change of intracellular glutamine is constant, provided there is a high amount of
glutamine available. The case of limited glutamine availability is considered in Appendix
A. By making the assumption that the rate of change of intracellular glutamine is constant
and Ccpt; G1bq  0 at G1b  0, then BCcpt;G1b qBG1b  R and Ccpt; G1bq  RG1b . Equation
(3.69) is now simplied to
hpG1bq 
R
S
e


RG1b
S
 1
2


1  e

RG1b
S
 1
2

 : (3.70)
In this transition function  is related to the maximum value of the cumulative distribution
function and S is related to the steepness of the sigmoidal function.
Non-dimensionalisation Using the New Transition Function
The choice of the new variables obtained in the non-dimensionalisation process, previously
discussed, depend largely on the transition function. As such, it is sucient to only
consider the non-dimensionalisation of the equations for the G1b part of the G1 phase to
determine the new variables. For the G1b compartment the equation governing the cell
density is given by Equation (3.17), which using the transition function given in Equation
(3.70), becomes
B
BtnG1bpt; G1bq  
B
B nG1bpt; G1bq  
R
S
e


RG1b
S
 1
2


1  e

RG1b
S
 1
2

nG1b : (3.71)
Upon making the substitutions given by Equations (3.24b, 3.24d and 3.24h) this becomes
a
b
B
B~t ~nG1bp~t; ~G1bq  
a
b
B
B~ ~nG1bp~t; ~G1bq  
R
S
e


Rb~G1b
S
 1
2


1  e

Rb~G1b
S
 1
2

a~nG1b ; (3.72)
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i.e.
B
B~t ~nG1bp~t; ~G1bq  
B
B~ ~nG1bp~t; ~G1bq  
Rb
S
e


Rb~G1b
S
 1
2


1  e

Rb~G1b
S
 1
2

 ~nG1b : (3.73)
By setting b  S
R
this simplies to
B
B~t ~nG1bp~t; ~G1bq  
B
B~ ~nG1bp~t; ~G1bq  
ep~G1b 2q
1  ep~G1b 2q
~nG1b : (3.74)
3.4 Numerical Scheme
The system of dierential equations governing the simplied system described in Sec-
tion 3.2 may be solved analytically for specic initial conditions and short time intervals.
However, in order to be able to study and manipulate the model for dierent transition
functions for longer time intervals involving many cell cycles it is necessary to use numer-
ical techniques.
Derivation of Numerical Scheme
In this section a nite dierence scheme analogous to the Lax-Wendro scheme is derived.
The Lax-Wendro scheme was chosen as it is a second order explicit method and as
such yields high accuracy for relatively large time steps where there is a rapid change or
discontinuity such as the initial ow of cells into the main cycle. The non dimensionalised
form of the Equation (3.17) may be written as
nt   n  hn: (3.75)
Note for ease the time and age dependence has been omitted together with the phase
subscript. Subscripts now denote the partial derivatives. Also h is a assumed to be a
function of  only. Rearranging and dierentiating Equation (3.75) gives
nt  n  hn; (3.76a)
ntt  nt  hnt; (3.76b)
nt  n  hn  hn: (3.76c)
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The Taylor expansion of n is given by
npt  t; q  n  tnt   ptq
2
2
ntt  Opttu3q; (3.77)
which, on substitution from Equations (3.76), becomes
npt  t; q  n  tpn  hnq   ptq
2
2
pnt  hntq  Opttu3q; (3.78)
i.e.
npt  t; q  n  tpn  hnq   ptq
2
2
pn   2hn   h2n  hnq  Opttu3q: (3.79)
Choice of the Transition Function, h
The non-dimensionalised form of the new transition rule has been chosen for use in this
numerical scheme,
h  e
p 
2
q
1  ep 2 q : (3.80)
It is also worth noting that
h  e
p 2q
1  ep 2q

!
ep 2q
)2
!
1  ep 2q
)2  h h2: (3.81)
Substituting for h and its derivative into Equation (3.79) and simplifying gives
npt  t; q  n tpn   hnq   ptq
2
2
pn   2hn   hnq  Opttu3q: (3.82)
Collecting the derivatives of n together this becomes
npt  t; q  n

1 th  ptq
2
2
h


  n
 t  ptq2h  n ptq2
2
 Opttu3q: (3.83)
Finally, standard formulae for the rst and second derivatives of n with respect to  are
used, namely
n


i;j
 ni;j 1  ni;j1
2
; (3.84)
2n
 2

i;j
 ni;j1  2ni;j   ni;j 1pq2 ; (3.85)
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where ni;j is the cell density of cells aged rjs; pj  1qsq in the time interval rits; pi  1qtsq
where ts and s are the length of the discretised elements. This leads to the nite dierence
scheme
ni 1;j  ni;j

1 thi;j   ptq
2
2
hi;j


  ni;j 1  ni;j1
2
 t  ptq2hi;j
  ni;j1  2ni;j   ni;j 1pq2
ptq2
2
:
(3.86)
Which, on re-arranging becomes
ni 1;j  ni;j

1 ptq
2
pq2  thi;j  
ptq2
2
hi;j


  ni;j 1
 ptq2
2pq2 
t
2
  ptq
2
2
hi;j


  ni;j1
 ptq2
2pq2  
t
2
 ptq
2
2
hi;j


:
(3.87)
Because of the `dispersive' nature of any numerical dierence scheme if   t additional
errors are introduced at each time step. For example if at t  0 all cells are age zero and
the age step is set to  and the time step set to 
2
, then after evolving the system for one
time step there would be cells whose age is , this clearly makes no sense. Similarly if the
time step is set to 2 after one step there are no cells present whose age is 2 since  ¤ 
for all cells. Hence, additional interpolation is required if the age and time steps are not
equal. By setting t     Equation(3.87) becomes
ni 1;j  ni;j
"
2
2
 


hi;j
*
  ni;j 1

2
hi;j
	
  ni;j1

1 
2
hi;j
	
: (3.88)
3.4.1 Stability of the Numerical System
For a numerical scheme to produce accurate solutions to a partial dierential equation,
not only must the error at each time step be small enough, any errors must not grow
exponentially, i.e. the numerical scheme must also be stable. If the nutrient supply is
unlimited and uptake is uniform then the cell cycle may be simplied into two `phases',
G1b on it's own and the remaining phases all put together. A two compartment model is
not suitable for analysing the dynamics of a population of cells as too much information
is lost by combining the MAIN phase and G1a phases of the model discussed in Section
3.2, in particular the timing of the cell division. However, a two compartment model is
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sucient for conducting a stability analysis. Once the system has reached steady growth
(i.e. no further input from G11) then it may be represented as shown in Figure 3.10 where
X and Y represent the two `phases'. To perform the stability analysis the time step
matrix is constructed, the norm of which is shown to be bounded. It is helpful to start
by dening some notation.
s
XY
Cell Death
hpvq
2

-
Figure 3.10: Illustration of the Two Compartment Model Used in the Stability Analysis
of the Numerical Scheme.
Notation
If the numerical scheme is discretised into elements of time of length ts and age elements of
length s then let cells in phaseX of age P ris; pi 1qsq in the time interval P rjts; pj 1qtsq
be denoted by X ij. Also let all cells in phase X in the time interval P rmts; pm  1qtss be
denoted by Xm, where Xm is now a column vector. Also assume the time line is moved
such that at t  t0; t1  0, where t1 is the time used for the purposes of the subscript; for
convenience the 1 notation is now dropped.
Construction of the Time Step Matrix
Let the maximum durations of the X and Y phases be Ns and Ks respectively then at
time t  t0,
X00 cells entering X;
XN10 cells in X dying due to old age at the next time step,
Y 00 cells entering Y;
Y K10 cells leaving Y and doubling at the next time step.
(3.89)
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Clearly,
X0a  2Y K1a1 : (3.90)
Also the cells entering Y are a function of the cells who were in X at the previous time
step, therefore
Y 0a  hpXa1q; (3.91)
where hpvq is the probability of transition from X to Y . Since nothing happens to the
cells during their time in Y , it can be thought of as merely a time delay phase, therefore
Y ja  Y j1a1 for 1 ¤ j   K: (3.92)
Note, the inequality is strictly less than K as cells of age Ks have undergone division
and the ospring are now in X0a .
Assuming a nite central dierence scheme is used for calculating the cell densities in the
X phase then
X ia  fpX i1a1; X ia1; X i 1a1q for 1 ¤ i   N; (3.93)
and
XNa  fpXN1a1 ; XNa1q: (3.94)
From equations (3.90) and (3.92) it is clear that
X0a  2Y K1a1  2Y K2a2  : : :  2Y 0aK : (3.95)
Now using equation (3.91) yields
X0a  2hpX0aK1q: (3.96)
Equations (3.90-3.96) may be expressed in matrix notation as
X0m 1
X1::N2m 1
XN1m 1
Y 0m 1
Y 1::K1m 1

M

X0m
X1::N2m
XN1m
Y 0m
Y 1::K1m

; (3.97)
where M is an pN   Kq  pN   Kq matrix. Details of the construction of M may be
found in Appendix B.
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To prove the numerical scheme is stable it is sucient to show [58] that the norm of M
in Equation (3.97) satises M ¤ 1  ; (3.98)
where t     and  is a constant independent of . In Appendix C the existence
of  is discussed. It can be shown that if the trapezium rule is used for approximating
Equation (3.91) then the norm of M is given by
M  supt2;  N2¸
j1
hpjq   
2
php0q   hpN  2qqu: (3.99)
For the transition functions considered h is monotonically increasing so

N2¸
j1
hpjq   
2
php0q   hpN  2qq ¤ 
» Xmax
0
hpqd; (3.100)
it is therefore sucient to show 
³Xmax
0
hpqd remains bounded. For the sigmoidal
transition rule » Xmax
0
ep 2q
1  ep 2q
d 

ln

1  e 2
	Xmax
0
; (3.101)
which for typical  values this is approximately equal to ln

1  eXmax 2
	
. For Xmax ¤ 2
then
ln

1  eXmax 2
	
 eXmax 2 ¤ 1: (3.102)
For Xmax ¡ 2 then
ln

1  eXmax 2
	
 Xmax  2 : (3.103)
Thus, in all cases
M remains bounded. In most cases  Xmax  2   1, this leads to
a stronger constraint on the bound i.e.
M ¤ 2. An alternative approach for showingM remains bounded is given in Appendix C.
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3.5 PDE Model Validation and the Eect of The Transition Func-
tion
The new, three compartment age structured model has two fewer phases than the Cel-
CyMUS model. Additionally, a new sigmoidal transition function has been implemented.
To test the validity of the new model comparisons are needed with experimental data.
Experimental data from [31] was chosen and concerns a batch experiment which was con-
ducted using a mouse-mouse hybridoma cell line (mm321). This data was chosen as it
allowed a direct comparison between the tting of the three compartment model and the
CelCyMUS model. This is discussed at the end of this section. In this experiment 28 %
of the starting cell population did not divide but remained viable, 36 % of the starting
population were evenly distributed in the S phase of the cell cycle and the remaining
36 % were initially at the beginning of the G1b phase. For the purposes of modelling it
was assumed the cells starting in the G1b phase were of a phase age between zero and
two hours. The numerical scheme described in Section 3.2, was implemented using both
sigmoidal and constant transition (h  c) functions. Parameters for the length of dierent
phases were taken from [23], and are stated in Table 3.1. The  and c parameters were
allowed to vary in the sigmoidal and constant transition rules respectively, until a best t
had been obtained. Several starting values for  and c were used in the optimisations of
the ts to ensure the global best ts had been found for each transition rule and that the
results were not a local minimum. Optimisations were carried out using Matlab's [44] least
squares curve tting algorithm lsqcurvefit. The Matlab code for these optimisations is
available from [15].
Parameter Notation Value
Maximum age in G1a phase TG1a 2.5 hours
Maximum age in G1b phase TG1b 10 hours
Maximum age in S phase TS 5 hours
Maximum age in G2  M phase TG2 M 4 hours
Table 3.1: Parameters from [23].
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As can be seen in Figure 3.11, both the constant transition rule (Figure 3.11a) and the
sigmoidal rule (Figure 3.11b) provide a good t to the experimental data resulting in
residual norm values of 0.1 and 0.2 respectively. The parameters in Table 3.1 were varied
by 20%. Dierent values for the Table 3.1 parameters resulted in dierent values for
the tted parameters ( and c) values but did not signicantly change the goodness of
the t shown in Figure 3.11 with no residual norms exceeding 0.2. Note that the model
did not impose any restrictions on the available nutrients, indicating nutrients were not
a limiting factor for cell growth over the course of the experiment. This suggests, that if
population growth is the only concern, that a constant transition rule is sucient.
No measure of goodness of t was provided in [23], however visual inspection of Figure 2
in [23] indicates that the t to the experimental data provided by the three compartment
model is comparable to that of the CelCyMUS model.
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3.5.1 The Eect of the Transition Function
Although the eect of the dierent transition functions is not apparent in the tting of
the model to the experimental growth curve, the transition function does impact on the
phase distribution of cells.
In the experimental data used to validate the model the initial population of cells was
partially synchronised using a thymidine double block. Full details of this block can
be found in [31]. This partial synchronisation meant the initial population of cells was
situated in the S phase and the latter part of the G1 phase, i.e. the G1b compartment. It
therefore seems reasonable to assume that most cells will initially progress round the cycle
in a group. This grouping would result in the phase distribution being oscillatory. The
oscillations would be expected to decay slowly as the synchronicity of the cell population
was lost. Such oscillations may be one cause for apparent `errors' in phase distributions
obtained from such experiments as the timing of observations would need to occur at
known positions on the oscillation, the period of which may not be known. The time
scale required for the transient oscillations to have decayed suciently is of the order of
500 hours, at this point the population of cells is undergoing exponential growth and has
a steady DNA distribution. Due to the length of time needed for this to occur and the
number of data points required it is not feasible to obtain experimental data.
To fully appreciate the dierences these transition functions have on the underlying model
properties the percentages of cells in each compartment may be compared once transient
oscillations have decayed and the system has reached a steady state of phase distributions.
In order to investigate this, the mathematical model was numerically integrated using the
same parameters and initial conditions used in Section 3.5 for long enough that a steady
phase distribution had been obtained for both the sigmoidal and constant transition
functions. The results are shown in Figure 3.12. The two resulting phase distributions
dier in two important ways. Firstly, both simulations initially show an oscillation in the
phase distribution, however the rate of decay of the oscillations depends on the transition
function chosen, with the oscillations decaying much more slowly for a sigmoidal transition
function. The dierence in the decay rates may be appreciated by considering the area
under the cumulative probability function F for the dierent transition functions (Figures
3.13 and 3.14). For a steep sigmoidal probability distribution function the area under the
curve initially increases slowly then has a rapid increase for a short time interval then
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returns to a slow increase as shown in Figure 3.14. This rapid increase would result in the
majority of the population remaining in a group as it progressed round the cycle, with
each complete cycle the population would disperse slightly due to the ages corresponding
to a low probability of transition. With the value of the constant transition function used
in this simulation the area under the corresponding cumulative probability distribution
function does not change as rapidly as with the sigmoidal function as shown in Figure
3.13. This results in the population of cells transitioning more evenly, leading to a more
rapid de-synchronisation. The second important dierence between the two simulations
is that once the transient oscillations have decayed the percentages of cells in each of the
model's `phases' dier: in the sigmoidal transition rule there are 20.2%, 33.3% and 46.5%
in the G1a, G1b and MAIN phases respectively, whereas in the constant transition rule
these change to 22.6%, 24.4% and 53.0%.
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It has been shown that an age-structured population balance model provides a good t to
a growth curve obtained experimentally. The model shows however there is a noticeable
change in the proportion of cells in each phase for the two dierent transition functions
considered. The sigmoidal transition function predicts 53.5% of the cell population being
in the G1 phase, whilst the constant transition function places 47.0 % of cells in the G1
phase. For comparison the CelCyMUS model presented in [23] placed 53.0% of the cell
population in the G1 phase.
Chemotherapy drugs can be divided into several types, each of which target a specic
process within the cell cycle such as RNA synthesis or cell division. Hence the ecacy of
many chemotherapy drugs (e.g. [11], [40] and [50]) is dependent on the cell cycle phase.
The radiosensitivity of cells is also phase dependent (e.g. [13], [43] and [64]) with cells in the
M (mitotic) phase having their chromosomes arranged in a line prior to separation making
them particularly sensitive to ionising radiation. Due to the phase dependent nature of
chemotherapy drugs and radiotherapy, knowledge of how the cells progress through the
dierent phases is crucial. Since the relationship between cell phase and ecacy may
be non-linear a small dierence in phase distribution may produce a large change in the
ecacy of treatments resulting in the model producing results outside the bounds of
experimental error. Therefore, the dierence in the phase distributions produced by this
model, using the dierent transition functions, will eect the model's ability to accurately
represent the eects of a given treatment on a population of cells. Consequently, it is
important to ascertain the correct transition function if such models are to be used to give
a quantitative prediction of the cell population's response to treatments. Whilst there is
no consensus on the error on cell phase distributions obtained using ow cytometry [18] the
dierence in phase distributions produced by the model with the dierent transition rules
lie within the typical bounds of current experimental error ( [18], [19] and [36]). As noted
in Section 3.5.1 the diculty of measuring the phase distribution may be compounded by
underlying oscillations induced by the blocking. Improvements in experimental techniques
may reduce the level of potential error in phase distributions obtained experimentally, this
may allow some transition functions to be discounted.
Thus, the form of the probability distribution function controlling the G1  S checkpoint
in an age structured population balance model has little impact on the models ability
to t to experimental data, due to the typical bounds of experimental error. The lack
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of eect of the form of the probability transition function explains why the quadratic
transition function used in [23] tted experimental data despite having a singularity. As
such, a simplied transition function may be used to gain a qualitative understanding of
the dynamics of a population of cells.
3.6 Ordinary Dierential Equation Model Validation and Compar-
ison of Ordinary Dierential Equation and Partial Dierential
Equation Models
As discussed in Section 2.1.2 it is possible to construct a structured ODE model for the
cell cycle which may be adequate if only a limited amount of information about the
population is required. To determine the suitability of an ODE model for estimating the
total number of cells and the proportion of cells in each phase it is necessary to compare
the results obtained with those from a PDE based model such as that described in Section
3.2. The PDE model described in Section 3.2 consists of three compartments G1a, G1b
and MAIN . Therefore, any ODE model need only distinguish between the G1 phase and
the remainder of the cell cycle. Since the G1a and G1b division concerns the minimum
amount of time a cell must spend in the G1 phase before proceeding through the cycle
it is not possible to include this in an ODE framework as there is no distinction between
cells based upon their age. As such a two compartment ODE model is suitable for this
comparison. Consider a two compartment ODE model. One compartment X, containing
cells in the G1 phase of the cycle and the other compartment Y containing the remainder
of the cell population, as illustrated in Figure 3.15. Let the rate at which cells progress
from the X to the Y compartment occur at a constant rate a and the rate at which cells
leave Y and divide so that two new cells join X occur at the constant rate b, then the
system may be described mathematically by two linear rst order dierential equations,
one for each compartment as
dXptq
dt
 2bY ptq  aXptq;
dY ptq
dt
 aXptq  bY ptq:
(3.104)
whereXptq and Y ptq are the number of cells in the two compartments at time t. Equations
(3.104) may be solved analytically if suitable initial or boundary conditions are known. To
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YX
a
b2b
x2
Figure 3.15: Illustration of a Two Compartment ODE Model.
allow a direct comparison of this ODE model with the PDE model described in Section
3.2 the ODE model may be tted to the experimental data presented in [31]. Unlike
the PDE model where the  and c values were allowed to vary the ODE model has two
parameters, a and b, which need to be optimised to t the growth curve. Several starting
values for a and b were used in the optimisation to ensure the global best ts had been
found and that the results were not a local minimum. Optimisations were carried out
using Matlab's [44] least squares curve tting algorithm lsqcurvefit. Unlike, with the
PDE model, it was found that the ODE model was not very sensitive to the values of a
and b and that dierent combinations of a and b provided good ts to the experimental
data as shown in Figure 3.16. Several such sets of values and the resulting residual norms
are given in Table 3.2 together with the fraction of cells in the Y compartment which is
analogous to the MAIN compartment in the PDE model.
a b Y Percentage Residual Norm of Fit
0.0791 0.1258 32.2 0.16
0.1138 0.0946 41.4 0.18
0.1266 0.0883 49.0 0.18
0.1316 0.0863 50.4 0.18
0.1342 0.0853 51.0 0.18
Table 3.2: Parameters Fitted to A Two Compartment ODE Model.
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Figure 3.16: Growth Curve Produced from a Two Compartment ODE Model Fitted
Against Experimental Batch Data Presented in [23].
By looking at the proportion of cells in the Y compartment it can be seen that the bottom
three rows in Table 3.2 are close to the values obtained using a three compartment PDE
model cf. Figure 3.12. However, it should be noted that using the formulae given in
Equations (2.35-2.38) the average time cells spends in the Xand Y compartments is
approximately 1
a
 7:5 hours and 1
b
 11:5 hours respectively. This is in disagreement
with the experimental values given in Table 3.1. By carefully comparing the growth curves
shown in Figure 3.11 and Figure 3.16 it can be seen that whilst the ODE model produces
a good overall t the growth curve is smooth and does not capture the step like nature
of the experimental data, unlike the PDE model. This is due to the fact that the PDE
model is age structured and can therefore take into account the initial age distribution of
the population of cells.
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In this Chapter two new models were formulated. The rst of these was a structured
ODE model consisting of four compartments, each corresponding to a dierent phase of
the cell cycle, details of which were given in Section 3.1. General results for the phase
distribution of the population were derived. For the specic case where the rate constants
were chosen to all be unity it was shown that the phase distribution of the population
obtained using this model is identical to that given by Steel's formulae. For the more
general case the reasons why the phase distribution obtained using this method diers
from Steel's formulae were discussed.
Using the CelCyMUS model as a starting point a new three compartment, age-structured
PDE model was presented in Section 3.2. Section 3.3 contains a comprehensive review
of the transition functions which model how the cells progress from the G1 to S phase
of the cycle. Existing constant [6], quadratic [22] and [23], and sigmoidal [57] transition
functions were discussed in detail. It was noted that the constant form of the transition
function is independent of the time spent in the G1b phase and is therefore not biologically
realistic as it implies all cells in the G1b phase have an equal probability of progressing
to the S phase regardless of how long they have spent acquiring nutrients and preparing
for DNA synthesis. Despite this it was shown in Section 3.5.1 that the use of such a
transition function may be justied. The mathematical validity of the quadratic transition
function was called into question due to the possible singularity which can occur. This
transition function was therefore deemed unsuitable. The sigmoidal transition function
proposed by [57] was considered but it was noted that the sigmoidal form suggested has
multiple independent parameters when non-dimensionalised, making tting of the model
to experimental data more dicult. Motivated, by the biologically realistic nature of
the sigmoidal transition function given in [57] a new sigmoidal transition function was
presented together with the appropriate non-dimensionalisation consistent with the non-
dimensionalisation given in Section 3.2 for the new simplied age-structured model. This
new sigmoidal transition function has only one independent parameter which needs to be
tted, thus making the problem more tractable.
In Section 3.4 a numerical scheme for the new simplied age-structured model was presen-
ted, together with a discussion on the scheme's stability. It was shown that for a mono-
tonically increasing probability of transition the numerical scheme is stable.
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Section 3.5 saw the simplied age structured model with both constant and sigmoidal
transition functions compared with experimental data. The experimental data chosen
concerned a batch experiment which was conducted using a mouse-mouse hybridoma cell
line (mm321) [31]. It was shown that if population growth is the only concern, that a
constant transition rule is sucient to accurately t the experimental data. However, if
the phase distribution for the cell population is important then the form of the transition
function becomes more critical. Further discussion on this may be found in [16].
The ODE model framework discussed in Section 3.1 was modied to allow direct com-
parision with the PDE model described in Section 3.2. The ODE model was then tted
to the same experimental data as that used in Section 3.5 and the ODE and PDE results
were compared. All of the parameter values obtained in the ODE optimisation provided
a good match to the experimental cell growth curve. The fraction of cells in the dier-
ent compartments varies by 19% whilst lying outside the bounds of experimental error
( [18], [19] and [36]) this is still suciently accurate to gain a qualitative understanding
of the behaviour of the cell population.
From this comparison it may be concluded that if the duration of the phases is not
important and the only information required is a qualitative understanding of the phase
distribution or an approximation on the total number of cells within the population then
a simple ODE model may be used. If a more accurate measure of the phase distribution
of the cell population is required then a PDE or integral equation model may be required.
Chapter 4
Integral Equations for an Age
Structured Population Balance Model
Systems of PDEs governing the cell population density may also be expressed in terms
of integral equations. By converting a system of PDEs to integral equations it may be
possible to utilise dierent analytical techniques to gain a greater understanding of the
system. There may also be computational advantages to using this approach. Much of
the analysis in this chapter is motivated by, and closely follows, work undertaken in [55].
In this chapter a four compartment age-structured model, similar to that discussed in
Section 3.4, is constructed and the corresponding dierential equations for the population
density in each phase are found. Two new functions Mptq and P ptq are introduced, where
Mptq represents the number of cells dividing and P ptq is the total number of cells in
the population. The system is then expressed in terms of integral equations for these
two new functions. Once Mptq and P ptq have been found the integral equations for the
population densities are readily derived by solving the partial dierential equations along
characteristics. It should be noted in this chapter the integral equations are derived and
no analysis of the resulting system is undertaken. The integral equation approach has
been included to indicate alternative methods for the modelling of the cell population are
available.
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4.1 Construction of the Population Balance Model
Consider a cell cycle model comprising of four compartments. The rst of these consists
of the rst part of the G1 phase, G1a, denoted in this chapter by A. The second part B,
contains the latter part of the G1 phase, G1b. The S, G2 and M phases are all contained
in the C compartment. The nal compartment contains non-cycling cells which have
not entered C after reaching the maximum time allowed in the B compartment, the
compartment containing these cells is denoted D. It should be noted that this model is
the same as that described in Section 3.2 with the addition of compartment D. In [55] a
further compartment is added which includes cells which do not divide at the end of C
due to some overcrowding function fpP q; this scenario is not considered here. The model
presented here may be extended to allow some of the population in C to re-enter the
main cycling population at a later stage when the conditions for progression, i.e. nutrient
availability, improve. A graphical representation of this model is shown in Figure 4.1.

hpq
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BC
k
2
^
 ptq+


Figure 4.1: Illustration of a Four Compartment Cell Cycle Model, Including a Quiescent
Phase.
For i P tA;B;C;Du, let nipt; iq denote the population density of cells in the compartment
i at time t and of age i. For ease, the compartment subscript on  will be omitted
throughout this chapter, unless it is ambiguous which i is being referred to. Let Ti be
the maximum duration cells may spend in compartment i. TA, TB and TC are assumed
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to be nite, while TD is innite. In reality TD is also nite as the non-cycling cells will
eventually die then degrade, however for the purposes of this model it is sucient to
assume that it is innite.
Assuming there is no exit from the system then for i P tA;C;Du, nipt; q satises the
PDEs
Bnipt; q
Bt  
Bnipt; q
B  0  P p0; Tiq; t ¥ 0; (4.1)
and BnBpt; q
Bt  
BnBpt; q
B  hpqnBpt; q;  P p0; TBq; t ¥ 0; (4.2)
where hpqq P Cpr0; TBs; r0; 1sq is a transition function, as described in Section 3.3, which
describes the proportion of cells which leave the B compartment and enter the C com-
partment at age  .
The initial conditions for the system are
nip0; q  0  P p0; Tiq; (4.3)
for i P tA;B;C;Du.
The total number of the cells, both cycling and quiescent, is given by P ptq, where
P ptq 
¸
i
» Ti
0
nipt; q d: (4.4)
This is a special case of the P ptq dened in [55]. Here P ptq is dened as
P ptq 
¸
i
» Ti
0
wipqnipt; q d; (4.5)
where wipq is a weighting function which allows cell degradation of the non-cycling cells
in the D compartment to be considered. This is necessary if there is an overcrowding
function that is dependent on P ptq. Since the model considered here does not include any
form of overcrowding this is not needed.
To determine the boundary conditions at i  0 for i P tA;B;C;Du it is rst necessary
to dene Mptq. Let
Mptq  nCpt; TCq; (4.6)
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cf. in [55] Mptq  fpP qnCpt; TCq where f : R  Ñ r0; 1s is a function such that fpP q
describes the proportion of cells which undergo division at the end of the C compartment.
The boundary conditions at   0 for i P tA;B;C;Du are given by
nApt; 0q  2Mptq; (4.7a)
nBpt; 0q  nApt; TAq    ptq; (4.7b)
nCpt; 0q 
» TB
0
hpqnBpt; q d; (4.7c)
nDpt; 0q  nBpt; TBq; (4.7d)
where  ptq is a function which describes how cells enter the system from an initial quiescent
phase, G'.
4.2 Solution of the PDE System
Using the method of characteristics it is possible to express the solution for the system of
PDEs in terms of integrals involving Mptq. It is then possible to obtain an expression for
P ptq. In order to solve the system of PDEs the relative maximum durations of the dierent
compartments are required. By considering the maximum duration of the dierent phases
in a mouse-mouse hybridoma cell line (mm321) [31] it may be assumed TB ¥ TC ¥ TA and
that TA  TC ¥ TB. For dierent cell lines this may not be the case but the methodology
described in this section will work for dierent relative phase age assumptions.
4.2.1 Solution for Compartment A
Using the method of characteristics the solution of the equation for the A compartment
is given by
nApt; q 
$&%nAp0;   tq if t   ;nApt ; 0q if t ¥ ;

$&%0 if t   ;2Mpt q if t ¥ :
(4.8)
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4.2.2 Solution for Compartment B
The solution of the equation for the B compartment is given by
nBpt; q 
$&%nBp0;   tqe
 ³t hpsq ds if t   ;
nBpt ; 0qe
³
0 hpsq ds if t ¥ :
(4.9)
However, from the initial condition given in Equation (4.3) it is clear for t    that
nBpt; q  0. Substituting the solution for nApt; q into Equation (4.7b) gives
nBpt; 0q 
$&% ptq if t   TA;2Mpt TAq    ptq if t ¥ TA: (4.10)
as the boundary condition at   0 for the B compartment. Using these boundary
conditions, together with nBpt; q  0 for t    , Equation (4.9) now becomes
nBpt; q 
$'''&'''%
0 if t   ;
 pt qe ³0 hpsq ds if  ¤ t      TA;
t2Mpt   TAq    pt qu e
³
0 hpsq ds if t ¥    TA:
(4.11)
4.2.3 Solution for Compartment C
The solution of the equation for the C compartment is given by
nCpt; q 
$&%nCp0;   tq if t   ;nCpt ; 0q if t ¥ : (4.12)
From the initial condition given in Equation (4.3) it is clear nCpt; q  0 for t    .
To obtain the solution for t ¥  it is necessary to use the boundary condition given in
Equation (4.7c).
For t   TA the initial assumptions made about the relationships between the maximum
compartment times mean t   TB. Therefore t   TA ñ t   TA    . Thus for 0 ¤ t   TA,
nCpt; 0q 
» TB
0
hpqnBpt; q d;

» t
0
hpqnBpt; q d;

» t
0
hpq pt qe
³
0 hpsq ds d:
(4.13)
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Let ~  t  , then » t
0
d 
» t
0
d~ :
This change of variables is applied to Equation (4.13), which, after dropping the tilde
notation, becomes
nCpt; 0q 
» t
0
hpt q pqe
³t
0 hpsq ds d if 0 ¤ t   TA: (4.14)
For TA ¤ t   TB
nCpt; 0q 
» TB
0
hpqnBpt; q d;

» t
0
hpqnBpt; q d:
(4.15)
Unlike the case t   TA, t may now be      TA or ¥    TA depending on the value of  .
Therefore to calculate the integral given by Equation (4.15) it must be split into the two
cases t TA    and t TA ¥  , i.e.
nCpt; 0q 
» tTA
0
hpqnBpt; q dloooooooooooomoooooooooooon
part (i)
 
» t
tTA
hpqnBpt; q dloooooooooooomoooooooooooon
part (ii)
: (4.16)
For part (i) t ¥    TA, therefore from Equation (4.11) it follows
nBpt; q  t2Mpt   TAq    pt qu e
³
0 hpsq ds: (4.17)
For part (ii) t      TA therefore,
nBpt; q   pt qe
³
0 hpsq ds: (4.18)
Substituting the expressions for nBpt; q given in Equations (4.17-4.18) into Equation
(4.16) gives
nCpt; 0q 
» tTA
0
hpq t2Mpt   TAq    pt qu e
³
0 hpsq ds d part (i)
 
» t
tTA
hpq pt qe
³
0 hpsq ds d part (ii):
(4.19)
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Dene ^  t  and ~  t   TA, then
» tTA
0
d 
» tTA
0
d~ ;
and » t
tTA
d 
» TA
0
d^ :
Using these substitutions Equation (4.19) may now be written as
nCpt; 0q 
» tTA
0
hpt ~  TAq t2Mp~q    p~   TAqu e
³t~TA
0 hpsq ds d~
 
» TA
0
hpt ^q p^qe
³t^
0 hpsq ds d^ ;

» tTA
0
2hpt ~  TAqMp~qe
³t~TA
0 hpsq ds d~
 
» tTA
0
hpt ~  TAq p~   TAqe
³t~TA
0 hpsq ds d~
 
» TA
0
hpt ^q p^qe
³t^
0 hpsq ds d^ ;
(4.20)
but ^  ~   TA, therefore the second of integrals in Equation (4.20) may be written as
» t
TA
hpt ^q p^qe
³t^
0 hpsq ds d^ : (4.21)
Thus, Equation (4.20) becomes
nCpt; 0q 
» tTA
0
2hpt ~  TAqMp~qe
³t~TA
0 hpsq ds d~
 
» t
0
hpt ^q p^qe
³t^
0 hpsq ds d^ :
(4.22)
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Proceeding in a similar manner for TB ¤ t   TA   TB gives
nCpt; 0q 
» TB
0
hpqnBpt; q d;

» tTA
0
hpqnBpt; q dloooooooooooomoooooooooooon
part (i)
 
» TB
tTA
hpqnBpt; q dloooooooooooomoooooooooooon
part (ii)
;

» tTA
0
hpq t2Mpt   TAq    pt qu e
³
0 hpsq ds dlooooooooooooooooooooooooooooooooooomooooooooooooooooooooooooooooooooooon
part (i)
 
» TB
tTA
hpq pt qe
³
0 hpsq ds dlooooooooooooooooooomooooooooooooooooooon
part (ii)
:
(4.23)
Making the substitutions ~  t  TA and ^  t  into parts (i) and (ii) respectively
leads to
nCpt; 0q 
» tTA
0
hpt ~  TAq t2Mp~q    p~   TAqu e
³t~TA
0 hpsq ds d~
 
» TA
tTB
hpt ^q p^qe
³t^
0 hpsq ds d^ ;

» tTA
0
2hpt ~  TAqMp~qe
³t~TA
0 hpsq ds d~
 
» tTA
0
hpt ~  TAq p~   TAqe
³t~TA
0 hpsq ds d~
 
» TA
tTB
hpt ^q p^qe
³t^
0 hpsq ds d^ ;

» tTA
0
2hpt ~  TAqMp~qe
³t~TA
0 hpsq ds d~
 
» t
TA
hpt ^q p^qe
³t^
0 hpsq ds d^
 
» TA
tTB
hpt ^q p^qe
³t^
0 hpsq ds d^ ;

» tTA
0
2hpt ~  TAqMp~qe
³t~TA
0 hpsq ds d~
 
» t
tTB
hpt ^q p^qe
³t^
0 hpsq ds d^ :
(4.24)
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For t ¥ TA   TB then
nCpt; 0q 
» TB
0
hpqnBpt; q d;

» tTB
0
hpq t2Mpt   TAq    pt qu e
³
0 hpsq ds d;

» tTB
0
hpq2Mpt   TAqe
³
0 hpsq ds d
 
» tTB
0
hpq pt qe
³
0 hpsq ds d;
(4.25)
which upon making the substitutions ~  t   TA and ^  t  becomes
nCpt; 0q 
» tTA
tTATB
2hpt ~  TAqMp~qe
³t~TA
0 hpsq ds d~
 
» t
tTB
hpt ^q p^qe
³t^
0 hpsq ds d^ :
(4.26)
Thus, the solution for the C compartment given in Equation (4.12) together with the
boundary conditions given in Equations (4.14), (4.22), (4.25) and (4.26), leads to
nCpt; q 
$&%0 if t   ;nCpt ; 0q if t ¥ ;

$'''''''''''''''''''''''&'''''''''''''''''''''''%
0 if t   ;³t
0
hpt   q pqe ³t0 hpsq ds d if  ¤ t   TA   ;³tTA
0
2hpt     TAqMpqe
³tTA
0 hpsq ds d
  ³t
0
hpt   q pqe ³t0 hpsq ds d if TA    ¤ t   TB   ;³tTA
0
2hpt     TAqMpqe
³tTA
0 hpsq ds d
  ³t
tTB hpt   q pqe
³t
0 hpsq ds d if TB    ¤ t   TA   TB   ;³tTA
tTATB 2hpt     TAqMpqe
³tTA
0 hpsq ds d
  ³t
tTB hpt   q pqe
³t
0 hpsq ds d if t ¥ TA   TB   :
(4.27)
This result is analogous to the result presented in [55].
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4.2.4 Solution for the D Compartment
The solution for the D compartment is given by
nDpt; q 
$&%nDp0;   tq if t   ;nDpt ; 0q if t ¥ : (4.28)
From the initial condition given in Equation (4.3) it is clear nDpt; q  0 for t    .
To obtain the solution for t ¥  it is necessary to use the boundary condition given in
Equation (4.7d). Substituting the solution given for nBpt; q into Equation (4.7d) gives
nDpt; 0q 
$'''&'''%
0 if t   TB;
 pt TBqe
³TB
0 hpsq ds if TB ¤ t   TA   TB;
t2Mpt TA  TBq    pt TBqu e
³TB
0 hpsq ds if t ¥ TA   TB;
(4.29)
as the boundary condition at   0 for the D compartment. Thus, the solution for the
D compartment is given by
nDpt; q 
$&%0 if t   ;nDpt ; 0q if t ¥ ;

$'''&'''%
0 if t   TB   ;
 pt   TBqe
³TB
0 hpsq ds if TB    ¤ t   TA   TB   ;
t2Mpt   TA  TBq    pt   TBqu e
³TB
0 hpsq ds if t ¥ TA   TB   :
(4.30)
4.3 Equations for M(t)
By the denition given in Equation (4.6),Mptq  nCpt; TCq. Using the solution of nCpt; q
given by Equations (4.27) it can be seen there are the following cases for Mptq.
If t   TC then
Mptq  0: (4.31)
If TC ¤ t   TA   TC then
Mptq 
» tTC
0
hpt TC  q pqe
³tTC
0 hpsq ds d: (4.32)
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If TA   TC ¤ t   TB   TC then
Mptq 
» tTATC
0
2hpt   TA  TCqMpqe
³tTATC
0 hpsq ds d
 
» tTC
0
hpt TC  q pqe
³tTC
0 hpsq ds d:
(4.33)
However, since the range for  in the rst integral is  P t0; t TA  TCu, then  ¤ TB 
TA @ t P rTC ; TA   TCq. The assumption TC ¥ TB  TA means  ¤ TC @ t P rTC ; TA   TCq.
Using Equation (4.31) it is clear Mpq  0, thus the rst of these integrals must also be
zero. Therefore, for TA   TC ¤ t   TB   TC
Mptq 
» tTC
0
hpt TC  q pqe
³tTC
0 hpsq ds d: (4.34)
If TB   TC ¤ t   TA   TB   TC then
Mptq 
» tTATC
0
2hpt   TA  TCqMpqe
³tTATC
0 hpsq ds d
 
» tTC
tTBTC
hpt TC  q pqe
³tTC
0 hpsq ds d:
(4.35)
Unlike the previous case the rst of these integrals is not always zero since TB ¥ TC .
Because Mpq  0 for    TC the lower limit of the rst of these integrals may be
changed to TC . For the integral to be strictly positive (this must be the case as it is
a measure of cell density) the upper limit needs to be greater than the lower limit, i.e.
t  TA  TC ¥ TC . It is possible for this inequality not to hold as the minimum value of
t  TA  TC is TB  TA and by assumption TB  TA ¤ TC . Thus the upper limit is now
max tTC ; t TA  TCu. Hence for TB   TC ¤ t   TA   TB   TC
Mptq 
» maxtTC ;tTATCu
TC
2hpt   TA  TCqMpqe
³tTATC
0 hpsq ds d
 
» tTC
tTBTC
hpt TC  q pqe
³tTC
0 hpsq ds d:
(4.36)
If t ¥ TA   TB   TC then
Mptq 
» tTATC
tTATBTC
2hpt   TA  TCqMpqe
³tTATC
0 hpsq ds d
 
» tTC
tTBTC
hpt TC  q pqe
³tTC
0 hpsq ds d:
(4.37)
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In the same manner as before the lower limit on the rst integral may be changed to
max tTC ; t TA  TB  TCu, thus for t ¥ TA   TB   TC
Mptq 
» tTATC
maxtTC ;tTATBTCu
2hpt   TA  TCqMpqe
³tTATC
0 hpsq ds d
 
» tTC
tTBTC
hpt TC  q pqe
³tTC
0 hpsq ds d:
(4.38)
4.4 Equations for P(t)
As dened in Equation (4.5)
P ptq 
¸
i
Piptq;

¸
i
» Ti
0
nipt; q d; for i P tA;B;C;Du:
(4.39)
Using this, the integral equations for Piptq are now derived.
4.4.1 Equations for PA(t)
By denition,
PAptq 
» TA
0
nApt; q d:
If t   TA the initial condition given in Equation (4.3) implies t ¥  , therefore the up-
per limit of the integral may now be changed to t. Furthermore, from Equation (4.8),
nApt; q  2Mpt q for t ¥  , thus for t   TA
PAptq 
» t
0
2Mpt q d: (4.40)
Similarly, for t ¥ TA
PAptq 
» TA
0
2Mpt q d: (4.41)
For both Equations (4.40) and (4.41) the change of variables ~  t   may now be
applied, which, after dropping the tilde notation, gives
PAptq 
$&%
³t
0
2Mpq d if t   TA;³TA
tTA 2Mpq d if t ¥ TA:
(4.42)
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4.4.2 Equations for PB(t)
By denition,
PBptq 
» TB
0
nBpt; q d:
If t   TA then t   TB, using this together with the initial condition given in Equation
(4.3) implies t ¥  , therefore the upper limit of the integral may now be changed to
t. Furthermore, if t   TA then t   TA    @ so from Equation (4.11), nBpt; q 
 pt qe ³0 hpsq ds.
Thus for t   TA
PBptq 
» t
0
 pt qe
³
0 hpsq ds d: (4.43)
The change of variables ~  t   may now be applied to Equation (4.43), which after
dropping the tilde notation, becomes
PBptq 
» t
0
 pqe
³t
0 hpsq ds d: (4.44)
If TA ¤ t   TB then, like for the case t   TA, the upper limit of the integral may be
changed to t. However, t   TA    @t P rTA; TBq and  P r0; tq, therefore the integral
needs to be considered in the two parts
PBptq 
» tTA
0
nBpt; q dlooooooooomooooooooon
part (i)
 
» t
tTA
nBpt; q dlooooooooomooooooooon
part (ii)
: (4.45)
For part (i) t ¥  TA, so from Equation (4.11), nBpt; q  t2Mpt   TAq    pt qu e
³
0 hpsq ds.
Similarly, for part (ii) t      TA so nBpt; q   pt qe
³
0 hpsq ds, thus
PBptq 
» tTA
0
t2Mpt   TAq    pt qu e
³
0 hpsq ds d  
» t
tTA
 pt qe
³
0 hpsq ds d;

» tTA
0
2Mpt   TAqe
³
0 hpsq ds d  
» t
0
 pt qe
³
0 hpsq ds d:
(4.46)
The change of variables ~  t  TA and ^  t  may now be applied to the rst and
second of these integrals respectively which, after dropping the hat and tilde notations,
gives
PBptq 
» tTA
0
2Mpqe
³tTA
0 hpsq ds d  
» t
0
 pqe
³t
0 hpsq ds d: (4.47)
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If TB ¤ t   TA   TB the two cases t   TA    and t ¥ TA    are still both possible so
proceeding in a similar manner as for the TA ¤ t   TB case gives
PBptq 
» tTA
0
nBpt; q d  
» TB
tTA
nBpt; q d;

» tTA
0
t2Mpt   TAq    pt qu e
³
0 hpsq ds d  
» TB
tTA
 pt qe
³
0 hpsq ds d;

» tTA
0
2Mpt   TAqe
³
0 hpsq ds d  
» TB
0
 pt qe
³
0 hpsq ds d;

» tTA
0
2Mpqe
³tTA
0 hpsq ds d  
» t
tTB
 pqe
³t
0 hpsq ds d:
(4.48)
Since  ¤ TB, then when t ¡ TA   TB then t ¡ TA    , therefore
PBptq 
» TB
0
t2Mpt   TAq    pt qu e
³
0 hpsq ds d;

» tTA
tTATB
2Mpqe
³tTA
0 hpsq ds d  
» t
tTB
 pqe
³t
0 hpsq ds d:
(4.49)
4.4.3 Equations for PC(t)
By denition,
PCptq 
» TC
0
nCpt; q d:
If t   TA then t   TC , using this together with the initial condition given in Equation
(4.3) implies t ¥  , therefore the upper limit of the integral may now be changed to
t. Furthermore, if t   TA then t   TA    @ so from Equation (4.27), nCpt; q ³t
0
hpt   q pqe ³t0 hpsq ds d.
Thus for t   TA
PCptq 
» t
0
» t
0
hpt   q pqe
³t
0 hpsq ds d d: (4.50)
The order of integration may now be changed but as a result the limits will also change.
The new limits may be found by considering a graphical representation of the region of
integration as in Figure 4.2.
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Figure 4.2: Graphical Representation of the Region of Integration for PCptq when t   TA.
From Figure 4.2 it can be seen that» t
0
» t
0
d d 
» t
0
» t
0
d d;
therefore Equation (4.50) may be written as
PCptq 
» t
0
» t
0
hpt   q pqe
³t
0 hpsq ds d d: (4.51)
This may be simplied further to
PCptq 
» t
0
 pq
» t
0
hpt   qe
³t
0 hpsq ds d d: (4.52)
If TA ¤ t   TC then as for the previous case the upper limit of the integral for PCptq may
be changed to t. Also, D t and  that satisfy t ¥ TA    and t   TA    therefore the
integral for PCptq for this range of t may be divided into two parts
PCptq 
» tTA
0
nCpt; q dlooooooooomooooooooon
part (i)
 
» t
tTA
nCpt; q dlooooooooomooooooooon
part (ii)
: (4.53)
For part (i) of Equation (4.53) TA    ¤ t. Since t   TC it is clear t   TB    , thus for
part (i) t satises TA    ¤ t   TB    , therefore from Equation (4.27)
nCpt; q 
» tTA
0
2hpt     TAqMpqe
³tTA
0 hpsq ds d
 
» t
0
hpt   q pqe
³t
0 hpsq ds d:
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For part (ii) of Equation (4.53) t   TA    . Also TA ¤ t thus from Equation (4.27)
nCpt; q 
» t
0
hpt   q pqe
³t
0 hpsq ds d:
Therefore, if TA ¤ t   TC then
PCptq 
» tTA
0
» tTA
0
2hpt     TAqMpqe
³tTA
0 hpsq ds d d
 
» tTA
0
» t
0
hpt   q pqe
³t
0 hpsq ds d d
 
» t
tTA
» t
0
hpt   q pqe
³t
0 hpsq ds d d;

» tTA
0
» tTA
0
2hpt     TAqMpqe
³tTA
0 hpsq ds d d
 
» t
0
» t
0
hpt   q pqe
³t
0 hpsq ds d d;

» tTA
0
» tTA
0
2hpt     TAqMpqe
³tTA
0 hpsq ds d d
 
» t
0
» t
0
hpt   q pqe
³t
0 hpsq ds d d;

» tTA
0
Mpq
» tTA
0
2hpt     TAqe
³tTA
0 hpsq ds d d
 
» t
0
 pq
» t
0
hpt   qe
³t
0 hpsq ds d d:
(4.54)
104 4.4 Equations for P(t)
For TC ¤ t   TB
PCptq 
» tTA
0
» tTA
0
2hpt     TAqMpqe
³tTA
0 hpsq ds d d
 
» tTA
0
» t
0
hpt   q pqe
³t
0 hpsq ds d d
 
» TC
tTA
» t
0
hpt   q pqe
³t
0 hpsq ds d d;

» tTA
0
» tTA
0
2hpt     TAqMpqe
³tTA
0 hpsq ds d d
 
» TC
0
» t
0
hpt   q pqe
³t
0 hpsq ds d d;

» tTA
0
» tTA
0
2hpt     TAqMpqe
³tTA
0 hpsq ds d d
 
» tTC
0
» TC
0
hpt   q pqe
³t
0 hpsq ds d d
 
» t
tTC
» t
0
hpt   q pqe
³t
0 hpsq ds d d;

» tTA
0
Mpq
» tTA
0
2hpt     TAqe
³tTA
0 hpsq ds d d
 
» tTC
0
 pq
» TC
0
hpt   qe
³t
0 hpsq ds d d
 
» t
tTC
 pq
» t
0
hpt   qe
³t
0 hpsq ds d d:
(4.55)
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Details of the change of variables are given in Appendix D.
For t ¥ TB it is necessary to consider the ranges TB ¤ t   TA TC , TA TC ¤ t   TA TB,
TA   TB ¤ t   TB   TC , TB   TC ¤ t   TA   TB   TC , t ¥ TA   TB   TC . After similar
manipulations of the expression for PCptq the following are obtained.
For TB ¤ t   TA   TC
PCptq 
» tTA
0
Mpq
» tTA
0
2hpt     TAqe
³tTA
0 hpsq ds d d
 
» tTC
0
 pq
» TC
0
hpt   qe
³t
0 hpsq ds d d
 
» t
tTC
 pq
» t
0
hpt   qe
³t
0 hpsq ds d d

» tTB
0
 pq
» tTB
0
hpt   qe
³t
0 hpsq ds d d:
(4.56)
For TA   TC ¤ t   TA   TB
PCptq 
» tTCTA
0
Mpq
» TC
0
2hpt     TAqe
³tTA
0 hpsq ds d d
 
» tTA
tTCTA
Mpq
» tTA
0
2hpt     TAqe
³tTA
0 hpsq ds d d
 
» tTC
0
 pq
» TC
0
hpt   qe
³t
0 hpsq ds d d
 
» t
tTC
 pq
» t
0
hpt   qe
³t
0 hpsq ds d d

» tTB
0
 pq
» tTB
0
hpt   qe
³t
0 hpsq ds d d:
(4.57)
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For TA   TB ¤ t   TB   TC
PCptq 
» tTATC
0
Mpq
» TC
0
2hpt     TAqe
³tTA
0 hpsq ds d d
 
» tTA
tTATC
Mpq
» tTA
0
2hpt     TAqe
³tTA
0 hpsq ds d d

» tTATB
0
Mpq
» tTATB
0
2hpt     TAqe
³tTA
0 hpsq ds d d
 
» tTC
0
 pq
» TC
0
hpt   qe
³t
0 hpsq ds d d
 
» t
tTC
 pq
» t
0
hpt   qe
³t
0 hpsq ds d d

» t
tTB
 pq
» tTB
0
hpt   qe
³t
0 hpsq ds d d:
(4.58)
For TB   TC ¤ t   TA   TB   TC
PCptq 
» tTATC
0
Mpq
» TC
0
2hpt     TAqe
³tTA
0 hpsq ds d d
 
» tTA
tTATC
Mpq
» tTA
0
2hpt     TAqe
³tTA
0 hpsq ds d d

» tTATB
0
Mpq
» tTAtb
0
2hpt     TAqe
³tTA
0 hpsq ds d d
 
» tTC
tTBTC
 pq
» TC
0
hpt   qe
³t
0 hpsq ds d d
 
» t
tTC
 pq
» t
0
hpt   qe
³t
0 hpsq ds d d

» tTB
tTBTC
 pq
» tTB
0
hpt   qe
³t
0 hpsq ds d d:
(4.59)
4.4 Equations for P(t) 107
For t ¥ TA   TB   TC
PCptq 
» tTATC
tTATBTC
Mpq
» TC
0
2hpt     TAqe
³tTA
0 hpsq ds d d
 
» tTA
tTATC
Mpq
» tTA
0
2hpt     TAqe
³tTA
0 hpsq ds d d

» tTATB
tTATBTC
Mpq
» tTATB
0
2hpt     TAqe
³tTA
0 hpsq ds d d
 
» tTC
tTBTC
 pq
» TC
0
hpt   qe
³t
0 hpsq ds d d
 
» t
tTC
 pq
» t
0
hpt   qe
³t
0 hpsq ds d d

» tTB
tTBTC
 pq
» tTB
0
hpt   qe
³t
0 hpsq ds d d:
(4.60)
4.4.4 Equations for PD(t)
By denition,
PDptq 
» t
0
nDpt; q d:
If t ¤ TB then no cells have yet had chance to enter the D compartment, therefore
PDptq  0. For t ¥ TB then there are two ranges which need to be considered, namely
TB ¤ t   TA  TB and t ¥ TA  TB. Proceeding in a similar manner as for PCptq leads to
the following expressions for PDptq. For TB ¤ t   TA   TB
PDptq  e
³TB
0 hpsqds
» tTB
0
 pq d: (4.61)
For t ¥ TA   TB
PDptq  e
³TB
0 hpsq ds
» tTATB
0
2Mpq d
  e
³TB
0 hpsq ds
» tTB
0
 pq d:
(4.62)
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4.5 Integral Equations Summary
As discussed at the start of this chapter no analysis of these integral equations has been un-
dertaken and they are included here to illustrate the availability of dierent techniques for
modelling a population of cells using a population balance framework. The key equation
in this integral equation approach is given by Equation (4.38). In order to solve Equation
(4.38), it is necessary to solve the equations for Mptq for earlier t, these are given by
Equations (4.32-4.36). Once Equation (4.38) is solved the cell densities may readily be
calculated. Numerical calculations involving the integral equations may provide a faster
alternative to using a nite dierence scheme for solving the PDEs directly but this has
not been investigated further.
Chapter 5
Pharmacokinetic and
Pharmacodynamic Models
Pharmacokinetics (PK) and pharmacodynamics (PD) are the branches of pharmacology
which are concerned with how a drug interacts with a biological environment. Phar-
macokinetics is the study of the eects of a biological system on a drug including the
absorption of the drug, the distribution of the drug through the biological system and the
excretion of the drug from the system. Pharmacodynamics is the study of the eects of
a drug on a biological system.
Pharmacokinetic/pharmacodynamic (PKPD) modelling is an attempt to model the in-
teraction of a drug with a particular biological environment. Using a PKPD model it
is often possible to describe the interactions between the drug and the biological system
in a simple, concise way. Once an appropriate model has been found it may be used to
explain how the drug is interacting with the biological system. A major advantage of
using PKPD models over actual experimental data is that a wider range of parameter
values and scenarios may be considered and the models are not subject to the same level
of uncertainty and error which can never be fully eliminated from experiments.
This chapter starts by giving a brief overview of how PKPD may be modelled. In the
case of pharmacodynamics the way in which this may be incorporated directly into a cell
cycle model is discussed. A brief introduction to widely used pharmacokinetic modelling
is then undertaken. Firstly, a single compartment model for a single intravenous bolus
dose is discussed, together with the resulting analytic solution. A single compartment
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model for a single period of constant rate intravenous infusion is then considered. For
multiple periodic doses an iterative map of ODEs and initial conditions is discussed, but
not solved. For drugs administered extravascularly there is a delay before the drug enters
the blood plasma. This delay means an extra compartment is necessary to accurately
model the drug distribution. A simple two compartment model for a single extravascular
dose is discussed, together with the resulting analytic solution for the concentration of
the drug in the plasma. It is explained how the eects of bioavailability may be included
and what eect this would have on the resulting solution. The chapter concludes with a
brief discussion of the type of PKPD model which will be used in conjunction with a cell
cycle model in Chapter 6.
5.1 Mathematical Modelling of Pharmacokinetics and Pharmaco-
dynamics
PKPD models vary considerably in their complexity and level of detail, however it is
often possible to gain qualitative insight using a model which still retains the essential
properties of the interactions between a drug and it's environment.
The PKPD modelling for a particular drug needs may be divided into two parts. The
rst of these relates to the pharmacokinetics.
The rst consideration is how the drug is administered into the system. If the drug is
administered intravenously it enters the blood plasma and hence the system directly. This
means the model does not need to take into account the absoption of the drug by the
body. Furthermore, if the drug is administered as a single bolus intravenous dose then the
infusion period may be considered to be negligible in comparision to the other time scales
in the model thus, the administration of the drug may be included as initial conditions in
the model, this type of model is discussed further in Section 5.1.1. If the drug is infused
over a period of time then this is not the case and the model needs to be broken into two
phases, during infusion and post infusion, this is also considered in Section 5.1.1. Drugs
administered orally, or by other means, need the absoption of the drug into the plasma
to be included within the model, this scenario is examined in Section 5.1.2.
Once the drug is in the system how the drug leaves needs consideration. The clearance
of the drug consists of several processes however, for the purposes of most models these
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may normally be grouped together into one term. Unless the concentration is above
the clearance capacity of the system the rate of clearance may be assumed to be rst
order. For higher concentrations a Michaelis-Menten term may be used to model the
clearance [26].
Whilst in the system the distribution of the drug and its interaction with the system may
also be included in the model.
Simple pharmacokinetic models with and without absorption are shown in Figures 5.1
and 5.2.
Plasma- -Input Clearance
Figure 5.1: Pharmacokinetic Model Without Absorption.
Outer
System Plasma
-- -AbsorptionInput Clearance
Figure 5.2: Pharmacokinetic Model With Absorption.
The pharmacodynamic part of the modelling is included in the model for the main biolo-
gical system. How it is included depends on the actions of the drug and also the system
on which it is acting.
As the biological system being considered is a population of cancerous cells the purpose
of the drug is to reduce the rate of growth of the population. There are two ways the
pharmacodynamics may be included.
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If a drug is cytotoxic then it is toxic to the cells. This results in some of the cells dying
directly as a result of the drug. Some drugs do not kill cells directly, instead they inhibit
a cell's ability to divide and successfully undergo mitosis, this is known as a cytostatic
eect. The proportion of cells that are eected by a drug is dependent on factors such as
dosage and the drug's ecacy.
Cytotoxic drugs may be modelled by introducing a function linking the drug concentration
to its ecacy. This may be added to the equations for the cell population. The resulting
term is likely to be negative as it represents a decline in the number of cells.
If the drug being used is cytostatic then instead of a simple doubling at cell division a
function may be used to govern the average number of daughter cells each cell within the
population will produce when exposed to a particular concentration of the drug. Clearly,
a cell either divides into two daughter cells or it does not and such averaging approaches
are only suitable when the population of cells being considered is large enough so each
individual division is not important and an average value of divisions is meaningful.
5.1.1 Simple Intravenous Models
If the drug is administered intravenously it immediately enters the blood plasma and
hence the biological system. This means models for intravenous delivery do not need to
take into account the absoption of the drug by the body. A graphical representation of
this is shown in Figure 5.1. Furthermore, if the drug is administered as a single bolus
intravenous dose then the infusion period may often be considered to be negligible in
comparison to the other time scales in the model such as the rate at which the drug leave
the system. Thus, the administration of the drug may be included as initial conditions in
the model. If the drug is infused over a period of time then this is not the case and the
model may be broken into two phases, during infusion and post infusion.
Bolus Dose Model
The most simple type of pharmacokinetic model considers a single, bolus dose which leaves
the system at a known rate. This results in a rst order ordinary dierential equation for
the concentration of the drug in the system. Let Dptq denote the drug concentration at
time t in a compartment representing the biological system with volume V . If the drug
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is known to leave the system in a linear way, relative to its concentration, and an initial
bolus dose of DI is given at t  0 then the concentration of the drug may be expressed as
dDptq
dt
 KDptq and Dp0q  DI
V
; (5.1)
where K is a rate constant associated with how fast the drug is removed from the system
either by leaving the system or being irreversibly changed via interactions with the system,
such as cell absorption or binding. Equation (5.1) may easily be solved to give
Dptq  DI
V
eKt; (5.2)
for the drug concentration, Dptq, at any given time.
Intravenous Infusion Model
Delivering the drug via a constant rate infusion is preferable to a single bolus dose or
extravascular methods, especially when the drug has a narrow therapeutic index1 as a
constant rate infusion allows greater control over the input of the drug. Regular monitor-
ing allows an accurate picture of the concentration in the biological system to be obtained.
If the drug is infused, at a constant rate R, which is greater than the rate at which the
drug leaves the system K, then the concentration of the drug in the system will increase
over the period of infusion. Once the infusion has stopped the bolus dose model, previ-
ously described, may be used with DI equal to the concentration of the drug at the end
of the infusion period.
Let Dptq denote the drug concentration at time t in a compartment representing the
biological system with volume V . If the drug is known to leave the system in a linear
way, relative to its concentration at rate K, and for t P r0; TIq the drug is infused at a
constant rate R then if the initial drug concentration in the system is assumed to be zero
the concentration of the drug may be expressed as
dDptq
dt

#
R
V
KDptq for 0 ¤ t   TI ;
KDptq for t ¥ TI ;
and Dp0q  0: (5.3)
1The therapeutic index is a measure of the range of concentration for which the drug is therapeutically
eective but not toxic. For humans the therapeutic index is given as the ratio of the dose which produces
a toxicity response in 50% of the population and the dose which produces a therapeutic eect in 50% of
the population.
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During the period of constant infusion, t P r0; TIq, the rst part of Equation (5.3) and the
initial condition apply. This ODE has the analytic solution
Dptq  R
KV
 
1 eKt for 0 ¤ t   TI : (5.4)
After the infusion has nished then the second part of (5.3) applies, with the initial
condition being given by setting t  TI in Equation (5.4), i.e. DpTIq  RKV
 
1 eKTI.
Solving for t P rTI ;8q gives
Dptq  R
KV
 
eKTI  1 eKt for TI ¤ t: (5.5)
A sketch of a typical drug concentration administered via constant infusion is shown in
Figure 5.3. If the same equal dose is given via constant infusion and a single bolus dose it is
possible to derive a relationship for the back extrapolated intercept for the concentration
of the constant infusion and the single bolus dose [26] and [27]. Let CI denote the back
extrapolated intercept of the constant infusion concentration curve, post infusion. Let
CB denote the concentration immediately after the bolus dose (If the dose is DI clearly
CB  DIV ). By setting t  0 in Equation (5.5) gives
CI  R
KV
 
eKTI  1 ; (5.6)
but the total dose given is the rate R multiplied by the length of time of the infusion
period TI , and this is equal to the single bolus dose DI . Therefore R  DITI  CBVTI , thus
Equation (5.6) may be rewritten as
CI  CB
KTI
 
eKTI  1 ; (5.7)
or
CB  CIKTI
eKTI  1 : (5.8)
This result is shown in [26] and [27] and applies to all mammillary compartment models
[27].
5.1.2 Simple Absorption Models
For drugs administered by any other means other than intravenously there will be some
delay before the drug distributes through the system and into the plasma and tissues.
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Figure 5.3: A Sketch of a Typical Plasma Drug Concentration Curve When the Dose is
Administered Via Constant Infusion.
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Because of this delay a single compartment model is often not sucient to predict the
concentration. By introducing more compartments additional exponential terms are intro-
duced into the prediction for the concentration. These additional terms represent dierent
rates for the drug distribution. This often provides a better t to experimental data.
A two compartment model as depicted in Figure 5.2 may be used as a rst approximation
for an absorption model. For a single extravascular, bolus dose DE this model is described
by the following pair of coupled ODEs.
dDOptq
dt
 KODOptq and DOp0q  DE
V
; (5.9a)
dDP ptq
dt
 KODOptq KPDP ptq and DP p0q  0; (5.9b)
where DOptq and DP ptq are the concentrations of the drug in the outer compartment
and plasma respectively and KO and KP are the rates at which the drug leaves the out
compartment and plasma respectively. Equation (5.9a) is the same as Equation (5.1) and
hence has the solution
DOptq  DE
V
eKOt: (5.10)
DOptq may now be substituted into Equation (5.9b) to give
dDP ptq
dt
 KODE
V
eKOt KPDP ptq and DP p0q  0; (5.11)
as the equation describing the drug concentration in the plasma DP ptq. Equation (5.11)
may be solved yielding
DP ptq  KODE
 
eKP t  eKOt
pKO KP qV : (5.12)
This result appears in [26]. Providing KO " KP this shows a two compartment model
may be approximated by a single compartment as eKP t is the dominant term. A sketch
of a typical concentration curve in the plasma compartment is shown in Figure 5.4.
In reality not all the drug that is in the outer compartment enters the plasma as shown
in Figure 5.5. For example, if the outer compartment represents the gut then a small
amount of the drug will be lost via excretion and degradation.
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Figure 5.4: A Sketch of a Typical Plasma Drug Concentration Curve When the Dose is
Administered Via an Absorption Process.
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Figure 5.5: Pharmacokinetic Absorption Model with Loss from Outer Compartment.
The proportion of the drug which leaves the out compartment and enters the plasma is
known as the bioavailability B. Mathematically this may expressed as
B  KO
KO  Klost ; (5.13)
where Klost is the rate constant representing drug which leaves via other means, such as
degradation. Equation (5.9b) may be modied to take this into account simply by scaling
the input term appropriately
dDP ptq
dt
 KOBDOptq KPDP ptq and DP p0q  0: (5.14)
Other two compartment models such as that depicted in Figure 5.6 may provide a more
accurate representation of the concentration of the drug if it is administered extravascu-
larly. The corresponding solution of which is similar to that given Equation (5.12) in as
much as it contains two exponential terms.
?
Outer
System Plasma
-- exchange
Two way drug
Input
Clearance
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Figure 5.6: Pharmacokinetic Absorption Model With Loss From the Outer Compartment
and Two Way Drug Diusion.
It is possible to create more sophisticated and detailed models using more compartments.
The rates at which the drug pass between the compartments and volumes of the com-
partments may also be time dependent.
5.1.3 Periodic doses
A drug which is administered periodically may have its concentration modelled using an
iterative map. The rst step in constructing the iterative map is to use a periodic function
instead of the constant infusion R as described in Section 5.1.1 If the infusion rate is now
a function of time, Rptq, then Equation (5.3) may be modied to
dDptq
dt

#
Rptq
V
KDptq for TI2n   t ¤ TI2n 1 for 1 ¤ n ¤ N;
KDptq for TI2n 1   t ¤ TI2n 2 for 1 ¤ n   N and t ¥ TI2N 1 ;
and Dp0q  0:
(5.15)
where tn P N0 | n   Nu and N ¡ 1 is the number of infusions. It follows TI2n are the
times the infusions start and TI2n 1 are the corresponding times the infusions nish. If
N is small then it is possible to construct a piecewise continuous solution directly from
Equation (5.15), similar to the solution given by Equations (5.4) and (5.5). For large N
an iterative map is used for which an analytic solution may be dicult to obtain.
During periods of infusion if the rate at which the drug is administered is at a constant
rate R then the the drug concentration, Dnptq, during the nth period of infusion/post
infusion out of a total N infusions is given by
dDnptq
dt

#
R
V
KDnptq for 0   t ¤ TIn ;
KDnptq for TIn   t ¤ Tn;
and Dnp0q  Dn1pTnq; (5.16)
where TIn is the length of the infusion period in the n
th infusion and Tn is the time that
the pn   1qst infusion starts. Clearly for t P pTIn ; Tns there is no infusion. It should be
noted that at the start of each new mapping t is reset to zero. For completeness the initial
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condition D1p0q  0 together with the equation
dDENDptq
dt
 KDENDptq and DENDp0q  DNpTNq; (5.17)
for t ¥
N°
1
TN are required.
5.2 Pharmacokinetic and Pharmacodynamic Model Summary
There are a wide variety of compartment based models available to accurately represent
drug concentration for drugs delivered by both intravenous and extravenous methods. As
a rst approximation to gain a qualitative understanding of how a system behaves it is
possible to use a single compartment model. The addition of further compartments makes
the analysis of the drug concentration more dicult and since the additional compart-
ments add exponential terms as long as KO " KP then a single exponential term is a
good rst approximation of the multi-compartment model. It was shown in Section 5.1.1
that it was possible to back extrapolate from the graph of the concentration caused by
a constant rate infusion to obtain the equivalent bolus dose which would give the con-
centration curve post infusion. As such to simplify the model further the dose may be
assumed to be administered in a single bolus dose.
Chapter 6
A Cell Cycle Model with Drug
Interaction
In Section 3.1 a four compartment, ODE cell cycle model was constructed. By comparing
the phase distributions given by PDE and ODE models it was shown in Section 3.6 that an
ODE model was sucient to gain qualitative information concerning how the population
of cells grow. This chapter starts with Section 6.1 extending this four compartment,
ODE cell cycle model to account for the ways in which drugs may interact with the
population of cells. In Chapter 5 a number of basic PKPD models were considered. It
was concluded in Section 5.2 that to gain a rst approximation for most PKPD situations
a single bolus, intraveneous dose model would suce. The purpose of this model is to
develop a method for obtaining a semi-analytical solution which may be used to gain
a qualitative understanding of the way in which dierent types of drug-cell interactions
eect a given population. Since only a qualitative understanding of the system is sought
it is therefore possible to combine the ODE model described in Section 3.1 with a simple
PKPD model similar to that described in Section 5.1.1.
As previously discussed in Section 5.1 drugs may eect a cell in a number of dierent
ways. It is therefore sensible to consider two separate models, one for each of the phar-
macodynamic processes by which chemotherapy drugs eect a population of cells, namely
cytostasis and cytotoxicity. In Section 6.2 the model is modied to take into account the
eects of a cytotoxic drug on the population of cells. The modied system of equations
are presented and non-dimensionalised. It is observed that the model may be divided into
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three categories dependent on the order of one of the parameters of the system. For one
of these cases an asymptotic approach cannot be used. This case corresponds to a region
of parameter space which is unlikely to be of biological interest and is not considered
further, leaving only two cases to be considered. It is shown one of these has a trivial
solution, leaving only one of interest. For this remaining case (Case I) it is noted that for
the special case detailed in Section 6.1 an analytic solution may be found. However, for
the generic model it may not be possible to nd an analytic solution. As such, a technique
for obtaining an approximate solution is given. This technique is rst demonstrated on a
simpler system, of two ODEs, which has similarities to the biological system of interest.
This enables the approximation to easily be compared with the analytical solution. Once
the technique has been veried on the simple system it is used on the cytotoxic model
and the results compared once more to the analytical solution.
Section 6.3 follows a similar format to Section 6.2 with the model now modied to take
into account the eects of a cytostatic drug on the population of cells. As this scenario is
worked through a number of similarities between the cytotoxic and cytostatic model are
noted.
In Section 6.4 the cytotoxic and cytostatic models are compared. It is shown that for
long term qualitative predictions both models produce the same results. The rationale
for why this is the case is then discussed.
The chapter concludes with a summary of the ndings.
6.1 Outline of Model
The model described in this section combines the four compartment ODE model de-
scribed in Section 2.1.2 with a simple PKPD model, similar to the single compartment
intraveneous model described in Section 5.1.1.
Consider a closed population of cells where no quiescent cells are present. As discussed
in Section 2.1.2 such a population may be modelled as four compartments each of which
contain one phase. The rate at which cells pass between each phase is given by ki; i P
tG1; S;G2;Mu. In Section 2.1.2 only the case where ki, @ i are constants was considered.
It is possible that this may not be the case, for example the rates at which cells progress
between the compartments may be a function of nutrient levels or the concentration of
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some drug. Furthermore, let the average number of new cells produced per cell division
be P , which is a function of the drug concentration Dptq. The cell population density in
each of the four compartments is governed by the equations
dNG1ptq
dt
 P pDptqqk1pDptqqNMptq  k2pDptqqNG1ptq  f1pDptqqNG1ptq;
dNSptq
dt
 k2pDptqqNG1ptq  k3pDptqqNSptq  f2pDptqqNSptq;
dNG2ptq
dt
 k3pDptqqNSptq  k4pDptqqNG2ptq  f3pDptqqNG2ptq;
dNMptq
dt
 k4pDptqqNG2ptq  k1pDptqqNMptq  f4pDptqqNMptq;
(6.1)
where NG1ptq; NSptq; NG2ptq and NMptq are the number of cells in the four compartments
at time t and Dptq is the drug concentration in the inter cellular media at time t. The
functions fipDptqq, i P t1; 2; 3; 4u represent the cytotoxic eect of the drug on the popula-
tion of cells. Due to the processes which occur internally in a cell during its progression
through the cell cycle there may be certain parts of the cycle for which a cell is particu-
larly vulnerable to the cytotoxic eects of a drug. Conversely, there may also be periods
for which the cell's immunity is increased, as such the functions, fipDptqq, may vary sig-
nicantly. The drug concentration in the inter cellular media, Dptq, may be modelled in
a similar way to the single compartment, bolus dose PKPD model described in Section
5.1.1 Let the rate at which the drug enters the media be given by dinptq. Also, let the rate
at which the drug leaves the media via clearance be directly proportional to the amount
of drug in the media. Let this clearance occur at the rate doutptq. The amount of drug
absorbed by the cells is given by a function of the respective cell densities and the amount
of drug available gpNG1ptq; NSptq; NG2ptq; NMptq; Dptqq. The drug concentration in the
inter cellular media is now governed by the equation
dDptq
dt
 dinptq  doutptqDptq  gpNG1ptq; NSptq; NG2ptq; NMptq; Dptqq: (6.2)
Equations (6.1) and (6.2), together with suitable boundary conditions, fully dene the
cell cycle population and the inter cellular drug concentration, i.e. the complete system
under consideration. A graphical representation of this system is shown in Figure 6.1.
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Figure 6.1: Four Compartment ODE Cell Cycle Model Incorporating Drug Interaction.
The purpose of this model is to develop a method for obtaining a semi-analytical solution
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which may be used to gain a qualitative understanding of the way in which dierent types
of drug-cell interactions eect a given population. Since only a qualitative understanding
of the system is sought it is possible to make some assumptions which in turn simplify
the system of equations. The assumptions made in this model are
 The drug is delivered in a single bolus dose.
 The rate of clearance is directly proportional to the amount of drug in the system.
 The drug is taken up equally by all cells, regardless of phase.
 The drug concentration is below the cell's saturation level.
 Cells pass between each of the four compartments at a constant rate, which is
independent of any external factors.
By assuming the drug is delivered in a single bolus dose, dinptq may be incorporated
into the initial conditions. This assumption, together with the clearance being directly
proportional to the amount of drug in the system simplify Equation (6.2) to
dDptq
dt
 doutDptq  gpNG1ptq; NSptq; NG2ptq; NMptq; Dptqq; (6.3)
where dout is now a constant and not a function of time. Since the drug is assumed to be
absorbed equally by all cells and the drug concentration is below the level required for
saturation the rate the drug is used up is rst order with respect to the drug concentration,
thus gpNG1ptq; NSptq; NG2ptq; NMptq; Dptqq  NT ptqDptq where NT ptq is the total cell
population density at time t, and  is the amount of the drug a cell absorbs per unit time.
Equation (6.3) now becomes
dDptq
dt
 doutDptq  NT ptqDptq: (6.4)
By assuming that cells pass between each of the four compartments at a constant rate
which is independent of any external factors, the constants kipDptqq may be expressed as
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k1pDptqq  k2pDptqq  k3pDptqq  k4pDptqq  k. Equations (6.1) now become
dNG1ptq
dt
 P pDptqqkNMptq  kNG1ptq  f1pDptqqNG1ptq;
dNSptq
dt
 kNG1ptq  kNSptq  f2pDptqqNSptq;
dNG2ptq
dt
 kNSptq  kNG2ptq  f3pDptqqNG2ptq;
dNMptq
dt
 kNG2ptq  kNMptq  f4pDptqqNMptq:
(6.5)
This last assumption may be relaxed to allow a more biologically realistic distribution of
cells across the four compartments. In Appendix F the model detailed in Section 6.2 is
worked through with this assumption removed.
Depending on how a drug interacts with the population it may be possible to make further
assumptions, and thus simplify the model further.
6.1.1 Types of Drug Interaction
There are many ways in which a drug may interfere with the normal progression of a
cell through the cell cycle. The eects of a drug may be broken down into two broad
categories cytotoxic and cytostatic. Cytotoxic literally means toxic to cells and as such
may be considered as directly killing cells and reducing the population. There are many
ways in which the toxicity may actually kill a cell such as the breaking down of the cell
membrane, inducing apoptosis1 or reducing the rate of growth of a cell to a point where it
is no longer viable. However, the specic mechanism of cell death is not important for the
purposes of this model. Cytostatic drugs inhibit the division of cells. Strictly speaking,
cytostasis may also refer to inhibition of growth of cells but for the purposes of this
analysis this type of eect is included under cytotoxicity. Many drugs have a synergistic
eect consisting of both cytotoxic and cytostatic components, but for simplicity these
eects are treated separately here.
1Apoptosis is the genetically pre-programmed cell shut down process leading to the cell's death.
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6.2 The Eect of a Cytotoxic Drug Interaction on A Population of
Cells
If a drug has a cytotoxic eect on a cell population then its eect may by phase dependent
[2]. In extreme cases the drug is only eective for cells in one particular phase. The
special case where the drug only eects cells in the S phase is considered here; thus
f1pDptqq  f3pDptqq  f4pDptqq  0. Furthermore, let the drug eect cells in the S phase
in a way which is directly proportional to the drug concentration in the inter cellular
media, hence f2pDptqq  eDptq where e can be thought of as the ecacy of the drug.
Since the drug only has a cytotoxic eect the average number of cells produced at each
division is not dependent on the drug concentration and is therefore a constant, thus
P pDptqq  2. Equations (6.5) now simplify to
dNG1ptq
dt
 2kNMptq  kNG1ptq;
dNSptq
dt
 kNG1ptq  kNSptq  eDptqNSptq;
dNG2ptq
dt
 kNSptq  kNG2ptq;
dNMptq
dt
 kNG2ptq  kNMptq:
(6.6)
Equations (6.4) and (6.6) together with suitable initial conditions now represent a sim-
plied model with a cytotoxic drug interaction.
To complete the system initial conditions are required. It is assumed each of the four
compartments contain the same number of cells; therefore
Nip0q  NT p0q
4
where i P tG1; S;G2;Mu: (6.7)
It should be noted that the initial conditions given in Equation (3.10) could have been
chosen. However, since this model now considers the eects of a drug, which may have a
large eect at the beginning of the model, such initial conditions may distort the eect of
the drug due to the cells only being present in one of the four phases. Whilst assuming an
equal distribution of cells is still unrealistic this does alleviate this issue. Let the initial
drug concentration be given by
Dp0q  DI : (6.8)
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6.2.1 Non-Dimensionalisation of the Equations
As previously discussed in Section 3.2 any potential numerical problems caused by multi-
scale parameters and variables may be removed by non-dimensionalising the system of
equations. Furthermore, by non-dimensionalising the system of equations it may be pos-
sible to reduce the number of dependent parameters making the system more tractable.
The rst step in the non-dimensionalisation process is to introduce new, dimensionless
variables ~t, ~Dp~tq, ~NG1p~tq, ~NSp~tq, ~NG2p~tq, ~NMp~tq and ~NT p~tq dened as
~t  t
b
; (6.9a)
~NG1p~tq  NG1ptqa ; (6.9b)
~NSp~tq  NSptq
a
; (6.9c)
~NG2p~tq  NG2ptqa ; (6.9d)
~NMp~tq  NMptq
a
; (6.9e)
~NT p~tq 
¸
i
~Nip~tq; (6.9f)
~Dp~tq  Dptq
c
: (6.9g)
Where a, b and c are dimensional constants which may be arbitrarily chosen to simplify
the system. Note, the cell densities in the dierent compartments are all scaled equally
to avoid potentially misleading distributions. Substituting the non-dimensional variables
into Equations (6.4) and (6.6) gives
a
b
d ~NG1p~tq
d~t
 2ak ~NMp~tq  ak ~NG1p~tq;
a
b
d ~NSp~tq
d~t
 ak ~NG1p~tq  ak ~NSp~tq  ace ~Dptq ~NSp~tq;
a
b
d ~NG2p~tq
d~t
 ak ~NSp~tq  ak ~NG2p~tq;
a
b
d ~NMp~tq
d~t
 ak ~NG2p~tq  ak ~NMp~tq;
(6.10)
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and
c
b
d ~Dp~tq
d~t
 cdout ~Dp~tq  ac ~NT p~tq ~Dp~tq: (6.11)
The corresponding initial conditions are now given by
~Nip0q 
~NT p0q
4
where i P tG1; S;G2;Mu; (6.12)
and
~Dp0q  ~DI where ~DI  DI
c
: (6.13)
Equations (6.10) and (6.11) may be re-arranged to give, upon dropping the tilde notation,
dNG1ptq
dt
 2bkNMptq  bkNG1ptq;
dNSptq
dt
 bkNG1ptq  bkNSptq  bceDptqNSptq;
dNG2ptq
dt
 bkNSptq  bkNG2ptq;
dNMptq
dt
 bkNG2ptq  bkNMptq;
(6.14)
and
dDptq
dt
 bdoutDpptq  abNT ptqDptq: (6.15)
The parameters b and c are now chosen as b  1
k
and c  k
e
, thus, the system of equations
now become
dNG1ptq
dt
 2NMptq NG1ptq;
dNSptq
dt
 NG1ptq NSptq DptqNSptq;
dNG2ptq
dt
 NSptq NG2ptq;
dNMptq
dt
 NG2ptq NMptq;
(6.16)
and
dDptq
dt
 dout
k
Dptq  a
k
NT ptqDnptq: (6.17)
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The parameter a may be chosen arbitrarily, but a sensible choice is a  NT p0q
4
. This value
is chosen such that the normalised initial conditions for the cell population densities in
each of the four compartments are all one. It should be noted that a " 1. Since dout
represents the clearance of the drug per unit time and k represents the rate at which
cells progress between the compartments dout
k
 Op1q. The parameter  represents the
amount of drug absorbed per cell per unit time and as such may be assumed to be very
small. It should be noted that since  is dependent on the timescale used the  used in the
non-dimensional system has been scaled by a factor of k compared to the original  given
in Equation (6.4). It is now helpful to introduce two new parameters   dout
k
which is of
order Op1q and   a
k
whose order is unknown. Equation (6.17) may now be rewritten
as
dDptq
dt
 Dptq  NT ptqDptq: (6.18)
The non-dimensionalised form of the initial conditions for the cell population densities
are now
Nip0q  1 where i P tG1; S;G2;Mu: (6.19)
Thus Equations (6.16) and (6.18) together with the initial conditions given by Equations
(6.13) and (6.19) fully dene the non-dimensionalised system.
Since the order of  is unknown there are three cases to consider
 Case I :  ! 1,
 Case II : Opq  1,
 Case III :  " 1.
6.2.2 Case I :  ! 1
If  ! 1, then since NT p0q  4 clearly NT ptq ! 1 for some range of t ¥ 0. Subsequently
however NT ptq  Op1q or even NT ptq " 1 may occur. However, since   Op1q the
growth rate of NT ptq is the same order as the decay rate of Dptq, so that when NT ptq " 1
then Dptq ! 1. Therefore, only NT ptq ! 1 needs to be considered.
For the zeroth order approximation all terms with  may be ignored. Thus Equation
(6.18) decouples from the system and simplies to
dDptq
dt
 Dptq; (6.20)
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hence
Dptq  Aet; (6.21)
where A is a constant. Using the initial condition given in Equation (6.13) gives Dptq 
DIe
t. This expression for Dptq may now be inserted back into Equations (6.16) giving
dNG1ptq
dt
 2NMptq NG1ptq; (6.22a)
dNSptq
dt
 NG1ptq NSptq DIetNSptq; (6.22b)
dNG2ptq
dt
 NSptq NG2ptq; (6.22c)
dNMptq
dt
 NG2ptq NMptq: (6.22d)
In order to analyse the solution of this system of equations it is helpful to convert them
into a single fourth order equation. By dierentiating Equation (6.22d) the second order
equation
d2NMptq
dt2
 dNG2ptq
dt
 dNMptq
dt
; (6.23)
is obtained. Substituting the expression for the derivative of NG2ptq from Equation (6.22c)
gives
d2NMptq
dt2
 NSptq NG2ptq  dNMptq
dt
: (6.24)
It is now possible to eliminate NG2ptq by making it the subject of Equation (6.22d) and
substituting this expression into Equation (6.24) which leads to
d2NMptq
dt2
 2dNMptq
dt
NMptq  NSptq: (6.25)
Proceeding in a similar manner it is possible to eliminate NG2ptq and NMptq giving a single
fourth order ODE for NG1, i.e.
d4NG1ptq
dt4
   4 DIet d3NG1ptq
dt3
   6  3DIet d2NG1ptq
dt2
   4  3DIet dNG1ptq
dt
  1DIetNG1ptq  0:
(6.26)
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By utilising the dsolve routine in Maple [42] it can be seen that Equation (6.26) has the
solution
NG1ptq  C1ep2
1
41qt
3F3 pr;;s ; r1 2; 1  p1  iq; 1 p1  iqs ;ptqq
  C2ep2
1
4 1qt
3F3 pr; ; s ; r1  2; 1  p1  iq; 1  p1 iqs ;ptqq
  C3ep2
1
4 i1qt
3F3 pri;i;is ; r1 2i; 1  p1 iq; 1 p1  iqs ;ptqq
  C4ep2
1
4 i 1qt
3F3 pri; i; is ; r1  2i; 1  p1  iq; 1  p1  iqs ;ptqq ;
(6.27)
where Ci for i P t1; 2; 3; 4u are constants to be determined from imposing the boundary
conditions,   2 14

, ptq is the auxillary function dened as
ptq  DIe
t

; (6.28)
and pFqpa;b; zq is a generalised hypergeometric function2, with a and b being lists con-
taining p and q entries respectively. The function pFqpa;b; zq is dened as
pFqpa;b; zq 
8¸
n0
zn
p±
i1
 pai nq
 paiq
n!
q±
j1
 pbj nq
 pbjq
: (6.29)
Despite Equation (6.26) having an exact analytic solution this does not lend itself readily
to analysis. When all the rate constants k are equal an exact solution exists, generally
this is not the case and as such an exact solution may not easily be found. It is therefore
desirable to obtain an adequate approximation which is more amenable to analysis. To
determine the form such an approximation may take it is helpful to rst consider a simpler
second order ODE of a similar form.
2Further details about hypergeometric functions may be found in [63].
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Approximation to a Second Order ODE
Consider the second order ODE
d2xptq
dt2
  p2  etqdxptq
dt
  p1 qetxptq  0; (6.30)
on which appropriate boundary conditions may be imposed. For   1 Equation (6.30)
has the unique solution
xptq  Ae et2t2t2

I 2
2
pptqq   I 2 
2
pptqq
	
 Be et2t2t2

K2
2
pptqq K 2 
2
pptqq
	
;
(6.31)
where A and B are constants, to be determined by imposing suitable boundary conditions,
ptq is the auxillary function dened as
ptq  e
t
2
; (6.32)
and I and K are the modied Bessel functions of order  of the rst and second kind
respectively. Although this solution is expressed in a dierent form to that of Equation
(6.27) it should be noted that Bessel functions may be readily converted into hypergeo-
metric functions. To obtain a full numerical solution with which an approximation may
be compared the arbitrary Dirichlet boundary conditions xp0q  0 and xp8q  1 are
imposed. Despite the original fourth order ODE given in Equation (6.26) being an ini-
tial value problem, Dirichlet boundary conditions are imposed on this second order ODE
so that the solution remains bounded and as such approximations may be easily veri-
ed. Upon applying these boundary conditions and assigning a value to  the solution to
Equation (6.30) given by (6.31) may now be obtained. Plots of this solution for the case
  5 are shown in Figures 6.2 and 6.3. An approximation for the solution can be found
by applying a change of variables. Let
~t  ptq; (6.33)
which, upon substitution into Equation (6.30) gives
~t
d2xp~tq
d~t2
 p2  2~t qdxp~tq
d~t
  2p1 qxp~tq  0: (6.34)
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Figure 6.2: Plot of the Analytical Solution for the Second Order ODE Given in Equation
(6.30) for t P r0; 5s and   5.
For ease of later calculations it is helpful to multiply Equation (6.34) by
~t

to give
~t2
d2xp~tq
d~t2


2~t

  2~t2  ~t


dxp~tq
d~t
p~tq   2~t

1

 1


xp~tq  0: (6.35)
This equation is singular at the point ~t  0. To determine the nature of this singularity
it is noted that Equation (6.35) is now of the form
P p~tqd
2xp~tq
d~t2
 Qp~tqdxp~tq
d~t
 Rp~tqxp~tq  0; (6.36)
where
P p~tq  ~t2;
Qp~tq  

2~t

  2~t2  ~t


;
Rp~tq  2~t

1

 1


:
(6.37)
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Figure 6.3: Plot of the Analytical Solution for the Second Order ODE Given in Equation
(6.30) for t P r0; 1s and   5.
For a regular singularity lim
~tÑ0
~tQp~tq
P p~tq and lim~tÑ0
~t2Rp~tq
P p~tq must both remain nite. From the
values of P p~tq, Qp~tq and Rp~tq given in Equations (6.37) it can be seen that
lim
~tÑ0
~tQp~tq
P p~tq  lim~tÑ0
~tp2~t

  2~t2  ~tq
~t2
;
 lim
~tÑ0


2

  2~t 1


;
 1 2

;
and
lim
~tÑ0
~t2Rp~tq
P p~tq  lim~tÑ0
~t22p ~t

 ~tq
~t2
;
 lim
~tÑ0
2~t

1

 1


;
 0:
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Thus the singularity at ~t  0 is regular. Because the singularity is regular, Equation
(6.35) may be solved using Frobenius' Method.
The rst step in this method is to make the ansatz
xp~tq  ~tr
8¸
n0
an~t
n;

8¸
n0
an~t
n r;
where a0  0. If a0  0 and the rst non-zero a is am then r may be replaced by r  m
and consequently am may be replaced by a0. Clearly
dxp~tq
d~t

8¸
n0
an
n
0
~t
n1 ; (6.38)
and
d2xp~tq
d~t2

8¸
n0
an
n
0
n
1~t
n2 ; (6.39)
where nj is the auxillary function dened as
nj  n  r   j: (6.40)
Substituting these expressions for xp~tq and its derivatives into Equation (6.35) yields
8¸
n0
an
n
0
n
1~t
n0  

1 2


 8¸
n0
an
n
0
~t
n
0
 2
8¸
n0
an
n
0
~t
n
1   2

1

 1

 8¸
n0
an~t
n1  0:
(6.41)
The last two summations in Equation (6.41) may be expressed as
 2
8¸
n1
an1n1~t
n0 ; (6.42)
and
2

1

 1

 8¸
n1
an1~t
n
0 ; (6.43)
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respectively. Thus, Equation (6.41) may be re-written as
a0

00
0
1   00

1 2



~t
0
0
 
8¸
n1
"
n0
n
1  

1 2



an  

2

1

 1


 2n1

an1
*
~t
n
0  0;
(6.44)
i.e.
a0

r

r  2



~tr
 
8¸
n1
!
n0

n 2

	
an  

2

n 1

	
an1
)
~t
n
0  0:
(6.45)
For Equation (6.45) to be satised the coecient for each power of ~t must equal zero.
Firstly, the coecient of the ~tr term is considered,
a0

rpr  1q   r

1 2



 0: (6.46)
Since a0  0 it is clear r  0 or r  2 . Equation (6.35) is linear in xp~tq therefore the
general solution will be given by
xp~tq  c1x1p~tq   c2x2p~tq; (6.47)
where x1p~tq and x2p~tq are two linearly independent solutions and c1 and c2 are constants to
be determined using the boundary conditions. The two values of r which satisfy Equation
(6.46) produce two linearly independent solutions, therefore let x1p~tq and x2p~tq correspond
to r  0 and r  2

respectively. For the remaining coecients, an and An for n ¥ 1, to
be zero
8¸
n1
"
n

n 2



an  

2

n 1



an1
*
~tn  0; (6.48)
and
~t
2


A0  
8¸
n1
"
n  2



n  2

 2



An  

2

n  2

 1



An1
*
~tn

 0;
(6.49)
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i.e.
~t
2


A0  
8¸
n1
"
n

n  2



An  

2

n  1



An1
*
~tn

 0: (6.50)
Thus for an and An, n ¥ 1, to be zero the recurrence relations
an  2
 
n 1


n
 
n 2

an1; (6.51)
and
An  2
 
n  1


n
 
n  2

An1; (6.52)
must be satised.
The auxillary function ji is introduced, where
ji  i  j: (6.53)
The rst three terms in the recurrence relation given by Equation (6.51) are
a1 2
1
1
21
a0; (6.54)
a2 
1
2
22
a1;
2
1
2 
1
1
22 
2
1
a0; (6.55)
and
a3 2
1
3
323
a2;
2
313 
1
2 
1
1
623 
2
2 
2
1
a0: (6.56)
Since  pn 1q
 pnq  n, it may be shown that an may be expressed using the   notation as
an  2
n 
 
21

 
 
n  11

n! 
 
n  21

 
 
11
a0: (6.57)
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In a similar way it is possible to express An as
An  2
n  p21q  pn  11q
n!  pn  21q  p11qA0: (6.58)
Thus, the expressions for x1p~tq and x2p~tq may now be written as
x1p~tq  a0  
8¸
n1
#
2n 
 
21

 
 
n  11

n! 
 
n  21

 
 
11
+ a0~tn;
 a0

1 
8¸
n1
#
2n 
 
21

 
 
n  11

n! 
 
n  21

 
 
11
+ ~tn ; (6.59)
and
x2p~tq  ~t 2

A0  
8¸
n1
"
2n  p21q  pn  11q
n!  pn  21q  p11q
*
A0~t
n

;
 A0~t 2

1 
8¸
n1
"
2n  p21q  pn  11q
n!  pn  21q  p11q
*
~tn

; (6.60)
respectively.
Hence, the complete solution is given by
xp~tq  C1

1 
8¸
n1
#
2n 
 
21

 
 
n  11

n! 
 
n  21

 
 
11
+ ~tn
  C2~t 2

1 
8¸
n1
"
2n  p21q  pn  11q
n!  pn  21q  p11q
*
~tn

; (6.61)
where C1 and C2 are constants incorporating a0 and A0, respectively. To check the
convergence of the two innite sums in this expression the ratio test is implemented. For
8¸
n1
#
2n 
 
21

 
 
n  11

n! 
 
n  21

 
 
11
+ ~tn; (6.62)
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it can be seen the limit of the ratio of two successive terms is given by
L  lim
nÑ8

"
2n 1 p21 q pn 12 q
pn 1q! pn 22 q p11 q
*
~tn 1"
2n p21 q pn 11 q
n! pn 21 q p11 q
*
~tn
 ;
 lim
nÑ8
 2 
 
n  12

 
 
n  21

pn  1q   n  11    n  22 ~t
 ;
 lim
nÑ8
 2
 
n  11

pn  1q  n  21 ~t
 ;
 0: (6.63)
Since L   1 the series converges absolutely for all ~t.
Similarly, for
8¸
n1
"
2n  p21q  pn  11q
n!  pn  21q  p11q
*
~tn; (6.64)
it can be seen the limit of the ratio of two successive terms is given by
L  lim
nÑ8

"
2n 1 p21q pn 12q
pn 1q! pn 22q p11q
*
~tn 1"
2n p21q pn 11q
n! pn 21q p11q
*
~tn
 ;
 lim
nÑ8
 2  pn  12q  pn  21qpn  1q  pn  11q  pn  22q~t
 ;
 lim
nÑ8
 2 pn  11qpn  1q pn  21q~t
 ;
 0: (6.65)
Hence this series also converges absolutely for all ~t. Since the expression for xptq given
by Equation (6.61) converges it is possible to obtain an approximation by truncating the
innite series. For small ~t assume all terms greater than ~tm may be ignored, xp~tq may be
written as
xp~tq  P p~tq  Op~tm  2 q; (6.66)
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where
P p~tq  C1

1 
m¸
n1
"
2n  p21q  pn  11q
n!  pn  21q  p11q
*
~tn

  C2~t 2

1 
m1¸
n1
"
2n  p21q  pn  11q
n!  pn  21q  p11q
*
~tn

: (6.67)
To compare this approximation with the solution given in Equation (6.31), the values of
two and ve are assigned to m and  respectively. It should be noted this is the same
value of  used in Figures 6.2 and 6.3. For this xp~tq may be written as
xp~tq  P p~tq  Op~t 125 q; (6.68)
where
P p~tq  C1

1 
2¸
n1
#
2n 
 
3
5

 
 
n  4
5

n! 
 
n  3
5

 
 
4
5
+ ~tn
  C2~t 25

1 
1¸
n1
#
2n 
 
7
5

 
 
n  6
5

n! 
 
n  7
5

 
 
6
5
+ ~tn ;
 C1

1  8
3
~t  3~t2


  C2~t 25

1  12
7
~t


: (6.69)
When t  8, ~t  0 and when t  0, ~t  1
2
 1
10
, therefore from the Dirichlet boundary
conditions xp0q  0 and xp8q  1, we obtain P p0q  1 and P p 1
10
q  0. By setting
P p0q  1 it is clear that
C1  1: (6.70)
Imposing the boundary condition P p 1
10
q  0, together with C1  1, yields
C2  2723
2460
10
2
5 ;
 2:78: (6.71)
Thus, for small ~t a second order approximation of xp~tq is given by
xp~tq 

1  8
3
~t  3~t2


 2:78~t 25

1  12
7
~t


: (6.72)
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By using the substitution given in Equation (6.33) this may be expressed in terms of the
original variable, t as
xptq 

1  8
3

e5t
10


  3

e5t
10

2
 2:78

e5t
10

 2
5

1  12
7

e5t
10



: (6.73)
This approximation is plotted together with the actual solution in Figure 6.4.
Second
Figure 6.4: Plot Showing a Second Order Approximation Together with Actual Solution
for the Second Order ODE Given in Equation (6.30).
Since the analytical solution to Equation (6.30) is known it is possible to conduct a further
check of this approximation. Further details of this can be found in Appendix E.
Motivated by the techniques used to solve Equation (6.30) the transformation
~t  ptq; (6.74)
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where ptq is dened in Equation (6.28), is applied to Equation (6.26), yielding
4~t4
d4NG1p~tq
d~t4
 

64~t3  43~t3  3~t4


d3NG1p~tq
d~t3
 

74~t2  123~t2  33~t3   62~t2   32~t3


d2NG1p~tq
d~t2
 

4~t 43~t 3~t2   62~t  32~t2  4~t 3~t2


dNG1p~tq
d~t
   ~t 1NG1p~tq  0:
(6.75)
Equation (6.75) is singular at the point ~t  0. Proceeding in a similar manner as before
it is noted that Equation (6.75) is of the form
P p~tqd
4NG1p~tq
d~t4
 Qp~tqd
3NG1p~tq
d~t3
 Rp~tqd
2NG1p~tq
d~t2
  Sp~tqdNG1p~tq
d~t
  T p~tqNG1p~tq  0; (6.76)
where
P p~tq  4~t4; (6.77a)
Qp~tq  64~t3  43~t3  3~t4; (6.77b)
Rp~tq  74~t2  123~t2  33~t3   62~t2   32~t3; (6.77c)
Sp~tq  4~t 43~t 3~t2   62~t  32~t2  4~t 3~t2; (6.77d)
and
T p~tq  ~t 1: (6.77e)
For ~t  0 to be a regular singularity lim
~tÑ0
~tQp~tq
P p~tq , lim~tÑ0
~t2Rp~tq
P p~tq , lim~tÑ0
~t3Sp~tq
P p~tq and lim~tÑ0
~t4T p~tq
P p~tq
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must all remain nite. Using the expressions from Equations (6.77) yields
lim
~tÑ0
~tQp~tq
P p~tq  lim~tÑ0
~tp64~t3  43~t3  3~t4q
4~t4
;
 lim
~tÑ0
6

4  ~t



;
 2

p3 2q; (6.78)
and
lim
~tÑ0
~t2Rp~tq
P p~tq  lim~tÑ0
~t2p74~t2  123~t2  33~t3   62~t2   32~t3q
4~t4
;
 lim
~tÑ0
7

12  3~t



 

6  3~t
2


;
 1
2
p72  12  6q; (6.79)
and
lim
~tÑ0
~t3Sp~tq
P p~tq  lim~tÑ0
~t3p4~t 43~t 3~t2   62~t  32~t2  4~t 3~t2q
4~t4
;
 lim
~tÑ0
1

4  ~t



 

6  3~t
2




4  3~t
3


;
 1
3
p3  42   6 4q; (6.80)
and
lim
~tÑ0
~t4T p~tq
P p~tq  lim~tÑ0
~t4p~t 1q
4~t4
;
 lim
~tÑ0
~t 1
4
;
 1
4
: (6.81)
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Hence the singularity at ~t  0 is regular, therefore Equation (6.75) may be solved using
Frobenius' Method, using the ansatz
NG1p~tq  ~tr
8¸
n0
an~t
n;

8¸
n0
an~t
n0 ; (6.82)
where nj is dened in Equation (6.40) and a0  0. The rst four derivatives of NG1p~tq
with respect to ~t are given by
dNG1p~tq
d~t

8¸
n0
an
n
0
~t
n1 ; (6.83a)
d2NG1p~tq
d~t2

8¸
n0
an
n
0
n
1~t
n2 ; (6.83b)
d3NG1p~tq
d~t3

8¸
n0
an
n
0
n
1
n
2~t
n3 ; (6.83c)
and
d4NG1p~tq
d~t4

8¸
n0
an
n
0
n
1
n
2
n
3~t
n4 : (6.83d)
Substituting these expressions for NG1p~tq, and its derivatives into Equation (6.75) gives
4
8¸
n0
an
n
0
n
1
n
2
n
3~t
n0    64  43 8¸
n0
an
n
0
n
1
n
2~t
n0
 3
8¸
n0
an
n
0
n
1
n
2~t
n1    74  123   62 8¸
n0
an
n
0
n
1~t
n0
  3  2  3 8¸
n0
an
n
0
n
1~t
n1    4  43   62  4 8¸
n0
an
n
0
~t
n
0
   32  3 3 8¸
n0
an
n
0
~t
n
1 
8¸
n0
an~t
n0  
8¸
n0
an~t
n1  0; (6.84)
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which may be rewritten as
4
8¸
n0
an
n
0
n
1
n
2
n
3~t
n0    64  43 8¸
n0
an
n
0
n
1
n
2~t
n0
 3
8¸
n1
an1n1
n
2
n
3~t
n0    74  123   62 8¸
n0
an
n
0
n
1~t
n0
  3  2  3 8¸
n1
an1n1
n
2~t
n0    4  43   62  4 8¸
n0
an
n
0
~t
n
0
   32  3 3 8¸
n1
an1n1~t
n0 
8¸
n0
an~t
n0  
8¸
n1
an1~t
n
0  0; (6.85)
i.e.
a0

400
0
1
0
2
0
3   p64  43q000102
  p74  123   62q0001   p4  43   62  4q00  1

~t
0
0
 
8¸
n1
 
an

4n0
n
1
n
2
n
3   p64  43qn0n1n2
  p74  123   62qn0n1   p4  43   62  4qn0  1

  an1
3n1n2n3   3p2  3qn1n2
  p32  3 3qn1   1
(
~t
n
0  0; (6.86)
which upon simplifying becomes
a0
pr  1q4  2q ~tr
 
8¸
n1
 
an
pn0 1q4  2q an1 pn1 1q3( ~tn0  0: (6.87)
If Equation (6.87) is to be satised then the coecient for each power of ~t must equal
zero. Considering the coecient of the ~tr term gives
a0
pr  1q4  2q  0: (6.88)
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Since a0  0 it is clear r satises the quartic equation
pr  1q4  2  0: (6.89)
Therefore
r  1 2
1
4

;
1 2 14 i

: (6.90)
Since all the roots, r, are distinct all four solutions are linearly independent. Equation
(6.75) is linear in NG1p~tq, therefore the general solution will be given by a linear combin-
ation of the four independent solutions corresponding to the four values of r satisfying
Equation (6.89). Hence,
NG1p~tq  c1x1p~tq   c2x2p~tq   c3x3p~tq   c4x4p~tq  0; (6.91)
where xjp~tq for j P t1; 2; 3; 4u are the four linearly independent solutions corresponding to
the four values of r satisfying Equation (6.89) and cjp~tq for j P t1; 2; 3; 4u are constants
to be determined using the initial conditions. Unlike the analysis of the second order
ODE, the recurrence relations and convergence of the four series resulting in the dierent
r values are considered together. For the coecients of ~t
n
0 for n ¥ 1 to equal zero the
recurrence relation
an  p
n1 1q3
ppn0 1q4  2qan1; (6.92)
must be satised. To check the resulting series converge the ratio test may be implemen-
ted. It can be seen that the ratio of two successive terms is given by
L  lim
nÑ8
 an~tn0an1~tn1
 ;
 lim
nÑ8

pn11q3
ppn01q42qan1
an1
~t
 ;
 lim
nÑ8
 pn1 1q3ppn0 1q4  2q~t
 ;
 0: (6.93)
Since L   1 the series converges absolutely for all ~t. To obtain a rst order approximation
(in terms of ~t), for the complete solution it is necessary to look at the real parts of the four
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r values given in Equation (6.90). Since Reprq ¥ 1 2 14 ¡ 1 it is necessary to calculate
the solution up to terms containing ~tr 2 to obtain a rst order approximation. Whilst
it is not necessary to include the terms for n  2 for all of the r to obtain a rst order
approximation they are included so that each series is truncated after the same number
of terms. Thus, for small ~t, NG1p~tq may be written as
NG1p~tq  P p~tq  Op~t2q; (6.94)
where
P p~tq 
4¸
j1
aj0~t
rj
"
1  prj 1q
3
prj   1q4  2
~t
  prj   1q
3prj 1q3
tprj  2 1q4  2u tprj   1q4  2u
~t2
*
;
(6.95)
where the j correspond to the four dierent values of r. It should be noted that the
constants cj have now been incorporated into the values of aj. In order to compare the
approximation with the analytic solution given by Equation (6.27) suitable parameter
values and initial conditions must be chosen. The parameters DI and  are chosen to
have the arbitrary values of one and two respectively. The initial conditions given in
Equation (6.7) state the cell population density is the same for all four phases, therefore
Njp0q  1 for j P tG1; S;G2;Mu : (6.96)
These initial conditions have been chosen to avoid any problems which might arise by us-
ing the unrealistic scenario of all cells initially being in one phase. Using Equations (6.23),
(6.24) and (6.25) these initial conditions can readily be transformed into the Cauchy initial
conditions
NG1p0q  1; (6.97a)
dNG1ptq
dt

t0
 1; (6.97b)
d2NG1ptq
dt2

t0
 1; (6.97c)
and
d3NG1ptq
dt3

t0
 1; (6.97d)
for Equation (6.26).
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The full analytic solution is now given by
NG1ptq  1:1927ep2
1
41qt
3F3 pr;;s ; r1 2; 1  p1  iq; 1 p1  iqs ;ptqq
 0:9724ep2 14 1qt3F3 pr; ; s ; r1  2; 1  p1  iq; 1  p1 iqs ;ptqq
 p0:2521  0:2128iqep2 14 i1qt3F3 pri;i;is ; r1 2i; 1  p1 iq; 1 p1  iqs ;ptqq
 p0:2521 0:2128iqep2 14 i 1qt3F3 pri; i; is ; r1  2i; 1  p1  iq; 1  p1  iqs ;ptqq ;
(6.98)
where   2 34 , and ptq is the auxillary function dened as
ptq  e
2t
2
: (6.99)
In order to nd the rst order approximation given by Equation (6.95) the initial condi-
tions given in Equations (6.97) must be transformed to suitable boundary conditions for
Equation (6.75). These correspond to the Cauchy boundary conditions
NG1p1q  1; (6.100a)
dNG1p~tq
d~t

~t1
 1
2
; (6.100b)
d2NG1p~tq
d~t2

~t1
 1
4
; (6.100c)
and
d3NG1p~tq
d~t3

~t1
 3
8
: (6.100d)
150 6.2 The Eect of a Cytotoxic Drug Interaction on A Population of Cells
Applying these boundary conditions to Equation (6.95) gives
a10  0:2527  0:2192i;
a20  1:1874;
a30  0:2527 0:2192i;
a40  0:9596;
(6.101)
where aj0 , j P t1; 2; 3; 4u, correspond to rj where
rj  1  2
1
4 ij
2
: (6.102)
Note, by using the substitution given in Equation (6.74), Equation (6.95) may be expressed
in terms of the original variable, t as
P ptq 
4¸
j1
aj0
 
e2t
rj "1  prj 1q3prj   1q4  2  e2t
  prj   1q
3prj 1q3
tprj  2 1q4  2u tprj   1q4  2u
 
e2t
2*
:
(6.103)
This approximation is plotted together with the actual solution in Figure 6.5. Since the
analytical solution to Equation (6.26) is known it is possible to conduct a further check
of this approximation. Further details of this can be found in Appendix E.
Whilst Figure 6.5 demonstrates that this technique for appoximating the solution is in
good agreement with the analytical solution further work is necessary to gain information
about the behaviour of the whole population of cells.
For the general case, where  and DI are arbitrary, an approximation to the population
of cells in the G1 compartment is given by Equation (6.95), or in terms of the original
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Figure 6.5: Plot Showing a First Order Approximation Together with Actual Solution for
the Fourth Order ODE Given in Equation (6.26) with DI  1 and   2.
time variable t
NG1ptq  P ptq 
4¸
j1
aj0
 
DIe
trj "1  prj 1q3prj   1q4  2  DIet
  prj   1q
3prj 1q3
tprj  2 1q4  2u tprj   1q4  2u
 
DIe
t2* :
(6.104)
Using this approximation, together with its rst derivative it is now possible to readily
obtain an approximation for NMptq by using Equation (6.22a). In turn, an approximation
for NG2ptq may be found using this approximation for NMptq and Equation (6.22d). Re-
peating the process once more allows an approximation to be found for NSptq via Equation
(6.22c). A plot for the total cell count, NT ptq, for the parameters DI  1 and   2 is
shown in Figure 6.6. As can be seen from Figure 6.6 for the parameter values chosen the
total number of cells is monotonically increasing, thus the eect of this drug is to only
slow down the population growth and not reduce the total population.
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N (t)
T
Figure 6.6: Plot Showing an Approximation to the Total Cell Population with Cytotoxic
Eect with DI  1 and   2.
To determine if it is possible to actually reduce the population of cells it is necessary to
consider the equations governing NT ptq. By combining Equations (6.22) it is possible to
obtain
dNT ptq
dt
 NMptq DIetNSptq: (6.105)
If the total population is to decrease then dNT ptq
dt
must be negative for some t. The
drug concentration, and hence its eects on the population, are monotonically decreasing
therefore if dNT ptq
dt
  0 for some t ¥ 0 then
dNT ptq
dt

t0
  0; (6.106)
therefore
NMp0q DINSp0q   0: (6.107)
From the initial conditions given in Equation (6.19) if Equation (6.107) is to be satised
then
DI ¡ 1: (6.108)
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Furthermore, if the population is initially in decline it is possible to nd the time at which
a minimum number of cells is present by nding when the derivative of NT ptq is zero, i.e.
NMptq DIetNSptq  0: (6.109)
It is clear that this will be a minimum by considering the physical nature of the system.
Any eects of the drug will diminish resulting in the population being able to recover.
A plot for the total cell count, NT ptq, for the parameters DI  2 and   2 is shown in
Figure 6.7. For the parameter values chosen, Equation (6.109) has the solution t  0:2,
N (t)
T
Figure 6.7: Plot Showing an Approximation to the Total Cell Population with Cytotoxic
Eect when DI  2 and   2.
which also agrees with the plot shown in Figure 6.7.
By considering dierent values of  for DI xed it can be shown that as  decreases the
time at which the turning point occurs increases and the minimum population decreases.
Recall,  is dened as   dout
k
which is the relative rate of the wash out of the drug dout
to the rate of cell progression through the cycle k. Intuitively if the drug remains in the
system for longer relative to the rate cells progress through the cycle more cells will be
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eected hence the minimum will be lower. Also, if the relative wash out rate is lower then
the time taken for the minimum to be achieved will be greater.
6.2.3 Case II :   Op1q
By denition   a
k
, therefore for Case II to occur the total amount of drug used per
unit time, a would need to be the same order as the average rate cells pass between the
phases k. For most situations the amount of drug used per unit time is several orders
of magnitude less than the rate cells pass between the phases. For Case II Equation
(6.18) does not decouple from the system, This case is said to be the distinguished limit.
Since no small parameter is present Equations (6.16) and (6.18) are now not able to be
solved using the approach described in Case I. For this scenario alternative analytical or
numerical techniques must be utilised. Since the purpose of this analysis is to develop
semi-analytical techniques using an asymptotic approach this case has not been considered
further.
6.2.4 Case III :  Ñ 8
If  Ñ 8, then since NT p0q  4 clearly NT ptq Ñ 8 for some range of t ¥ 0. Therefore
only NT ptq Ñ 8 will be considered for some range of t ¥ 0. Let ~  1 , so ~ Ñ 0 as
Ñ 8, and ~t  t  t
~
. Applying these rescalings to Equations (6.16) and (6.18) gives
1
~
dNG1p~tq
d~t
 2NMp~tq NG1p~tq; (6.110a)
1
~
dNSp~tq
d~t
 NG1p~tq NSp~tq Dp~tqNSp~tq; (6.110b)
1
~
dNG2p~tq
d~t
 NSp~tq NG2p~tq; (6.110c)
1
~
dNMp~tq
d~t
 NG2p~tq NMp~tq; (6.110d)
and
dDp~tq
d~t
 ~Dp~tq NT p~tqDp~tq: (6.111)
Note the initial conditions remain unaected by these rescalings, so
Nip~tq  Nip0q  1 where i P tG1; S;G2;Mu: (6.112)
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For the zeroth order approximation all ~ terms may be ignored. Thus Equations (6.110)
simplify to
dNG1p~tq
d~t
 0; (6.113a)
dNSp~tq
d~t
 0; (6.113b)
dNG2p~tq
d~t
ptq  0; (6.113c)
dNMp~tq
d~t
ptq  0: (6.113d)
Substituting NT p~tq with four in Equation (6.111) and neglecting the term multiplied by
~ gives
dDp~tq
d~t
 4Dp~tq: (6.114)
Hence,
Dp~tq  DIe4~t: (6.115)
Equation (6.115) may now be expressed in terms of the original time variable, t, as
Dptq  DIe4t: (6.116)
But Ñ 8 therefore Dptq  0. Thus, for the case Ñ 8 the drug has a negligible uptake
and has a minimal eect on the population. This means the population of cells grows in
the same manner as the untreated model described in Section 2.1.2.
6.3 The Eect of a Cytostatic Drug Interaction on A Population
of Cells
If a drug has a purely cytostatic eect on a cell population then the functions fipDptqq,
i P t1; 2; 3; 4u which represent the cytotoxic eect of the drug in the dierent phases
are all zero. To allow ease of comparison between the modelling of a cytostatic and
cytotoxic eects let the drugs aect on the proliferation be directly proportional to the
drug concentration, this is a good approximation for some cytostatic drugs [21] and [14].
Therefore, let P pDptqq  2p1  eDptqq where e can be thought of as the ecacy of the
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drug. Since the average number of cells produced per division must remain positive it is
clear eDptq ¤ 1 @t ¥ 0. Equations (6.5) now simplify to
dNG1ptq
dt
 2p1 eDptqqkNMptq  kNG1ptq;
dNSptq
dt
 kNG1ptq  kNSptq;
dNG2ptq
dt
 kNSptq  kNG2ptq;
dNMptq
dt
 kNG2ptq  kNMptq:
(6.117)
Equations (6.4) and (6.117) together with suitable initial conditions now represent a sim-
plied model with a cytostatic drug interaction. To complete the model initial conditions
are required. For consistency the initial conditions chosen are the same as those used in
Section 6.2, i.e.
Nip0q  NT p0q
4
where i P tG1; S;G2;Mu; (6.118)
and
Dp0q  DI : (6.119)
6.3.1 Non-Dimensionalisation of the Equations
Proceeding in a similar manner as for the cytotoxic case the rst step in the analysis of
the system is to non-dimensionalise the equations.The variables ~t, ~Dp~tq, ~NG1p~tq, ~NSp~tq,
~NG2p~tq, ~NMp~tq and ~NT p~tq are introduced, their denitions being given in Equations (6.9).
Substituting the non dimensional variables into Equations (6.4) and (6.117) gives
a
b
d ~NG1p~tq
d~t
 2p1 ec ~Dp~tqqak ~NMp~tq  ak ~NG1p~tq;
a
b
d ~NSp~tq
d~t
 ak ~NG1p~tq  ak ~NSp~tq;
a
b
d ~NG2p~tq
d~t
 ak ~NSp~tq  ak ~NG2p~tq;
a
b
d ~NMp~tq
d~t
 ak ~NG2p~tq  ak ~NMp~tq;
(6.120)
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and
c
b
d ~Dp~tq
d~t
 cdout ~Dp~tq  ac ~NT p~tq ~Dp~tq: (6.121)
The corresponding initial conditions are now given by
~Nip0q 
~NT p0q
4
where i P tG1; S;G2;Mu; (6.122)
and
~Dp0q  ~DI where ~DI  DI
c
: (6.123)
Equations (6.120) and (6.121) may be re-arranged to give, upon dropping the tilde nota-
tion,
dNG1ptq
dt
 2p1 ceDptqqbkNMptq  bkNG1ptq;
dNSptq
dt
 bkNG1ptq  bkNSptq;
dNG2ptq
dt
 bkNSptq  bkNG2ptq;
dNMptq
dt
 bkNG2ptq  bkNMptq;
(6.124)
and
dDptq
dt
 bdoutDptq  abNT ptqDptq: (6.125)
The parameters b and c are now chosen as b  1
k
and c  1
e
, thus, the system of equations
now become
dNG1ptq
dt
 2p1DptqqNMptq NG1ptq; (6.126a)
dNSptq
dt
 NG1ptq NSptq; (6.126b)
dNG2ptq
dt
 NSptq NG2ptq; (6.126c)
dNMptq
dt
 NG2ptq NMptq; (6.126d)
and
dDptq
dt
 dout
k
Dptq  a
k
NT ptqDnptq: (6.127)
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As in the cytotoxic non-dimensionalisation a is chosen as a  NT p0q
4
and the new para-
meters,   dout
k
and   a
k
are introduced. Thus Equation (6.127) may be rewritten
as
dDptq
dt
 Dptq  NT ptqDptq: (6.128)
The non-dimensionalised form of the initial conditions for the cell population densities
are now
Nip0q  1 where i P tG1; S;G2;Mu: (6.129)
Note, the non-dimensionalisation used in the cytotoxic and cytostatic cases is very similar
with the only dierence being the choice of the scaling parameter c. As before, there are
three cases to consider
 Case I :  ! 1,
 Case II : Opq  1,
 Case III :  " 1.
6.3.2 Case I :  ! 1
Proceeding in the same manner as for the cytotoxic model, it can be seen that for the
zeroth order approximation Equation (6.128) decouples from the system and may be read-
ily solved to give Dptq  DIet. Inserting this expression for Dptq back into Equations
(6.126) gives four rst order ODEs which may now be converted into a single fourth order
ODE for any of the dependent variables. For the cytostatic case the most convenient
dependent variable to use for the single fourth order ODE is NMptq. Thus, Equations
(6.126) may be expressed as
d4NMptq
dt4
  4d
3NMptq
dt3
  6d
2NMptq
dt2
  4dNMptq
dt
  1 2DIetNMptq  0: (6.130)
As with the cytotoxic model, in order to aid construction of an approximate solution a
change of variables is required. A suitable transformation is given by
~t  ptq; (6.131)
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where ptq is dened in Equation (6.28). Applying this transformation to Equation
(6.130) leads to
4~t4
d4NMp~tq
d~t4
 

64~t3  43~t3


d3NMp~tq
d~t3
 

74~t2  123~t2   62~t2


d2NMp~tq
d~t2
 

4~t 43~t  62~t 4~t


dNMp~tq
d~t
   2~t 1NMp~tq  0: (6.132)
This equation is singular at the point ~t  0. To determine the nature of this singularity
it is noted that Equation (6.132) is of the form given in Equation (6.76) where
P p~tq  4~t4; (6.133a)
Qp~tq  64~t3  43~t3; (6.133b)
Rp~tq  74~t2  123~t2   62~t2; (6.133c)
Sp~tq  4~t 43~t  62~t 4~t; (6.133d)
and
T p~tq  2~t 1: (6.133e)
For ~t  0 to be a regular singularity lim
~tÑ0
~tQp~tq
P p~tq , lim~tÑ0
~t2Rp~tq
P p~tq , lim~tÑ0
~t3Sp~tq
P p~tq and lim~tÑ0
~t4T p~tq
P p~tq
must all remain nite. Using the values given in Equation (6.133) yields
lim
~tÑ0
~tQp~tq
P p~tq  lim~tÑ0
~tp64~t3  43~t3q
4~t4
;
 6 4

;
 2

p3 2q; (6.134)
160 6.3 The Eect of a Cytostatic Drug Interaction on A Population of Cells
and
lim
~tÑ0
~t2Rp~tq
P p~tq  lim~tÑ0
~t2p74~t2  123~t2   62~t2q
4~t4
;
 7 12

  6
2
;
 1
2
p72  12  6q; (6.135)
and
lim
~tÑ0
~t3Sp~tq
P p~tq  lim~tÑ0
~t3p4~t 43~t  62~t 4~tq
4~t4
;
 1 4

  6
2
 4
3
;
 1
3
p3  42   6 4q; (6.136)
and
lim
~tÑ0
~t4T p~tq
P p~tq  lim~tÑ0
~t4p2~t 1q
4~t4
;
 lim
~tÑ0
2~t 1
4
;
 1
4
: (6.137)
Hence the singularity at ~t  0 is regular. Because the singularity is regular, Equation
(6.132) may be solved using Frobenius' Method. Furthermore, it should be noted that
despite Equation (6.75) and Equation (6.132) being dierent the limits obtained when
determining the order of the poles at ~t  0 for Qp~tq
P p~tq ,
Rp~tq
P p~tq ,
Sp~tq
P p~tq and
T p~tq
P p~tq , given by
Equations (6.78)-(6.81) and Equations (6.134)-(6.137) are the same. Using the ansatz
NMp~tq  ~tr
8¸
n0
an~t
n;

8¸
n0
an~t
n0 ; (6.138)
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where a0  0 and ji is dened in Equation (6.40), Equation (6.132) may be written as
4
8¸
n0
an
n
0
n
1
n
2
n
3~t
n0    64  43 8¸
n0
an
n
0
n
1
n
2~t
n0
   74  123   62 8¸
n0
an
n
0
n
1~t
n0    4  43   62 8¸
n0
an
n
0
~t
n
0

8¸
n0
an~t
n0   2
8¸
n1
an1~t
n
0  0; (6.139)
which upon simplifying becomes
a0
pr  1q4  2q ~tr   8¸
n1
 
an
pn0 1q4  2q  2an1( ~tn0  0: (6.140)
Equation (6.140) is very similar to (6.87), thus the general solution to Equation (6.132)
will be given by a linear combination of the four independent solutions corresponding to
the four values of r satisfying Equation (6.89). Hence,
NMp~tq  c1y1p~tq   c2y2p~tq   c3y3p~tq   c4y4p~tq  0; (6.141)
where yjp~tq for j P t1; 2; 3; 4u are the four linearly independent solutions corresponding to
the four values of r satisfying Equation (6.89) and cjp~tq for j P t1; 2; 3; 4u are constants to
be determined using the initial conditions. For the coecients of ~t
n
0 for n ¥ 1 to equal
zero the recurrence relation
an  2ppn0 1q4  2qan1; (6.142)
must be satised. To check the resulting series converge the ratio test may be implemen-
ted. It can be seen that the ratio of two successive terms is given by
L  lim
nÑ8
 an~tn0an1~tn1
 ;
 lim
nÑ8

2
ppn01q42qan1
an1
~t
 ;
 lim
nÑ8
 2ppn0 1q4  2q~t
 ;
 0: (6.143)
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Since L   1 the series converges absolutely for all ~t. Thus, for small ~t, NMp~tq may be
written as
NMp~tq  Qp~tq  Op~t2q; (6.144)
where
Qp~tq 
4¸
j1
aj0~t
rj
"
1 2prj   1q4  2
~t
  4
2
tprj  2 1q4  2u tprj   1q4  2u
~t2
*
;
(6.145)
where the j correspond to the four dierent values of r. It should be noted that the
constants cj have now been incorporated into the values of aj. Note, this approximation
is not strictly rst order but is of the same form as that used for the cytotoxic case
described in Section 6.2.2.
Proceeding as with the cytotoxic case it is possible to compare the approximation given
by Equation (6.145) with the analytic solution to Equation (6.130). In order to do this the
parameters DI and  are chosen to have the arbitrary values of one and two respectively.
The initial conditions given by Equation (6.129) are transformed into the Cauchy initial
conditions in terms of the transformed variable ~t as
NMp0q  1; (6.146a)
dNMp~tq
d~t

~t 1
2
 0; (6.146b)
d2NMp~tq
d~t2

~t 1
2
 0; (6.146c)
and
d3NMp~tq
d~t3

~t 1
2
 0: (6.146d)
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Applying these initial conditions to Equation (6.145) gives
a10  0:1966  0:1999i;
a20  0:6074;
a30  0:6140;
a40  0:1966 0:1999i;
(6.147)
where aj0 , j P t1; 2; 3; 4u, correspond to rj where
rj  1  2
1
4 ij
2
: (6.148)
This approximation, together with the analytic solution to Equation (6.130) are plotted
in Figure 6.8.
M
Figure 6.8: Plot Showing a First Order Approximation Together with Actual Solution for
the Fourth Order ODE Given in Equation (6.130) with DI  1 and   2.
As with the cytotoxic case Figure 6.8 demonstrates that this technique for appoximating
the solution is in good agreement with the analytical solution. But further work is neces-
sary to gain information about the behaviour of the whole population of cells. By using
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the approximation for the population of cells in the M compartment, given by Equation
(6.145) and Equations (6.126) it is possible to obtain approximations for the populations
of cells in the other three phases. A plot for the total cell count, NT ptq, for the para-
meters DI  1 and   2 is shown in Figure 6.9. As can be seen from Figure 6.9 for
N (t)
T
Figure 6.9: Plot Showing an Approximation to the Total Cell Population with Cytostatic
Eect with DI  1 and   2.
the parameter values chosen the total number of cells does decline initially. To determine
when this is the case, and when the minimum will occur it is necessary to consider the
equations governing NT ptq. By combining Equations (6.126) it is possible to obtain
dNT ptq
dt
  1 2DIetNMptq: (6.149)
If the total population is to decrease then dNT ptq
dt
must be negative for some t. The
drug concentration, and hence its eects on the population, are monotonically decreasing
therefore if dNT ptq
dt
  0 for some t ¥ 0 then
dNT ptq
dt

t0
  0; (6.150)
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therefore
p1 2DIqNMp0q   0: (6.151)
From the initial conditions given in Equation (6.129) if Equation (6.151) is to be satised
then
DI ¡ 1
2
: (6.152)
Furthermore, if the population is initially in decline it is possible to nd the time at which
a minimum number of cells is present by nding when the derivative of NT ptq is zero, i.e.
 
1 2DIet

NMptq  0: (6.153)
It is clear that this will be a minimum by considering the physical nature of the system.
Any eects of the drug will diminish resulting in the population being able to recover. If
NMptq  0 then for Equation (6.153) to hold
t  ln p2DIq

: (6.154)
Thus, when DI  1 and   2 a minimum value of NT ptq  3:838 will occur when
t  lnp2q
2
 0:347, which is in good agreement with Figure 6.9. Unlike the cytotoxic case
it is now clear that the time at which the minimum occurs is logarithmically proportional
to the initial dose and inversely proportional to . Intuitively this is correct since the
drug decay is exponential and if the relative wash out rate is lower then the time taken
for the minimum to be achieved will be greater. Furthermore, by substituting Equation
(6.154) into the expression for NT ptq it can be shown that as DI increases the value of
the minimum decreases.
6.3.3 Case II :   Op1q
This case will not be considered further for the reasons discussed for Case II of the
cytotoxic model.
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6.3.4 Case III :  Ñ 8
This case is similar to the third case for the cytotoxic model. The rescaling ~t  t  t
~
is
applied to Equations (6.126) and (6.128) giving
1
~
dNG1p~tq
d~t
 2p1Dp~tqqNMp~tq NG1p~tq; (6.155a)
1
~
dNSp~tq
d~t
 NG1p~tq NSp~tq; (6.155b)
1
~
dNG2p~tq
d~t
 NSp~tq NG2p~tq; (6.155c)
1
~
dNMp~tq
d~t
 NG2p~tq NMp~tq; (6.155d)
and
dDp~tq
d~t
 ~Dp~tq NT p~tqDp~tq: (6.156)
Note the initial conditions remain unaected by these rescalings, so
Nip~tq  Nip0q  1 where i P tG1; S;G2;Mu: (6.157)
For the zeroth order approximation all ~ terms may be ignored. Thus Equations (6.110)
simplify to
dNG1p~tq
d~t
 0; (6.158a)
dNSp~tq
d~t
 0; (6.158b)
dNG2p~tq
d~t
ptq  0; (6.158c)
dNMp~tq
d~t
ptq  0: (6.158d)
From Equation (6.157) it is readily seen that NT  4. Making this substitution into
Equation (6.156) and neglecting the term multiplied by ~ gives
dDp~tq
d~t
 4Dp~tq: (6.159)
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Hence,
Dp~tq  DIe4~t: (6.160)
Equation (6.160) may now be expressed in terms of the original time variable, t, as
Dptq  DIe4t: (6.161)
But Ñ 8 therefore Dptq  0. Thus, for the case Ñ 8 the drug has a negligible uptake
and has a minimal eect on the population. This means the population of cells grows in
the same manner as the untreated model described in Section 2.1.2.
6.4 Comparison of the Eects of Cytotoxic and Cytostatic Drug
Interactions
For both the cytotoxic and cytostatic models Case II is disregarded and only Case I and
Case III are considered. For both types of drug interaction Case III results in the drug
having negligible eect on the population resulting in normal growth. This only leaves
Case I for comparison.
The G1 phase in the cytotoxic model and the M phase in the cytostatic model are gov-
erned by two fourth order ODEs, given by Equations (6.26) and (6.130) respectively.
These dierent fourth ordeer ODEs appear to be of a similar form. Upon obtaining the
approximations it is clear they do share common features, this is apparent due to the r
values that were obtained in the construction of the approximations being the same, i.e.
r  12 14

; 12
1
4 i

. By comparing the approximate solutions to Equations (6.26) and (6.130)
it can be seen that as t Ñ 8 then both solutions tend to c  e2ptq 12 142 where c is a
constant, this is illustrated in Figure 6.10. Therefore, if the long term behaviour of a cyto-
toxic model is given by a
 
e2ptq
 12 14
2 then this may be expressed as b
 
e2ptq
 12 14
2
where the constants a and b are related via b  a pe2q 12 14
2
. Hence it is possible to view
the cytotoxic model as the cytostatic model with a time delay of . The idea that both
models only dier by a time shift is reinforced by comparing the original systems of four
rst order ODEs governing the models.
The ability to use either model may be further justied by considering how the dierent
models eect the population over a period of time. In both models a proportion of cells
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N (t)
T
Figure 6.10: Plot Showing a First Order Approximation for Both Cytotoxic and Cytostatic
Models, Together with the Asymptote Both Models Tend to as tÑ 8.
is stopped from dividing, either by killing them directly (cytotoxicity) or making division
impossible (cytostasis). For the population it is irrelevant how these cells have been made
non viable, it is only important that they are unable to contribute to the next generation
of cells. It therefore makes sense that either model may be used. For the examples given
in Sections 6.2 and 6.3 the population distributions are equal at t  0 it therefore seems
biologically realistic that the cytostatic drug would have a greater eect initially as this
immediately eects how many cells are able to divide.
6.5 ODE Drug Interaction Summary
In this chapter a generic, four compartment, ODE cell cycle model was constructed which
accounts for multiple ways in which drug interactions may eect a population of cells.
Since only a qualitative understanding of the system is sought some assumptions were
made which in turn simplied the system of equations governing the model.
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In Section 6.2 the model was rened to take into account the eects of a cytotoxic drug
on the population of cells. The modied system of equations were presented and non-
dimensionalised. It was observed that the model may be divided into three categories
dependent on the order of one of the parameters, , of the system. It was discussed that
one of these cases could be removed as it only applied to a very limited range of biological
parameters, leaving only two cases to be considered. One of these was shown to have a
trivial solution, leaving only one of interest. For Case I in the cytotoxic model an analytic
solution in terms of hypergeometric functions was found. However, due to the model being
simplied, it may not be possible to nd an analytical solution for a system which has
had fewer simplications. As such, a technique for obtaining an approximate solution was
given. This technique was rst demonstrated on a simpler system which has similarities to
the biological system of interest. Although this technique was only applied to the special
case where all ki are equal it may be extended to apply to any system where the r values
obtained in solving the equation for the a0 coecient are linearly independent. This
enabled the approximation to easily be compared with the analytical solution. Once the
technique had been veried on the simpler system it was used on the cytotoxic model and
the results compared once more to the analytical solution. Once the approximation was
veried against the analytic solution for a single phase an approximation was obtained for
the total cell population. It was also shown that from Equations (6.16) it was possible to
derive a single ODE for the total population of cells, Equation (6.105). From this equation
it was shown that for DI ¡ 1 there is an initial decline in the overall cell population and
the time taken for the overall population to attain its minimum value was determined.
Section 6.3 followed a similar format to Section 6.2 with the model now being rened
to take into account the eects of a cytostatic drug on the population of cells. As this
scenario was worked through a number of similarities between the cytotoxic and cytostatic
model were noted.
In Section 6.4 the cytotoxic and cytostatic models were compared. It was shown that for
long term qualitative predictions both models produce the same results. The rationale
for why this may be the case was then discussed. It was therefore concluded that either
model may be used for modelling the eects of a simple drug interaction with a population
of cells.
Chapter 7
Conclusion and Further Work
In this thesis the modelling of two biological processes, namely the cell cycle and PKPD
interaction have been considered. In Chapters 2, 3 and 4 dierent approaches for modelling
a population of cells were discussed. In Chapter 5 some common techniques for modelling
PKPD were introduced. In Chapter 6 these two dierent threads were brought together
and a framework for modelling a population of cells with drug interaction was presented.
7.1 Summary
7.1.1 Summary of Chapter 2 : Cell Cycle Models
In Chapter 2 a number of existing cell cycle models were considered. Some of the ap-
proaches utilising ODEs to model a population of cells were discussed in Section 2.1 and it
was shown that using Steel's formulae, which were derived in Section 2.1.1, it is possible
to obtain further information from a single unstructured ODE model. Structured and
molecular ODE models were also discussed.
Since an ODE based model does not consider the intraphase heterogeneity of the popu-
lation PDE models are often used. Most cell population models that utilise PDEs have
a population balance framework. A comprehensive review of existing population balance
models was given in Section 2.2.1. The review starts with a brief introduction of the
population balance framework, together with an overview of the most common types of
structuring used for a population of cells. The concept of partition functions for mass
and DNA structured population balance models was introduced and the advantage of not
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needing a partition function for an age structured model was also discussed. DNA, mass
and multi variable models were reviewed with both a single, generation type approach and
a multi-cell phase approach being considered. A detailed review of the DNA structured
framework presented by Basse et al. in [3] was undertaken and a number of potential
problems with this model were discussed.
In Section 2.2.1 age structured PDEs are considered. The structure used in [6] was
reviewed and whilst this work provides a good general framework for the solution of a multi
compartment, age structured model the assumption that the transition of cells between
the S and G1 phases in this model is independent of age, is biologically unrealistic. These
issues are addressed by the CelCyMUS model given by [22], [23] and [57]. In Section 2.2.1
the age structured PDE model, CelCyMUS, was reviewed in depth. This work consists
of a detailed and accurate model, which was veried against experimental data, and has
since been extended to consider external factors such as radiation [35]. Despite this model
providing a good t to experimental data there are issues concerning the validity of the
transition functions used in [23] and [57]. A number of simplications may be made
without compromising the model's ability to accurately simulate and t experimental
data.
7.1.2 Summary of Chapter 3 : Validation and Comparison of New Ordinary
Dierential Equation and Partial Dierential Equation Models
In Chapter 3 two new models were formulated. The rst of these was a structured ODE
model consisting of four compartments, each corresponding to a dierent phase of the
cell cycle. General results for the phase distribution of the population were derived. The
phase distributions obtained using this model were compared to Steel's formulae, and
it was shown in the special case when all the rate constants are unity the results are
identical. For the case when the rate constants are not all unity estimates were placed
on the upper bound for the dierence between Steel's formulae and this ODE modelling
approach.
Using the CelCyMUS model as a starting point a new three compartment, age-structured
PDE model was presented in Section 3.2. Section 3.3 contains a comprehensive review of
the transition functions which model how the cells progress from the G1 to S phase of the
cycle. Existing constant [6], quadratic [22] and [23], and sigmoidal [57] transition functions
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were discussed in detail. Motivated, by the sigmoidal transition function given in [57] a
new sigmoidal transition function was presented. When expressed in non-dimensionalised
form this new sigmoidal transition function was shown to have only one independent
parameter, thus making the problem more tractable.
In Section 3.4 a numerical scheme for the new age-structured model was presented, to-
gether with a discussion on the scheme's stability. It was shown that for a monotonically
increasing probability of transition the numerical scheme is stable.
Section 3.5 saw the new age structured model with both constant and sigmoidal transition
functions compared with experimental data. It was shown that a constant transition rule
is sucient to accurately t the experimental growth curve. The blocking process used in
the experiment considered introduces oscillations into the phase distribution of the cells
which could have exacerbated the measuring of the cell population, leading to a large
experimental error. Because of this, if information concerning the phase distribution for
the cell population is important then the form of the transition function becomes more
critical.
The ODE model framework discussed in Section 3.1 was modied to allow direct compar-
ision with the PDE model described in Section 3.2. All of the parameter values obtained
in the ODE optimisation provided a good match to the experimental cell growth curve.
The fraction of cells in the dierent compartments varies by 19% and whilst lying outside
the bounds of experimental error ( [18], [19] and [36]) this is still suciently accurate to
gain a qualitative understanding of the behaviour of the cell population.
From this comparison it was concluded that if the duration of the phases is not important
and the only information required is a qualitative understanding of the phase distribution
or an approximation on the total number of cells within the population then a simple
ODE model may be used. If a more accurate measure of the phase distribution of the cell
population is required then a PDE or integral equation model may be required.
7.1.3 Summary of Chapter 4 : Integral Equations for an Age Structured Pop-
ulation Balance Model
In Chapter 4 the construction of integral equations which may be used for the analysis of
the cell population was considered. Two new functions, Mptq and P ptq, representing the
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number of cells dividing and the total number of cells in the population were introduced.
The system was then expressed in terms of integral equations for these two new functions.
Once Mptq and P ptq had been found the integral equations for the population densities
were readily derived. No analysis of these integral equations was undertaken and they
were included in this thesis to illustrate the availability of dierent techniques for model-
ling a population of cells using a population balance framework. Numerical calculations
involving the integral equations may provide a faster alternative to using a nite dierence
scheme for solving the PDEs directly but this has not been investigated further.
7.1.4 Summary of Chapter 5 : Pharmacokinetic and Pharmacodynamic Mod-
els
Chapter 5 started by giving a brief overview of how PKPD may be modelled. In the case
of pharmacodynamics the way in which this may be incorporated directly into a cell cycle
model was discussed. A brief introduction to widely used pharmacokinetic modelling was
then undertaken. Drugs administered by intravenous infusion and also extravascularly
were considered and simple compartment models described. The idea of multiple periodic
doses resulting in an iterative map of ODEs was discussed, but not solved. It was explained
how the eects of bioavailability may be included and what eect this would have on the
resulting solution.
It was shown that as a rst approximation to gain a qualitative understanding of how a
system behaves it is possible to use a single compartment model. Furthermore, it was
shown, in Section 5.1.1, that it was possible to back extrapolate from the graph of the
concentration caused by a constant rate infusion to obtain the equivalent bolus dose which
would give the concentration curve post infusion. As such to simplify the model further
the dose may be assumed to be administered in a single bolus dose.
7.1.5 Summary of Chapter 6 : A Cell Cycle Model with Drug Interaction
In Chapter 6 a generic, four compartment, ODE cell cycle model was constructed which
accounts for multiple ways in which drug interactions may eect a population of cells.
Since only a qualitative understanding of the system was sought some assumptions were
made which in turn simplied the system of equations governing the model.
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In Section 6.2 the model was rened to take into account the eects of a cytotoxic drug
on the population of cells. The modied system of equations were presented and non-
dimensionalised. It was observed that the model may be divided into three categories
dependent on the order of one of the parameters, , of the system. It was discussed that
one of these cases could be removed as it only applied to a very limited range of biological
parameters, leaving only two cases to be considered. One of these was shown to have a
trivial solution, leaving only one of interest. For this remaining case an analytic solution in
terms of hypergeometric functions was found. However, due to the model being simplied,
it was noted it may not be possible to nd an analytical solution for a system which has
had fewer simplications. As such, a technique for obtaining an approximate solution
was given. This technique was rst demonstrated on a simpler system. Although this
technique was only applied to the special case where all ki are equal it may be extended
to apply to any system where the r values obtained in solving the equation for the a0
coecient are linearly independent. This enabled the approximation to easily be compared
with the analytical solution. Once the technique had been veried on the simpler system
it was used on the cytotoxic model and the results compared once more to the analytical
solution. An approximation was then obtained for the total cell population NT and it was
shown that it was possible to determine if the population was monotonically increasing
or if there was an initial dip in the population size due to the drug interaction, and if so
when the minimum number of cells would occur. Such information is of importance in
calculating when multiple doses should be given to optimise any eects.
Section 6.3 followed a similar format to Section 6.2 with the model now being rened
to take into account the eects of a cytostatic drug on the population of cells. As this
scenario was worked through a number of similarities between the cytotoxic and cytostatic
model were noted.
In Section 6.4 the cytotoxic and cytostatic models were compared. It was shown that
for long term qualitative predictions both models tended to the same limit, diering only
by a time delay. The rationale for why this may be the case was then discussed. It was
therefore concluded that either model may be used for modelling the eects of a simple
drug interaction with a population of cells.
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7.2 Conclusion
Whilst PDE models are necessary to capture the intraphase heterogeneity of a popula-
tion of cells if the only information required is a qualitative understanding of the phase
distribution or an approximation on the total number of cells within the population then
a simple ODE model may be used. For a qualitative understanding of a PKPD system
it was shown it is possible to use a single compartment model with a single bolus dose
included in the initial conditions. Combining such models for the cell population and the
PKPD eects it is possible to obtain a system of equations which can be solved to give a
semi analytical solution. Whilst the models presented in Chapter 6 are too simplistic to
be used to predict experimental results it is hoped this work provides a solid basis upon
which such models may be developed further.
7.3 Further Work
In this section several ideas for extending this work are discussed.
7.3.1 Overcrowding
The cell cycle models discussed in this thesis do not take into account the possible eects
of the physical overcrowding of the cells. Since there is no spatial element included in the
models, once any transient eects have diminished the population will grow exponentially.
In reality the physical limitations on space mean the cell population cannot remain in
an exponential growth phase. To stop the exponential phase of cell growth continuing
indenitely it is necessary to introduce some form of overcrowding control. There are
three possible ways the population size may be regulated.
For the age-structured PDE model discussed in Section 3.2 it is possible to control the
probability of cells passing through the G1  S checkpoint via the transition function.
If the probability of transition is dependent on nutrient uptake and there are limited
nutrients then this would clearly reduce the number of cells progressing through the cycle.
A transition function for limited nutrients is briey discussed in Appendix A. If nutrients
are not a limiting factor for the growth of the cell population then it is a reasonable
assumption to keep the uptake rate, R constant. If the ODE model discussed in Section
3.1 is used similar changes could be made to one of the rate constants k.
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The second method is to introduce some form of survival fraction which is dependent on
total population size. In eect this introduces a loss term into the dierential equations
for the cell population densities. Such a method has been considered in [17] and [28].
An alternative approach is to vary the proliferation rate at cell division. Clearly, a cell
either divides or it does not but it is possible to attribute an average number of daughter
cells produced for the population. If such a division rate is dependent on population size
this would have the eect of regulating the population's total size. This concept has been
explored by [17] and [28].
It is the latter of these approaches which is now considered further, with a new birth
rate function being introduced. Consider an articial cell line for which if the cells do
not have many neighbours (i.e. very low cell density) then the population dies, so for
low cell density the proliferation factor needs to be less than one. For moderate cell
densities then the growth is optimum and therefore the proliferation factor needs to be
close to two. For high cell densities the cells will be overcrowded therefore will have a
lower proliferation factor. If when overcrowded the proliferation factor is greater than one
then the population may continue to increase (depending on how many cells die due to
other events in the cycle) making the overcrowding worse. It therefore seems a reasonable
assumption to make the proliferation factor at high cell densities to be slightly less than
one. A suitable type of function which fullls these criteria is given by
1 c  tanhpNptq  aq  c tanhpNptq  bq; (7.1)
where Nptq is the total cell density and a, b and c are parameters which determine the
shape and asymptotic limit of the function as Nptq increases. A sketch of this function
is shown in Figure 7.1. This function asymptotes to 2  2c as Nptq Ñ 8 and has
a maximum value of two which approximately occurs when Nptq P ra; bs. If the cell
density is normalised so the starting population has a density of one then values of 0.1,
10 and 0.625 for a, b and c respectively give a function which has a maximum of two
for cell densities varying approximately between 0.1 and 10 times the starting density.
The asymptote is now 0.75 which also satises the requirement that the asymptote is less
than one. It is clear that the introduction of such a function to regulate the proliferation
factor will result in the population reaching a locally stable steady state at a normalised
population of 10.
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Figure 7.1: Sketch of A Suitable Overcrowding Function for which Cell Growth is Optimal
at Moderate Cell Densities.
To demonstrate the eect of introducing this overcrowding term, the new age structured
model described in Section 3.2 with the new sigmoidal transition function was run using
the parameters given in Table 3.1 together with the overcrowding term using the para-
meters given above. The resulting growth curve is shown in Figure 7.2. This plot only
displays viable cells, as such it starts at zero since cells entering the cycle from the G' are
not included.
By comparing Figures 7.2 and 3.12b it can be seen that the transient oscillations discussed
in Section 3.5.1 decay at a faster rate. This is possibly due to the sti nature of the
function given in Equation (7.1). Dierent approaches for taking into account the eects of
overcrowding, such as competition between cells and also competition with other cellular
populations has not been considered. This may provide more biologically meaningful
results.
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Figure 7.2: The Eect of Introducing an Overcrowding Function on the Cell Density.
7.3.2 Periodic Dosing
The idea of periodic dosing was discussed in Section 5.1.3. It was shown that it is possible
to express the drug concentration as a set of iterative dierential equations where the
initial conditions for the nth period of infusion/post infusion is the nal concentration
in the pn  1qth period. By combining this scheme with a cell cycle model it should be
possible to accurately simulate the eects of periodic dosing. However, it should be noted
that for periodic dosing it is possible that a scenario corresponding to Case II in Sections
6.2 and 6.3 (i.e. Opq  1) may no longer only apply for a small parameter space and as
such this case will need to be considered.
A good starting point for the time spacing between the periodic doses would be the time
taken for any minimum in the total population to occur. However, this may not be the
optimal strategy as this does not take into consideration the phase distribution of the
cells. It may therefore prove useful to consider when minimum cell densities occur within
a particular phase or when maximum relative phase density occurs for multiple dosing.
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7.3.3 Multiple Compartments
Using a population balance framework, heterogeneous populations of cells may be mod-
elled mathematically, resulting in a set of partial dierential equations for the cell pop-
ulation density. If the heterogeneity is not of interest then ordinary dierential equation
models suce. In both cases, the models may then be extended to account for external
factors aecting the population such as nutrient deprivation, radiation treatment or cyto-
toxic drugs allowing for a greater understanding of the carcinogenesis process. The model
may be rened still further by considering sub populations within the tumour which are
grouped according to a particular attribute, such as spatial location or proximity to a
nutrient source, i.e. how close cells are to the vascular network.
Tumour Vascular Networks
Malignant tumours often experience rapid growth resulting in regions of the tumour be-
coming hypoxic. Cells in these hypoxic regions are normally more resistant to treat-
ment [29] and [51]. These regions of hypoxia promote the angiogenesis process within the
tumour resulting in avascular growth. The random nature of tumour vascular networks
means there are often regions within the same tumour which are well perfused, hypoxic
and necrotic. Further details about the oxygenation of tumours may be found in [56].
Outline of a Multiple Compartment Model
By considering these populations separately it is possible to build a multiple compartment
model with each compartment representing a dierent level of oxygenation. Whilst this
approach lacks a spatial element it does allow a qualitative picture of the behaviour and
growth of cells in each compartment to be obtained. As discussed in Chapter 5 the
drug is delivered to the target cells via the blood plasma. Therefore, it is a reasonable
assumption that the amount of drug received at a particular site is proportional to the
level of oxygenation. It should be noted however, that the distance a drug diuses through
the inter cellular media is dierent to the distance oxygen diuses [34], but since the model
outlined here accounts for ranges of hypoxia / oxygen proliferation this is accounted for
via dierent rate constants.
A suitable three compartment model is shown in gure 7.3.
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The full set of equations for this model are now given by
Well Perfused Region
Cell Population density equations
dNG1ptq
dt
 PnpDnptqqk1pDnptqqNMptq  k2pDnptqqNG1ptq  f1pDnptqqNG1ptq; (7.2a)
dNSptq
dt
 k2pDnptqqNG1ptq  k3pDnptqqNSptq  f2pDnptqqNSptq; (7.2b)
dNG2ptq
dt
 k3pDnptqqNSptq  k4pDnptqqNG2ptq  f3pDnptqqNG2ptq; (7.2c)
dNMptq
dt
 k4pDnptqqNG2ptq  k1pDnptqqNMptq  f4pDnptqqNMptq: (7.2d)
Drug concentration equation
dDnptq
dt
d1ptq   d8ptqDhptq  d7ptqDnptq  d4ptqDnptq
 gnpNG1ptq; NSptq; NG2ptq; NMptqqDnptq: (7.3)
Hypoxic Region
Cell Population density equations
dHG1ptq
dt
 PhpDhptqqk5pDhptqqHMptq  k6pDhptqqHG1ptq  f5pDhptqqHG1ptq; (7.4a)
dHSptq
dt
 k6pDhptqqHG1ptq  k7pDhptqqHSptq  f6pDhptqqHSptq; (7.4b)
dHG2ptq
dt
 k7pDhptqqHSptq  k8pDhptqqHG2ptq  f7pDhptqqHG2ptq; (7.4c)
dHMptq
dt
 k8pDhptqqHG2ptq  k5pDhptqqHMptq  f8pDhptqqHMptq: (7.4d)
Drug concentration equation
dDhptq
dt
d2ptq   d7ptqDnptq  d8ptqDhptq   d10ptqDcptq  d9ptqDhptq  d5ptqDhptq
 ghpHG1ptq; HSptq; HG2ptq; HMptqqDhptq: (7.5)
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Necrotic Region
Cell Population density equations
dCG1ptq
dt
 PcpDcptqqk9pDcptqqCMptq  k10pDcptqqCG1ptq  f9pDcptqqCG1ptq; (7.6a)
dCSptq
dt
 k10pDcptqqCG1ptq  k11pDcptqqCSptq  f10pDcptqqCSptq; (7.6b)
dCG2ptq
dt
 k11pDcptqqCSptq  k12pDcptqqCG2ptq  f11pDcptqqCG2ptq; (7.6c)
dCMptq
dt
 k12pDcptqqCG2ptq  k9pDcptqqCMptq  f12pDcptqqCMptq: (7.6d)
Drug concentration equation
dDcptq
dt
 d3ptq   d9ptqDhptq  d10ptqDcptq  d6ptqDcptq
 gcpCG1ptq; CSptq; CG2ptq; CMptqqDcptq: (7.7)
Equations (7.2a)-(7.7), together with suitable boundary conditions fully dene the system.
Note, this model does not account for cells passing between the dierent compartments.
The reason for this not being included is the angiogenesis process and cell motility are
likely to occur on a timescale much greater than that being considered for drug interac-
tions.
7.3.4 Competition
The population of healthy cells near the tumour may be included in the model outlined
in Section 7.3.3 by the addition of an additonal compartment. This extra compartment
would have the same rate constants as the well perfused region but additionally may
include some form of competition between the healthy cells and the well perfused tumour
cells as these would be competing for space and nutrients. One possible way in which
this may be done is by adding an overcrowding term to the populations of healthy and
well perfused tumour cells. Such an overcrowding term may take the form described in
Section 7.3.1 where Nptq is now the sum of both of these populations.
Including the healthy cell population in any model for oncology treatments is important
as this allows for the toxicity eects on the healthy population to be included.
Appendix A
Modied Sigmoidal Transition
Function, Accounting for the Eects of
Limited Nutrient Availability
To properly take into account the eects of limited nutrient availability on the cells we
need to return to the assumptions made about the rate of nutrient uptake. When the
availability of nutrients is limited an alternative to the constant uptake rate is required,
a reasonable choice is to take a Michaelis-Menten type form such as
R  RmaxCglut
Ks   Cglut ; (A.1)
where Rmax is the maximum rate glutamine may be absorbed, Cglut is the remaining
amount of glutamine in the medium and Ks is a parameter to be determined.
Note, R is now a function of Cglut which is itself a function of time, however for ease
RpCglutptqq is simply written as R and Cglutptq as Cglut. Inserting this form for glutamine
183
184
APPENDIX A. MODIFIED SIGMOIDAL TRANSITION FUNCTION,
ACCOUNTING FOR THE EFFECTS OF LIMITED NUTRIENT AVAILABILITY
uptake into the new sigmoidal transition rule presented in Section 3.3.1 yields
hpq  
S
BCc
B
exp pCcS  12q
1 exp pCcS  12q ;
 R
S
exp 
 ³
0 Rd
1
S
 1
2


1 exp 
 ³
0 Rd
1
S
 1
2

 ;
 RmaxCglut
Ks Cglut

S
exp 
 ³0 RmaxCglutKs Cglut d 1S  12

1 exp 
 ³0 RmaxCglutKs Cglut d 1S  12

:
(A.2)
The non-dimensionalisation of this form of the transition rule is the same as in Section
3.3.1, however the rescaling is set so the maximum amount of glutamine a cell can uptake
in each unit of time is one. This was chosen to occur above the initial medium glutamine
concentrations.
Appendix B
Construction of the Time Step Matrix
The matrix M given in Equation (3.97) is composed of smaller sub matrices. Each of
these sub matrices relate to part of the time stepping of cells in the X and Y phases. M
may be written as
M 

0
...... 0
...... 0
...... 0
...... A
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : :
B
...... C
...... D
...... 0
...... 0
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : :
0
...... E
...... F
...... 0
...... 0
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : :
G
...... H
...... I
...... 0
...... 0
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : :
0
...... 0
...... 0
...... J
...... K

: (B.1)
The sub matrices A-K are dened as follows
A represents cells leaving the Y phase, doubling and entering the X phase. It is a (K-1)x1
matrix containing only one non-zero entry

0    0 2

: (B.2)
B, C and D form the main central dierence scheme i.e. Lax-Wendro. B is an 1x(N-2)
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matrix whose rst cell is the only non-zero entry
Ò
0
...
0
 ; (B.3)
C is an (N-2)x(N-2) tri-diagonal matrix
Ò Ò
0 : : : : : : : 0Ò Ò Ò . . . .....
0
Ò Ò Ò . . .
.....
. . . . . . . . . . . . 0
. . .
Ò Ò Ò
0 : : : : : : : 0
Ò Ò

; (B.4)
and D is a 1x(N-2) matrix whose last cell is the only non-zero entry
0
...
0Ò
 : (B.5)
E and F contain the nite dierence scheme for the last age component of the X phase.
This can either be a backward dierence scheme or a central dierence scheme with the
X 1 term assumed to be zero and therefore omitted. Using the central dierence scheme
(with X 1 term omitted) E is a 1x(N-2) matrix whose last cell is the only non zero entry
0    0 Ò ; (B.6)
and F is a single non-zero entry matrix Ò
: (B.7)
G,H and I represent the cells leaving the X phase and entering Y phase via the transition
function h(v). The number of cells leaving X at any time step via the transition rule is
given by » Xmax
0
hpqXd: (B.8)
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For discretization purposes this can be approximated using the trapezium rule
Y 0i 1 
» Xmax
0
hpqXd  
2
 
hp0qX0i   hpN  1qXN1i
   N2¸
j1
hpjqXji ; (B.9)
therefore G is a single celled matrix 

2
hp0q

; (B.10)
H is a (N-2)x1 matrix given by
hp1q    hpN  2q

; (B.11)
and I is a single celled matrix 

2
hpN  1q

: (B.12)
J and K represent cells moving through Y. J is a 1x(K-1) matrix containing a 1 in the
rst cell and zeros in all other cells. 
1
0
...
0
 ; (B.13)
and K contains ones on the lower diagonal and zeros elsewhere
0 0 : : : : : : : 0
1 0 : : : : : : : 0
0
. . . . . .
...
0
. . . . . . . . . 0
0    0 1 0

: (B.14)
Appendix C
An Alternative Approach for the Proof
of Stability of the Numerical Scheme
In Section 3.4 a numerical scheme for the simplied model is discussed. To prove the
stability of the numerical scheme it is sucient to show that a simpler numerical scheme,
for a two compartment model is also stable. As detailed in Section 3.4 this scheme may
be written as 
X0m 1
X1::N2m 1
XN1m 1
Y 0m 1
Y 1::K1m 1

M

X0m
X1::N2m
XN1m
Y 0m
Y 1::K1m

; (C.1)
where M is an pN   Kq  pN   Kq matrix. To prove the stability of this scheme it is
sucient to show the norm of M satisesM ¤ 1  ; (C.2)
where t     and  is a constant independent of . An argument following that
described on p66-67 of [58] shows that such a  can be found. Note that this  depends
on a bound for
Mj where j ¤ N , this is allowed by the theory discussed in [58]. The
norm of M is given byM  supt2;  N2¸
j1
hpjq   
2
php0q   hpN  2qqu: (C.3)
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By denition   Xmax
N
, also since h(v) is the probability of transition
hpiq ¤ 1@ i
therefore

N2¸
j1
hpjq  Xmax
N
N2¸
j1
hpjq ¤ XmaxpN  2q
N
; (C.4)
and therefore remains bounded. Therefore
M ¤ 1   so the scheme is stable.
Appendix D
Change of Order of Integration for
PCptq
In order to change the order of integration on the second of the integrals in Equation
(4.55) it is helpful to consider a graphical representation of the region of interest.
6
-


t
t-TC
TC
Figure D.1: Graphical Representation of the Region of Integration for PCptq when TC ¤
t   TB.
From considering this graphical representation of the region of integration it can be seen
that » TC
0
» t
0
d d 
» tTC
0
» TC
0
d d  
» t
tTC
» t
0
d d: (D.1)
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Appendix E
A Check of the Numerical
Approximations for the Solutions to
ODEs
E.1 Second Order ODE Solution Comparison
The analytic solution to Equation (6.30) given by Equation (6.31) may be expressed in
terms of ~t, as given in Equation (6.33), as
xptq  ~Ae~t ~t 22

I 2
2
 
~t
  I 2 
2
 
~t
	
  ~Be~t ~t 22

K2
2
 
~t
K 2 
2
 
~t
	
; (E.1)
where ~A and ~B are new constants. Upon making the substituion   5 Equation (E.1)
becomes
xptq  ~Ae~t ~t 710

I3
10
 
~t
  I 7
10
 
~t
	
  ~Be~t ~t 710

K 3
10
 
~t
K 7
10
 
~t
	
: (E.2)
I and K may be expressed as
Ip~tq 
8¸
r0
 
1
2
~t
 2r
r! p   r   1q ; (E.3)
and
Kp~tq  
2
 
Ip~tq  Ip~tq

cosecpq; (E.4)
respectively.
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Therefore,
I3
10
p~tq  2
3
10 ~t
3
10
 
 
7
10
   21710 ~t 1710
 
 
17
10
  O ~t 3710	 ; (E.5)
I 7
10
p~tq  2
7
10 ~t
7
10
 
 
17
10
  O ~t 2710	 ; (E.6)
K 3
10
p~tq  
2

I3
10
p~tq  I 3
10
p~tq
	
cosec

3
10


;
 
2

2
3
10 ~t
3
10
 
 
7
10
   21710 ~t 1710
 
 
17
10
  2310 ~t 310
 
 
13
10
 cosec3
10


 O

~t
23
10
	
; (E.7)
and
K 7
10
p~tq  
2

I7
10
p~tq  I 7
10
p~tq
	
cosec

7
10


;
 
2

2
7
10 ~t
7
10
 
 
3
10
   21310 ~t 1310
 
 
13
10
  2710 ~t 710
 
 
17
10
 cosec7
10


 O

~t
27
10
	
: (E.8)
Also,
e
~t  1  ~t  1
2
~t2  O  ~t3 ;
therefore
e
~t~t
7
10  ~t 710   ~t 1710   1
2
~t
27
10  O

~t
37
10
	
: (E.9)
Thus,
e
~t ~t
7
10

I3
10
 
~t
  I 7
10
 
~t
	  ~t 710   ~t 1710   1
2
~t
27
10

#
2
3
10 ~t
3
10
 
 
7
10
   21710 ~t 1710
 
 
17
10
   2710 ~t 710
 
 
17
10
+
 O

~t
27
10
	
;
 2
3
10 ~t
2
5
 
 
7
10
   2710 ~t 75
 
 
17
10
   2 310 ~t 75
 
 
7
10
  O ~t 125 	 ;
 2
3
10 ~t
2
5
 
 
7
10
  

10
7
2
7
10   2 310
	
~t
7
5
 
 
7
10
  O ~t 125 	 ;
 2
3
10 ~t
2
5
 
 
7
10
   127 2 310 ~t 75
 
 
7
10
  O ~t 125 	 ; (E.10)
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and
e
~t ~t
7
10

K 3
10
 
~t
K 7
10
 
~t
	  ~t 710   ~t 1710   1
2
~t
27
10

#

2

2
3
10 ~t
3
10
 
 
7
10
   21710 ~t 1710
 
 
17
10
  2310 ~t 310
 
 
13
10
 cosec3
10


 
2

2
7
10 ~t
7
10
 
 
3
10
   21310 ~t 1310
 
 
13
10
  2710 ~t 710
 
 
17
10
 cosec7
10

+
 O

~t
23
10
	
;
 
2
cosec

3
10


~t
7
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2
~t
27
10

#
2
3
10 ~t
3
10
 
 
7
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 
 
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10
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7
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7
10
 
 
3
10
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 
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
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
3
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
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 
 
3
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 
 
7
10
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 
 
13
10
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 
 
13
10
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 
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10

 2
7
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 
 
3
10
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 
 
7
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 
 
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3
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 O

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;
 

2
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 
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
 
 
3
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3
2
3
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3
2
13
10   10
3
2
3
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~t2
*
 

2
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 
3
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2
3
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 
 
7
10
 "~t 25   ~t 75   5
7
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7
5
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
2
2
7
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 
3
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
 
 
3
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3
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
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: (E.11)
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Substituting Equations (E.10) and (E.11) into Equation (E.2) gives
xp~tq  ~A

2
3
10 ~t
2
5
 
 
7
10
   127 2 310 ~t 75
 
 
7
10
 
 ~B

2
2
7
10 cosec
 
3
10

 
 
3
10
 "1  8
3
~t  3~t2
*
  ~B

2
cosec
 
3
10

2
3
10 ~t
2
5
 
 
7
10
 "1  12
7
~t
*
 O

~t
12
5
	
;
 2
3
10 ~t
2
5
 
 
7
10
 
2
cosec

3
10


~B   ~A

"
1  12
7
~t
*
 ~B

2
2
7
10 cosec
 
3
10

 
 
3
10
 "1  8
3
~t  3~t2
*
;
(E.12)
which on re-labelling the constants becomes
xp~tq  A^~t 25
"
1  12
7
~t
*
  B^
"
1  8
3
~t  3~t2
*
: (E.13)
Which is the same as Equation (6.69). Therefore it has been shown that for the second
order ODE given by Equation (6.30) the second order approximation obtained using
Frobenius' technique is identical to the second order approximation of the analytical
solution.
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The analytic solution to Equation (6.26) is given by Equation (6.27). Using the denition
of the hypergeometric function as given in Equation (6.29) it can be seen that a second
order approximation for a hypergeometric function is given by
pFqpa;b; zq 
8¸
n0
zn
p±
i1
 pai nq
 paiq
n!
q±
j1
 pbj nq
 pbjq
;

2¸
n0
zn
p±
i1
 pai nq
 paiq
n!
q±
j1
 pbj nq
 pbjq
 Opz3q:
(E.14)
Therefore an approximation to Equation (6.27) is given by
NG1ptq  C1pe2tq
12
1
4
2
$&%1 2
3
4
p2 2 14 q4  2pe
2tq  p2 2
1
4 q32 34!
p2 2 14 q4  2
)!
p4 2 14 q4  2
)pe2tq2
,.-
  C2pe2tq 1 2
1
4
2
$&%1  2
3
4
p2  2 14 q4  2pe
2tq   p2  2
1
4 q32 34!
p2  2 14 q4  2
)!
p4  2 14 q4  2
)pe2tq2
,.-
  C3pe2tq 12
1
4 i
2
$&%1  2
3
4 i
p2 2 14 iq4  2pe
2tq   p2 2
1
4 iq32 34 i!
p2 2 14 iq4  2
)!
p4 2 14 iq4  2
)pe2tq2
,.-
  C4pe2tq 1 2
1
4 i
2
$&%1 2
3
4 i
p2  2 14 iq4  2pe
2tq  p2  2
1
4 iq32 34 i!
p2  2 14 iq4  2
)!
p4  2 14 iq4  2
)pe2tq2
,.-
 Ope6tq: (E.15)
Since the parameter , has a value of two, the solution given by Equations (6.94 and
6.95), may be written as
NG1p~tq  P p~tq  Op~t2q; (E.16)
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where
P p~tq 
4¸
i1
ai0~t
ri
"
1  p2ri  1q
3
p2ri   1q4  2
~t
  p2ri   1q
3p2ri  1q3
tp2ri   3q4  2u tp2ri   1q4  2u
~t2
*
;
(E.17)
where the i correspond to the four dierent values of r. Upon making the substitution
given in Equation (6.74) to repose Equations (E.16 and E.17) in terms of t it can be seen
that Equations (E.16 and E.17) are identical to Equation (E.15). Thus, the approximation
obtained using Frobenius' technique is identical to the rst order approximation of the
analytical solution.
Appendix F
Case I for a Cytotoxic Drug-Cell Cycle
Model When Phase Rate Constants
Are Not Equal
The equations governing a population of cells with the eects of drug interaction are
given be Equations (6.1), the corresponding equation for drug concentration is given by
Equation (6.2). As detailed in Section 6.1 these equations may be simplied by making
certain assumptions about the model.
In this appendix these assumptions are re-stated, with the assumption k1pDptqq  k2pDptqq 
k3pDptqq  k4pDptqq  k being removed. However, it is assumed that the phase rates are
constant and not dependent on the drug concentration, Dptq. Case I for a cytotoxic drug
interaction is then analyised for this more general case.
By assuming the drug is delivered in a single, bolus dose dinptq may be incorporated into
the initial conditions. The rate of clearance may be assumed to be directly proportional
to the amount of drug in the system. Furthermore, the drug can be assumed to be
taken up equally by all cells, regardless of phase. The rate the drug is used up is clearly
proportional to the total cell population density. Also, if the concentration of the drug
in the system is not so high that the cells are being saturated with the amount of drug
they may take up then the rate the drug is used is rst order with respect to the drug
concentration thus gpNG1ptq; NSptq; NG2ptq; NMptq; Dptqq  NT ptqDptq where NT ptq is
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the total cell population density at time t. Equation (6.2) now becomes
dDptq
dt
 doutDptq  NT ptqDptq: (F.1)
For a cytotoxic drug the same assumptions as in Section 6.2 are made. That is, the drug
only eects cells in the S phase, thus f1pDptqq  f3pDptqq  f4pDptqq  0. Furthermore,
let the drug eect cells in the S phase in a way which is directly proportional to the drug
concentration in the inter cellular media, hence f2pDptqq  eDptq where e can be thought
of as the ecacy of the drug. Since the drug has a cytotoxic eect only the average
number of cells produced at each division is not dependent on the drug concentration and
is therefore a constant, thus P pDptqq  2. Equations (6.1) now simplify to
dNG1ptq
dt
 2k1NMptq  k2NG1ptq;
dNSptq
dt
 k2NG1ptq  k3NSptq  eDptqNSptq;
dNG2ptq
dt
 k3NSptq  k4NG2ptq;
dNMptq
dt
 k4NG2ptq  k1NMptq:
(F.2)
Equations (F.1) and (F.2) together with suitable initial conditions now represent a simpli-
ed model with a cytotoxic drug interaction where the phase constants, ki; i P tG1; S;G2;Mu,
are not equal. It should be noted by setting k1  k2  k3  k4  k Equation (F.2) simply
becomes (6.6). The initial conditions are chosen to be the same as that for the case con-
sidered in Section 6.2 where the phase rates are all equal and are given by Equations (6.7)
and (6.8).
F.1 Non-dimensionalisation of the Equations
As discussed in Section 6.2.1 it is helpful to non-dimensionalise the system of equations
given by Equations F.2 and (F.1). The rst step in the non-dimensionalisation process
is to introduce new, dimensionless variables ~t, ~Dp~tq, ~NG1p~tq, ~NSp~tq, ~NG2p~tq, ~NMp~tq and
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~NT p~tq dened as
~t  t
b
; (F.3a)
~NG1p~tq  NG1ptqa ; (F.3b)
~NSp~tq  NSptq
a
; (F.3c)
~NG2p~tq  NG2ptqa ; (F.3d)
~NMp~tq  NMptq
a
; (F.3e)
~NT p~tq 
¸
i
~Nip~tq; (F.3f)
~Dp~tq  Dptq
c
: (F.3g)
Where a, b and c are dimensional constants which may be arbitrarily chosen as to simplify
the system. Note, the cell densities in the dierent compartments are all scaled equally
to avoid potentially misleading distributions. Substituting the non-dimensional variables
into Equations (F.1) and (F.2) gives
a
b
d ~NG1p~tq
d~t
 2ak1 ~NMp~tq  ak2 ~NG1p~tq;
a
b
d ~NSp~tq
d~t
 ak2 ~NG1p~tq  ak3 ~NSp~tq  ace ~Dptq ~NSp~tq;
a
b
d ~NG2p~tq
d~t
 ak3 ~NSp~tq  ak4 ~NG2p~tq;
a
b
d ~NMp~tq
d~t
 ak4 ~NG2p~tq  ak1 ~NMp~tq;
(F.4)
and
c
b
d ~Dp~tq
d~t
 cdout ~Dp~tq  ac ~NT p~tq ~Dp~tq: (F.5)
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The corresponding initial conditions are now given by
~Nip0q 
~NT p0q
4
where i P tG1; S;G2;Mu; (F.6)
and
~Dp0q  ~DI where ~DI  DI
c
: (F.7)
Equations (F.4) and (F.5) may be re-arranged to give, upon dropping the tilde notation,
dNG1ptq
dt
 2bk1NMptq  bk2NG1ptq;
dNSptq
dt
 bk2NG1ptq  bk3NSptq  bceDptqNSptq;
dNG2ptq
dt
 bk3NSptq  bk4NG2ptq;
dNMptq
dt
 bk4NG2ptq  bk1NMptq;
(F.8)
and
dDptq
dt
 bdoutDpptq  abNT ptqDptq: (F.9)
The constants b and c are now chosen as b  1
k1
and c  k1
e
thus simplifying Equations
(F.8) and (F.9) to
dNG1ptq
dt
 2NMptq  k2
k1
NG1ptq;
dNSptq
dt
 k2
k1
NG1ptq  k3k1NSptq DptqNSptq;
dNG2ptq
dt
 k3
k1
NSptq  k4
k1
NG2ptq;
dNMptq
dt
 k4
k1
NG2ptq NMptq;
(F.10)
and
dDptq
dt
 dout
k1
Dpptq  a
k1
NT ptqDptq: (F.11)
The parameter a may be chosen arbitarily, but a sensible choice is a  NT p0q
4
. This value
is chosen such that the normalised initial conditions for the cell population densities in
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each of the four compartments are all one. It should be noted that a " 1. The parameters
dout and k are both Op1q as one represents the clearance of the drug per unit time and
the other the rate at which cells progress between the compartments. The parameter
 represents the amount of drug absorbed per cell per unit time and as such may be
assumed to be very small,  ! 1. Five new parameters are now introduced; A  k2
k1
,
B  k3
k1
, C  k4
k1
,   dout
k1
and   a
k1
. The order of A, B, C and  are all Op1q and the
order of  is unknown. Equations (F.10) and (F.11) may now be rewritten as
dNG1ptq
dt
 2NMptq  ANG1ptq;
dNSptq
dt
 ANG1ptq BNSptq DptqNSptq;
dNG2ptq
dt
 BNSptq  CNG2ptq;
dNMptq
dt
 CNG2ptq NMptq;
(F.12)
and
dDptq
dt
 Dpptq  NT ptqDptq; (F.13)
respectively.
F.2 Obtaining an Approximate Solution
For the case  ! 1 the process for obtaining a solution to the system of equations given
by Equations (F.12) and (F.13) is the same as that described in Section 6.2.2 As such the
description of the process here is brief, for a more detailed discussion see Section 6.2.2.
Equation (F.13) decouples from the system and may readily be solved. This solution may
then be put back into the remaining cell population equations, given by Equations (F.12),
resulting in a system of four rst order ODEs, which may then be converted into a single
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fourth order ODE, given by
d4NG1ptq
dt4
   A B   C   1 DIet d3NG1ptq
dt3
   A  AB   AC  B  BC   C   pA  C   1qDIet d2NG1ptq
dt2
   AB   ABC   AC  BC   pA  AC   CqDIet dNG1ptq
dt
  ABC  ACDIetNG1ptq  0:
(F.14)
It can readily be seen that if A  B  C  1 then Equation (F.14) simplies to Equation
(6.26). For ease of notation the new parameters    A   B   C   1,   A   AB  
AC  B  BC  C, E  A C   1, Z  AB  ABC  AC  BC and H  A AC  C
are introduced. Applying the change of variables given in Equation (6.74) to Equation
(F.14) yields
4~t4
d4NG1p~tq
d~t4
   64~t3   3~t3  3~t4( d3NG1p~tq
d~t3
   74~t2  3 3~t2  33~t3  2~t2   E2~t3( d2NG1p~tq
d~t2
   4~t  3~t 3~t2  2~t  E2~t2  Z~tH~t2( dNG1p~tq
d~t
  pAC~t ABCqNG1p~tq  0:
(F.15)
Equation (F.15) is singular at ~t  0 and is of the form given in Equation (6.76) where
P p~tq  4~t4; (F.16a)
Qp~tq  64~t3   3~t3  3~t4; (F.16b)
Rp~tq  74~t2  3 3~t2  33~t3  2~t2   E2~t3; (F.16c)
Sp~tq  4~t  3~t 3~t2  2~t  E2~t2  Z~tH~t2; (F.16d)
T p~tq  pAC~t ABCq: (F.16e)
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For ~t  0 to be a regular singularity lim
~tÑ0
~tQp~tq
P p~tq , lim~tÑ0
~t2Rp~tq
P p~tq , lim~tÑ0
~t3Sp~tq
P p~tq and lim~tÑ0
~t4T p~tq
P p~tq
must all remain nite. Using the expressions from Equations (F.16) yields
lim
~tÑ0
~tQp~tq
P p~tq  lim~tÑ0
~t
 
64~t3   3~t3  3~t4(
4~t4
;
 6 lim
~tÑ0

   ~t



;
 1

p6  q; (F.17)
lim
~tÑ0
~t2Rp~tq
P p~tq  lim~tÑ0
~t2
 
74~t2  3 3~t2  33~t3  2~t2   E2~t3(
4~t4
;
 7   3 
2
  lim
~tÑ0
~tpE  3q
2
;
 7   3 
2
; (F.18)
lim
~tÑ0
~t3Sp~tq
P p~tq  lim~tÑ0
~t3
 
4~t  3~t 3~t2  2~t  E2~t2  Z~tH~t2(
4~t4
;
 1 lim
~tÑ0

   ~t

    E~t
2
 Z  H~t
3


;
 1  

  
2
 Z
3
; (F.19)
lim
~tÑ0
~t4T p~tq
P p~tq  lim~tÑ0
~t4pAC~t ABCq
4~t4
;
 lim
~tÑ0
AC~t ABC
4
;
 ABC
4
: (F.20)
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Hence the singularity at ~t  0 is regular. Because the singularity is regular, Equation
(F.15) may be solved using the same technique detailed in Section 6.2.2.
Substituting these expressions for NG1p~tq, and its derivatives given by Equations (6.82)
and (6.83) into Equation (F.15) and proceeding as in Section 6.2.2 gives
4
8¸
n0
an
n
0
n
1
n
2
n
3~t
n0    64   3( 8¸
n0
an
n
0
n
1
n
2~t
n0
 3
8¸
n0
an
n
0
n
1
n
2~t
n1    74  3 3  2( 8¸
n0
an
n
0
n
1~t
n0
   E2  33( 8¸
n0
an
n
0
n
1~t
n1    4   3  2( 8¸
n0
an
n
0
~t
n
0  Z
8¸
n0
an
n
0
~t
n
0
   E2 H 3( 8¸
n0
an
n
0
~t
n
1  ABC
8¸
n0
an~t
n0   AC
8¸
n0
an~t
n1  0;
(F.21)
where  is dened in Equation (6.40). Equation (F.21) may be rewritten as
4r4   3r3  2r2  Zr  ABC a0~tr
 
8¸
n1
 
4 pn0 q4   3 pn0 q3  2 pn0 q2  Zn0  ABC

an
  3 pn0 q3    E2   33( pn0 q2   2E2   33  H(n0
  3   E2  H  AC an1( tn0  0:
(F.22)
If Equation (F.22) is to satised then the coecient for each power of ~t must equal zero.
Considering the coecient of the ~tr term gives
4r4   3r3  2r2  Zr  ABC a0  0: (F.23)
Since a0  0 it is clear r satises the quartic equation
4r4   3r3  2r2  Zr  ABC  0: (F.24)
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For general A, B and C this quartic does not have a simple solution, however an analytic
solution may be obtained using standard techniques for quartic polynomial. Let the roots
of this equation be given by Ri i P t1; 2; 3; 4u. In only a few specic cases will there be
multiple roots or roots diering by an integer. It is therefore assumed this is not the
case and the roots are all distinct and do not dier by an integer, thus ensuring all four
solutions are linearly independent. Since Equation (F.15) is linear in NG1p~tq the general
solution will be given by
NG1p~tq  c1x1p~tq   c2x2p~tq   c3x3p~tq   c4x4p~tq  0; (F.25)
where xip~tq is the solution corresponding to Ri.
For the coecients of ~t
n
0 for n ¥ 1 to equal zero the recurrence relation
an 
@
i


an1; (F.26)
where
@  3 pn0 q3 
 
E2   33( pn0 q2    2E2   33  H(n0
 3  E2 H AC;
(F.27)
and
i  4 pn0 q4   3 pn0 q3  2 pn0 q2  Zn0  ABC; (F.28)
must be satised. As before, to check the resulting series converge the ratio test may be
implemented. It can be seen that the ratio of two successive terms is given by
L  lim
nÑ8
 an~tn0an1~tn r1
 ;
 lim
nÑ8

 @
i

an1~t
an1
 ;
 lim
nÑ8
@i


~t
 ;
 0:
(F.29)
Since L   1 the series converges absolutely for all ~t. In order to check the validity of
this approximation on the solution it is possible to compare this result with a standard
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numerical discretisation approach. To do this it is necessary to choose suitable parameters
and initial conditions. The intial conditions are chosen to be those given by Equations
(6.23), (6.24) and (6.25) and the values of the parameters, ki, for i P t1; 2; 3; 4u, DI and
 are chosen as
k1  2; (F.30a)
k2  1
10
; (F.30b)
k3  1
5
; (F.30c)
k4  1
3
; (F.30d)
DI  1; (F.30e)
  2: (F.30f)
From Equations (F.30) the values
A  1
20
; (F.31a)
B  1
10
; (F.31b)
C  1
6
: (F.31c)
are readily obtained. Using these values Equation (F.24) becomes
16r4  158
15
r3   104
75
r2  37
600
r  1
1200
 0; (F.32)
which has the solutions
R1  0:5012; (F.33a)
R2  0:0107; (F.33b)
R3  0:0839  0:0515i; (F.33c)
R4  0:0839 0:0515i: (F.33d)
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Since these four valus are distinct and do not dier by an integer the four corresponding
solutions are linearly independent, meaning the full solution to Equation (F.14) is now
given by Equation (F.25). For a rst approximation to Equation (F.25) let
xip~tq  Pip~tq  Op~t2q; (F.34)
where
Pip~tq  Ci
 
ai0   ai1~t
(
;
 Ciai0
#
1  8R^
3
i  43315 R^2i   205160 R^i  53340
16R^4i  15815 R^3i   10475 R^2i  37600R^i  11200
~t
+
;
 ~Ci
#
1  8R^
3
i  43315 R^2i   205160 R^i  53340
16R^4i  15815 R^3i   10475 R^2i  37600R^i  11200
~t
+
;
(F.35)
for i P t1; 3; 4u, where R^i  1 Ri and
P2p~tq  C2
 
a20   a21~t  a22~t2
(
;
 ~C2
 
a20   a21~t  a22~t2
(
; (F.36)
where
a21 
8R^32  43315 R^22   205160 R^2  53340
16R^42  15815 R^32   10475 R^22  37600R^2  11200
; (F.37)
and
a22  V^ ~V ; (F.38)
with
V^  8R^
3
2  43315 R^22   205160 R^2  53340
16R^42  15815 R^32   10475 R^22  37600R^2  11200
; (F.39)
and
~V 
8

1  R^2
	3  433
15

1  R^2
	2   2051
60

1  R^2
	
 533
40
16

1  R^2
	4  158
15

1  R^2
	3   104
75

1  R^2
	2  37
600
R^2  11200
: (F.40)
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It should be noted it is necessary to approximate P2p~tq with three terms since RepR2q   0.
For Pip~tq, i P t1; 3; 4u ; only two terms are necessary since 0   RepRiq   1. Strictly
speaking truncating the terms as described does not give the expression given by Equation
(F.34) since the order of the lowest order of the rst terms ignoresd in the Pip~tq is 0:0839
Equation (F.34) should be rewritten as
xip~tq  Pip~tq  Op~t1:0839q: (F.41)
The initial conditions given by Equations (6.23), (6.24) and (6.25) may be transformed
to the Cauchy initial conditions
NG1p0q  1; (F.42a)
dNG1ptq
dt

t0
 39
20
; (F.42b)
d2NG1ptq
dt2

t0
 2117
1200
; (F.42c)
and
d3NG1ptq
dt3

t0
 124751
72000
; (F.42d)
which in terms of the variable ~t become
NG1p1q  1; (F.43a)
dNG1p~tq
d~t

~t1
 39
40
; (F.43b)
d2NG1p~tq
d~t2

~t1
 2563
4800
; (F.43c)
and
d3NG1p~tq
d~t3

~t1
 485831
576000
: (F.43d)
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Solving Equation (F.25), with xip~tq given by Equation (F.41), for ~Ci for i P t1; 2; 3; 4u
using the initial conditions given in Equations (F.43) yields
~C1  1:6754; (F.44a)
~C2  2:7045; (F.44b)
~C3  0:0128  0:9786i; (F.44c)
~C4  0:0:128 0:9786i: (F.44d)
A plot of this solution together with the solution obtained using Maples built in numerical
intergrator is shown in Figure F.1. As can be seen the rst order approximation given by
this technique is in good agreement with Maple's numerical approximation.
Figure F.1: Comparision of Solutions Obtained Using a First Order Frobenius Technique
and Maple's Numerical Intergrator for a Cytotoxic Drug-Cell Cycle Model where Rate
Constants Are Not Equal.
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Abstract
Tumours that are low in oxygen (hypoxic) tend to be more aggressive and respond less well to treatment. Knowing the
spatial distribution of oxygen within a tumour could therefore play an important role in treatment planning, enabling
treatment to be targeted in such a way that higher doses of radiation are given to the more radioresistant tissue. Mapping
the spatial distribution of oxygen in vivo is difficult. Radioactive tracers that are sensitive to different levels of oxygen are
under development and in the early stages of clinical use. The concentration of these tracer chemicals can be detected via
positron emission tomography resulting in a time dependent concentration profile known as a tissue activity curve (TAC).
Pharmaco-kinetic models have then been used to deduce oxygen concentration from TACs. Some such models have
included the fact that the spatial distribution of oxygen is often highly inhomogeneous and some have not. We show that
the oxygen distribution has little impact on the form of a TAC; it is only the mean oxygen concentration that matters. This
has significant consequences both in terms of the computational power needed, and in the amount of information that can
be deduced from TACs.
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Introduction
The rapid growth that is frequently associated with malignant
tumours results in regions of the tumour becoming low in oxygen,
in other words, hypoxic. Understanding tumour hypoxia is
important because hypoxic cells are both more aggressive and
harder to treat [1,2]. Furthermore, low oxygenation promotes the
growth of blood vessels within the tumour (angiogenesis)
contributing to the transition from avascular to vascular tumour
growth [3]. Yet tissue hypoxia is diffficult to identify in vivo.
Invasive techniques, such as the use of an Eppendorf probe, only
give local information and can seed cancerous cells along the line
of entry.
Non-invasive techniques for the detection of oxygen using
positron emission tomography (PET) scans are in the early stages
of clinical practice. With PET scanners, a patient is first injected
with a radioactive isotope of a molecule that takes a prominent
part in whatever process is of interest; most radioactive tracers that
are in clinical use focus on the metabolisation of glucose but there
are some new tracers, such as [F-18]-flouromisonidazole (Fmiso)
and Cu64 diacetyl-bis(N4-methylthiosemicarbazone) (Cu64-
ATSM), that are being developed to detect regions of low oxygen
concentration. The tracer is distributed around the body by the
blood. In the case of glucose detecting tracers, the highest
concentrations of the tracer will occur in very active areas, such as
tumours. Similarly with Fmiso or Cu64-ATSM the tracer will
accumulate in areas of hypoxic tissue. The PET scanner detects
the radiation that is emitted from the tracer as it undergoes
radioactive decay, and an image of the concentration of the tracer
at different parts of the body can then be re-constructed. This re-
construction process is difficult resulting in images of relatively
poor resolution, typically 2{3mm3. The time dependent decay
signal from the PET scanner is known as the tissue activity curve
(TAC).
The concentration of the tracer at any location gives a
qualitative picture of the degree of tumour hypoxia. Padhani [1]
notes that in clinical settings, such qualitative imaging can work
well enough, but does introduce a level of subjectivity and that
there is a need for greater quantitative understanding. In fact, the
concentration of the tracer at any given location is not related to
the oxygen concentration of the tissue in a trivial manner and
knowing the quantitative relationship between the tracer concen-
tration and tissue oxygenation levels is of great importance if
accurate deductions as to the radio-resistance of the tissue are to be
made [4]. Indeed, an image created by a snapshot at a single point
in time can give a misleading impression because, while for normal
tissue the TAC drops after an initial peak, for hypoxic tissue there
tends to be a gradual increase in the TAC. This can result in a
cross-over point where TACs from both normal and hypoxic tissue
give the same result [5] and it is therefore important to consider
the TAC at multiple time points. Methods that fit TACs to a
nonlinear mathematical model that includes the pharmaco-kinetic
behaviour of the tracer and thereby translate the concentration of
the tracer to the oxygenation level of the tissue have been
developed. The most widely tested of these mathematical models
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have been compartment models [5–8]. These divide the tracer
into, typically, three compartments: tracer in the blood plasma;
tracer that diffuses freely in the tissue, and tracer that is bound to
the tissue via a reaction that is dependent on the concentration of
oxygen. The resulting pharmaco-kinetic (PK) models have defined
rates of transfer between the different compartments and results in
a set of ordinary differential equations that can be solved
analytically. The total TAC is a weighted sum of the signal from
each of the compartments. The weights and some of the transfer
coefficients are calculated by fitting the experimentally determined
TACs to the TACs produced by the PK model. The values of the
weights and the transfer coefficients are then used to deduce
whether the tissue is hypoxic and what kind of hypoxia occurs.
Proof of concept experiments have been carried out which
demonstrate that PK models have the ability to qualitatively
reproduce the features of TACs and distinguish between different
types of hypoxia. However, compartment models take no account
of the spatial distribution of oxygen. So for PET scan data, the
fitting can be done for each individual 2mm3 voxel but there is an
inherent assumption that the tissue within that voxel is homoge-
neous and can be represented by an average value. This is not
necessarily the case–in vascular tumours, the vessels that deliver
oxygen tend to be irregular and tortuous making it likely that the
distribution of oxygen within a voxel is highly inhomogeneous.
There has been some initial work that includes space explicitly by
including tracer diffusion in the tissue and allowing the concen-
tration of oxygen to vary from one point to the next, initially by
Kelly and Brady [9] and subsequently by Mo¨nnich et al [10].
These studies replace the ordinary differential equation compart-
ment model with partial differential equations. Our original
interest was in comparing a partial differential equation model for
tracer reactions and diffusion with the analogous compartment
model to investigate whether the inhomogeneity of the distribution
of blood vessels actually matters on the scale of a voxel. However,
this comparison is dependent on first establishing the oxygen
distribution within the tissue and that has led to a number of other
considerations. In general, if more than a qualitative understand-
ing is to be developed, then one needs to be able to quantify the
uncertainties/errors that occur, be they uncertainty that is
introduced because of modelling assumptions (for example,
whether the tissue can be treated as homogeneous or not),
uncertainty due to the difficulty of experimentally measuring
parameters that are critical to the model behaviour and finally,
computational errors that are introduced due to numerical
inaccuracies.
Consequently, the aim of this paper is three-fold. Our first aim is
to understand the impact of two particular modelling assumptions.
The first relates to the way that oxygen is delivered to tissue. This
is a subject that many authors have focussed on and a review
article on this subject is given by Goldman [11], yet in even the
simplest models of oxygen diffusion and consumption different
authors have used different methods and, as we will see, these
different assumptions can give quantitatively quite different results.
In particular we find that modelling the discrete blood vessels by a
‘source’ term gives a good approximation to the, more realistic,
mixed boundary conditions between the vessel walls and the tissue
and suggests that efficient algorithms in three-space dimensions
could be developed using a source method. The second modelling
assumption that we examine is to what extent, on the scale of a
voxel, it is important to take account of the spatial distribution of
the oxygen in deducing information from TACs, by comparing the
results of a partial differential equation model that accounts for
oxygen and tracer diffusion with the analogous compartment
model.
Our second aim is to examine the sensitivity of the computed
oxygenation level of tissue to the various parameters in the model.
Measuring physical parameters such as consumption rate of
oxygen, diffusivity of oxygen and permeability of blood vessels and
the distribution of oxygen is challenging, making it hard to validate
any particular mathematical model. However, by understanding
the mathematical models one can examine which parameters have
a significant effect on predictions that are made by a model and,
therefore, which parameters one needs to find for an accurate
prediction or, equivalently, to what extent the uncertainty in a
particular parameter leads to an uncertainty in the results.
Our final aim is to demonstrate the impact of numerical error
that results in the solution of the partial differential equations on
too coarse a mesh. We provide computational parameters where
the discrete approximations can confidently be considered to be
close to the continuous PDE solution.
The paper is outlined as follows. In section 1.1 the simplest
models for the diffusion and consumption of oxygen in tissue are
re-visited. The different approaches to the different ways of
modelling the boundary between the vascular structures that
deliver the oxygen and the tissue are examined and a limit is
derived in section 1.2 where one expects the mixed boundary
conditions used by some authors [12] and the Dirichlet boundary
conditions of others [13] to give similar results. In order to
separate out the effects of the parameters on the oxygen
distribution as compared with how multiple vessels modify the
final oxygen distribution we consider a sequence of problems. In
section 1.3 we look at just a single vessel and then, we consider a
pair of vessels at different distances apart in section 1.4. In section
1.5 we consider multiple vessels and examine to what extent the
multivessel results can be understood as a superposition of the
single vessel results. In section 2.1 we introduce the particular
model of tracer reaction and diffusion that we have studied and
examine first the tracer dynamics around a single vessel in section
2.2 and then for multiple vessels in section 2.3, comparing the
TACs that results from both random and regular arrangements of
vessels. In section 2.4 we fit the TACs produced by the partial
differential equation model with a compartment model. In spite of
the heterogeneity of the oxygen model we find that the
compartment model can distinguish between different levels of
oxygen.
Analysis
1. Oxygen Distribution
Many mathematical models of oxygen transport are built on the
Krogh-Erlang cylinder model [14] that models oxygen transport
by a diffusive process through a homogeneous medium governed
by the equation
LP
Lt
~D+2P{K , ð1Þ
for the oxygen partial pressure P within the tissue, where D is the
diffusivity of oxygen in tissue and K describes oxygen consumption
by the tissue. In the original Krogh-Erlang model [14], the oxygen
partial pressure was fixed at the vessel wall (a Dirichlet boundary
condition) with the consumption rate K set to be constant. This
latter assumption means that equation (1) has to be supplemented
with a requirement that the consumption rate is zero when P is
zero to prevent the equations from giving solutions with regions of
negative partial pressures. A more realistic form for the oxygen
consumption term in equation (1) is the Michaelis-Menten form,
Tumour Oxygenation
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K~
KmaxP
PzP50
: ð2Þ
With this nonlinear consumption rate, as P?? the consumption
asymptotes to the constant value K~Kmax, so that when oxygen is
abundant, consumption is approximately constant. However,
when oxygen is scarce, oxygen consumption is proportional to
the amount of oxygen available. This choice for K means that the
oxygen partial pressure remains positive (or zero) at all times.
In Goldman [11] all the underlying assumptions of the Krogh-
Erlang cylinder model are listed and a thorough review of current
work that relaxes these assumptions is given. Of particular
relevance here is the intravascular O2 resistance (IVR); in the
original Krogh-Erlang model the use of Dirichlet boundary
conditions at the vessel wall excluded the possibility that the
oxygen delivery to the tissue may be dependent on the partial
pressure difference across the vessel wall. As discussed further
below, this is only valid if the vessel wall is sufficiently permeable to
oxygen.
One way of including IVR is to ignore intravascular processes
but to model the flux of oxygen as it diffuses across the vessel wall,
and then on into tissue explicitly via a mixed boundary condition,
sometimes known as a Robbins boundary condition. This mixed
boundary condition arises as follows: assuming that a blood vessel
wall consists of two concentric cylinders of outer radius R with
width w between the two cylinders, as shown in cross-section in
figure 1, and that there is just diffusion and no consumption by the
wall tissue, then the flux at r~R, FR is given by
FR~{Dw
LP
Ln DR~{DwR P0{Pln 1{w
R
  ð3Þ
where Dw is the diffusivity in the wall and P0 is the partial pressure
of oxygen inside the vessel. For capillaries w%R, (typical vessel
radii are 7mm [12] and vessel walls are 0:2{1mm [9]) and
equation (3) becomes
FR&
Dw
w
P0{Pð Þ~Pm P0{Pð Þ, ð4Þ
where Pm~Dw=w is the permeability of the vessel. The inclusion
of IVR can therefore be modelled by using the boundary condition
(4) at the vessel wall.
An alternative model that includes IVR is to model the vessels
by a so-called distributed source where instead of modelling the
vessels as discrete entities leading to the solution of the diffusion
equation on a punctured domain, the source is represented by a
function which has localised spikes at the vessel positions [9]. With
such a source term, the diffusion model becomes
LP
Lt
~D+2P{Kz
2Pm
R
P0{Pð Þ:S, ð5Þ
where S is referred to as the vascular map and is a function that
takes the value 1 for regions inside the vessel and 0 otherwise. This
is a modification of a term that was first introduced by Baxter and
Jain [15] for modelling tumours at the whole tumour scale. The
motivation for the particular form for the source term comes from
considering the flux across a membrane as in equation (4). Then
the net rate of oxygen diffusing for an individual blood vessel per
unit volume is given by
1
pR2L
ð
Lv
F :dn~
1
pR2L
2pRLFRf g~ 2Pm
R
P0{Pð Þ, ð6Þ
where Lv is the surface of the blood vessel. So the diffusion model
(1) then becomes equation (5).
The derivation of equation (4) and subsequently equation (6)
assume that oxygen within the blood vessel is well-mixed and that
consequently the partial pressure at the interior of the vessel is
fixed at P0. Detailed earlier work by Hellums and co-workers has
shown that IVR actually arises as a consequence of the way that
oxygen is transported and released by red blood cells [16,17].
Hellums et al [17] showed that the delivery of oxygen to tissue
could be described well by a flux of the same form as equation (6),
where P0 is the partial pressure in the vessel corresponding to the
mean haemoglobin saturation.
Some studies have included IVR [18] and some have not [13],
but there has been no systematic comparison of the two. Likewise,
although some authors have used source terms [9,12] and some
have used models that describe capillaries as discrete entities there
has been no comparison of these two methods. This is relevant
because, Dirichlet boundary conditions may sometimes be used for
the pragmatic reason that they are easier to code but, in fact, can
only be justified in the situation that the permeability of the wall is
sufficiently high. Similarly, there are computational advantages to
having a domain that is simply connected, as occurs if the source
term formulation is used. A number of studies have investigated
oxygen diffusion in three space dimensions [18,19]. However, the
difficultly in correctly implementing the vascular structure and the
high computational cost of such simulations mean that it is
valuable to thoroughly examine the modelling issues relating to the
boundary conditions at the vessel wall in two space-dimensions
before considering the three-dimensional problem.
In the rest of this section a quantity that determines whether
Dirichlet boundary conditions are appropriate is derived. Then, in
order to examine which parameters are significant in determining
the level of oxygenation we non-dimensionalise the equations and
consider a sequence of problems: first considering the impact of
the parameters on the oxygen distribution created by a single
vessel and then examining how a pair of vessels interact before,
finally, considering tissue with realistic vascular structures.
1.1 Mixed versus Dirichlet boundary conditions. If a
boundary is sufficiently ‘‘leaky’’, one would expect mixed and
Dirichlet boundary conditions to give the same results. An idea for
what is ‘‘sufficiently leaky’’ can be obtained by considering steady-
states of equation (1) for a single vessel which satisfy
D+2P~K: ð7Þ
Figure 1. Cross-section of a single vessel with a wall.
doi:10.1371/journal.pone.0038597.g001
Tumour Oxygenation
PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e38597
For a cylindrical vessel with no axial dependence, this reduces to
1
r
d
dr
r
d
dr
 
P~
K
D
: ð8Þ
In case that K is constant, equation (8) is exactly soluble and
gives
P~
1
4
K
D
r2zA ln rzB,
where A and B are integration constants. At some radius r~rm the
oxygen partial pressure will drop to zero and there will be no flux
of oxygen. Applying the boundary conditions P~dP=dr~0 at
gives
P~
1
4
K
D
r2{r2m
 
{
1
2
Kr2m
D
ln
r
rm
:
The maximum oxygen diffusion distance, rm, is determined by
the boundary condition at r~R. Using P~P0 at r~R leads to the
equation
r2m{R
2
 
z2r2m ln
R
rm
z
4DP0
K
~0: ð9Þ
Using the mixed boundary condition gives
r2m{R
2
 
1{
2D
PmR
 
z2r2m ln
R
rm
z
4DP0
K
~0: ð10Þ
As
2D
PmR
?0 equations (9) and (10) for rm become identical,
suggesting that provided
2D
PmR
%1 both mixed and Dirichlet
boundary conditions will give similar results. Typical values for
D,Pm and R for tumour blood vessels (see table S1). result in a
value for 2D=PmRw1, suggesting that Dirichlet boundary
conditions are unlikely to give similar results to mixed boundary
conditions.
1.2 Non-dimensionalisation. The original problem has six
parameters describing tissue and vessel properties, namely, the
tissue consumption parameters P50 and Kmax, the oxygen
diffusivity D, the permeability of the blood vessel to oxygen Pm,
the partial pressure of the oxygen within the blood vessel P0 and
the vessel radius, R. The process of non-dimensionalisation shows
that the six tissue and vessel parameters are not truly independent,
and the problem can be reduced to just three non-dimensional
parameters namely, the scaled partial pressure inside the vessel u0;
the scaled permeability ePm and the scaled vessel radius, eR. The
advantage of studying the non-dimensionalised equations is that
one has a much reduced parameter space to investigate.
The equations are rescaled by defining P~P50u and scaling the
length by
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
DP50=Kmax
p
. Consequently, for the steady-state
solution of the reaction-diffusion equation with rate given by
equation (2) three different problems are considered: (i) Dirichlet
boundary conditions, (ii) mixed boundary conditions, (iii) distrib-
uted source term. These are listed below.
For Dirichlet boundary conditions:
+2u~
u
uz1
for (x,y)[(0,Lx)|(0,Ly), (x,y)[=vessel , ð11Þ
u(vessel wall )~u0:
For mixed boundary conditions:
+2u~
u
uz1
for (x,y)[(0,Lx)|(0,Ly) (x,y)[=vessel ð12Þ
+uDvessel wall~{ePm u0{uð Þ,
where ePm~Pm ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃP50=KmaxDp .
For the source term:
+2u~
u
uz1
{
2ePmeR u0{uð Þ:S for (x,y)[(0,Lx)|(0,Ly),ð13Þ
where
S~
1 for (x,y)[ vessel interior
0 for (x,y)[= vessel
	
Typical values for the measured physical parameters are listed in
table S1 and the corresponding ranges of values for the non-
dimensional parameters are given in table S2.
1.3 Computations for a single vessel. With a single vessel
the diffusion problem is axi-symmetric and the diffusion problem
in two-space dimensions can be reduced to a diffusion problem in
one, radial, direction. For example, equation (12) becomes
1
r
d
dr
r
du
dr
 
~
u
uz1
for r[(eR,L), u(eR)~u0: ð14Þ
and the source case becomes
1
r
d
dr
r
du
dr
 
~
u
uz1
{
2ePmeR u0{uð Þ:S for r[(0,L), ð15Þ
where
S~
1 rveR
0 r§eR:
(
Each case leads to a boundary-value problem. For the flux and
Dirichlet cases this problem was solved on the large but finite
domain, r[(eR,L), corresponding to the region outside a vessel of
radius eR. The value for L was chosen sufficiently large (typically
L~20) that the results were independent of whether Dirichlet or
Neumann boundary conditions were chosen at r~L. In the cases
of the source term, r[(0,L) with Lu=Lr~0 at the lefthand
boundary. Each one-dimensional problem was solved using the
matlab boundary value problem solver bvp4c; typical solutions are
shown in figure 2. All boundary conditions lead to a simlar,
Tumour Oxygenation
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monotonically decreasing, profile: in fact the maximum principle
can be used to show that the maximum value of the oxygen has to
occur on the boundary. The difference between the various
boundary conditions is that with Dirichlet boundary conditions,
this maximum value is pinned to the value of u0, the scaled partial
pressure in the blood vessel, but in all other cases the maximum
value is at some value that is lower than this. The consequence of
this pinning of the partial pressure to the value of u0 at the vessel
boundary is that the Dirichlet boundary conditions tend to give
higher levels of oxygenation than mixed boundary conditions or
the source term. On figure 2 the vertical dashed line represents the
boundary of the vessel. The ‘maximum diffusion distance’ for
oxygen in tissue is often quoted as 70 microns, equating to
approximately 4 units in the non-dimensional units used in
figure 2. Considering just a single vessel with a Michelis-Menten
consumption term, there is no maximum diffusion distance for
oxygen in that the oxygen decreases monotonically with distance
from the vessel, with u(r)?0 only as r??. The ‘maximum
diffusion distance’ can therefore only be specified in terms of a
distance below which the level of oxygen is too small to be
detected.
In order to compare the different solutions systematically as the
parameters are varied, we have considered two different measures.
Firstly the the L1 norm, EuE1, where
EuE1~
ðð
DuDdx dy: ð16Þ
The L1 norm is related to the average level of oxygenation, u, of
a piece of tissue of area A by
u~
EuE1
A
:
Oxygenation of tissue samples on the microscale are often
examined using tissue staining where a dye that is oxygen sensitive
is applied to a tissue slice. This tends to lead to a binary measure:
either oxygen is present or not (or only at a concentration below a
threshold value). Results are often quoted as a hypoxic fraction,
that is the fraction of the tissue that is hypoxic. In order to mimic
this kind of measure we have also calculated the ‘oxygenated area’,
Aox, which is the area for which the oxygen partial pressure is
greater than a threshold value uh
Aox~
ðð
dx dy, and uwuh, ð17Þ
For a given area of tissue A the hypoxic fraction Ah could then be
calculated from
Ah~
A{Aox
A
:
As can be seen from figure 2, the calculated value for the
oxygenated area will depend strongly on the particular value of the
threshold uh that is chosen: for the Dirichlet boundary case
depicted in figure 2, threshold values uh~4 and uh~2 lead to
oxygenated radii of 2:28 and 3:15 respectively. In turn, these
values lead to oxygenated areas of 16:3 for uh~4 and nearly
double that value, 31:2 for uh~2. Different threshold values are
important for different aspects of a cell function, but broadly
oxygen levels below 5{15mmHg (uh~2{6, for typical param-
eter values) have a significant impact on the outcome of cancer
therapies [1]. In the case of radiation treatment, half-maximal
sensitivity to radiation therapy occurs at oxygen levels of
2{5mmHg (uh~0:8{2). Typical tissue staining techniques stain
tissue at threshold values of between 5mmHg and 10mmHg
(uh~2 and 4). Given the sensitivity of the results to the value of the
threshold, if comparison is to be made with experimental data, it is
particularly important that an accurate value for this threshold is
known and this in itself can be difficult. In Pogue et al [12] a careful
study fitting a diffusion model for oxygen with vascular maps
derived from real tissue samples was performed. They found their
results were very sensitive to the threshold that was chosen and
that their model fitted the data best for a value for the threshold
that was much lower than the conventionally accepted value. For
many of the results that are presented in this paper, we have
selected the value uh~2.
Results for the oxygenated area for fixed radius but varying
vessel partial pressure u0 and permeability ePm are shown in
figure 3. As is to be expected, these show that at high permeability,
all three sets of boundary conditions give similar results. At low
permeability, the source term representation gives a reasonable
approximation to the mixed boundary conditions. Note that the
condition found in }?? for the Dirichlet and flux boundary
conditions to coincide translates to ePmeR&2 or, for eR~0:55,ePm&3:6. For the experimentally measured range of values ofePm~0:55{2:75, figure 3(c) and (d) show that modelling
oxygenation using Dirichlet rather than flux boundary conditions
will result in an over estimate for the oxygenated area and that this
is more significant the lower the vessel partial pressure. So, for
example, for the low scaled vessel partial pressure of u0~8
(equivalent to 20mmHg), mixed boundary conditions give an
oxygenated area of 4:9 and Dirichlet boundary conditions give a
value that is more than two and a half times bigger of 12:7. Even
at the highest scaled vessel partial pressures, u0~40 (equivalent to
100mmHg), mixed boundary conditions give an oxygenated area
of 57:0 and Dirichlet boundary conditions give a 50% larger value
of 86:1.
In figure 4 the oxygenated area for varying scaled vessel radius
is shown. These show that the oxygenated area is approximately
linearly related to the scaled vessel radius.
Together, figures 3 and 4 show that, for the typical ranges of
permeability that are quoted for blood vessels, it is important to
take account of the IVR and that either using a mixed boundary
Figure 2. Typical solutions for the oxygen profiles from a single
vessel for different boundary conditions. Parameter values areeR~0:55,u0~16,ePm~2:75.
doi:10.1371/journal.pone.0038597.g002
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condition or a source term will give similar results. The
oxygenated area is sensitive to the scaled vessel partial pressure
and to the scaled permeability and an uncertainty of 10% in either
of these values will lead to a similar order of uncertainty in the
oxygenated area. The oxgyenated area is much less sensitive to the
scaled vessel radius.
1.4 Two vessels. In a piece of tissue there is typically many
vessels, not just a single isolated one. If two vessels are sufficiently
far apart, then each will be unaffected by the presence of the other,
as illustrated in figure 5(a) and (c). As they become closer and
closer, the oxygen distribution around each vessel will become
more and more affected by its neighbour, see figure 5(b) and (d).
The computations shown in figure 5 were carried out on a two-
dimensional domain with a grid of 401|201 grid points using a
square mesh of grid size 0:1. Grid refinement checks were carried
out to check that this was sufficiently fine (see table 1). The grid
refinement checks suggest that, for results that are accurate to
10%, a grid of between two and four grid points per vessel should
be used. We note that in order to minimize computational cost,
previous studies have frequently used a grid of spacing of the same
size as the vessel and that this will introduce an error of 30{40%,
depending on the type of boundary conditions used.
We have systematically examined how the L1 norm and the
oxygenated area vary as the separation between the vessels is
changed and the results are summarised in figure 6 as a function of
the separation. Only the oxygenated area is shown as the results
for the L1 norm are qualitatively similar. For vessels sufficiently far
apart, the L1 norm and the oxygenated area are twice the values
calculated in }?? for one vessel. This corresponds to the flat section
to the far right of figure 6 and shows that for a separation s greater
than about ten the vessels interact only minimally. Note that in
these non-dimensional units, this represents a separation of
approximately nine vessel diameters.
As the vessels get closer, the oxygenation of the tissue initially
increases but then decreases approaching the value of the
oxygenation produced by a single vessel as s?0. The increase is
much more prominent in the L1 norm than in the oxygenated
area, reflecting the fact that the dominant effect of two vessels close
together is that the level of oxygenation of the oxygenated tissue
increases, rather than that more tissue reaches the oxygen
threshold value of uh.
1.5 Multi-vessel. In normal tissue, blood vessels are regularly
spaced in order to deliver oxygen to tissue in an optimal manner.
In tumour tissue, this is not the case and the position of blood
vessels is much more closely represented by a random distribution,
resulting in a log-normal distribution for the distance between
blood vessels.
First we outline how we distribute vessels on the plane while still
being able to carry out computational grid refinements. In order to
randomly place the vessels without overlap we first construct a
‘vascular grid’ that has a grid length of 2eR. Vessels are placed so
that their centres are at random points of the vascular grid. The
choice of grid length means that no vessels can overlap each other.
A computational mesh is then constructed that forms a sub-grid of
the larger vascular grid, one example is shown in figure 7. This
computational mesh can be refined to give adequate numerical
Figure 3. Oxygenated area for a single vessel with non-dimensional radius eR~0:55 and uh~2. (a) Fixed permeability, ePm~2 and varying
vessel partial pressure, u0 . (b) Fixed permeability, ePm~50 and varying vessel partial pressure, u0. (c) Fixed vessel partial pressure, u0~8 and varying
permeability, ePm. (d) Fixed vessel partial pressure, u0~40 and varying permeability, ePm .
doi:10.1371/journal.pone.0038597.g003
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resolution. Computations were carried out on a domain of 55|55
in non-dimensional units, equating to 1mm2 of tissue for typical
values of the parameters. As for the two vessel case, a grid spacing
of 0:1 gave good resolution. The effect of varying microvessel
density (MVD), was considered by solving equations (13) for a
sequence of different MVDs. For each value of the MVD, ten
different random vascular maps were created and the L1 norm
and the oxygenated area calculated. The random selection of
Figure 4. Oxygenated area of a single vessel for uh~2 and varying vessel radius, eR. (a) ePm~2,u0~8. (b) ePm~2,u0~40. (c) ePm~50,u0~8.
(d) ePm~50,u0~40.
doi:10.1371/journal.pone.0038597.g004
Figure 5. Contour plots and solution profiles for two vessels placed at different separations. In all cases, u0~16,ePm~2:75,eR~0:55 and
the source model for the delivery of oxygen to the tissue was used. (a) Contour plot for two widely separated vessels, seperation s~15. (b) Contour
plot for two vessels that are close enough to interact, separation s~5. (c) Oxygen concentration profile along the line y~0 for s~15. (d) Oxygen
concentration profile along the line y~0 for s~5.
doi:10.1371/journal.pone.0038597.g005
Tumour Oxygenation
PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e38597
points on the vascular grid results in vascular maps which have a
log normal distribution of nearest neighbour distances. As the
MVD increases, both the mean and the variance of this
distribution decreases (mean !1=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
MVD
p
, variance !1=MVD).
We have considered MVDs in the range 0{200 per mm2, which
includes the values used in previous studies of tumour oxygenation
[9,13].
Commonly quoted values for vessel partial pressures range from
20mmHg to 100mmHg where, 100mmHg is typical of arterioles
and 40mmHg typical of venules. Often tumour supply is from the
venule side, and although some of the results that are presented
below are for the full range from 20mmHg to 100mmHg (8 to 40
in nondimensional units), more detailed results are shown for the
case of vessel partial pressure 40mmHg (16 in nondimensional
units). The results for the fraction of the area of the tissue that is
oxygenated for three different values of the vessel partial pressure
u0 and varying hypoxic levels uh are shown in figure 8. The
general trends are not surprising: more vessels are needed to
oxygenate more tissue up to some cut-off number beyond which
all the tissue is oxygenated; the vessel density that is needed for the
tissue to be oxygenated depends on the value that is used to specify
oxygenation (uh), with more vessels needed the higher the value of
uh. Typically, tissue is considered to be hypoxic if it has partial
pressures in the range 1-10mmHg and necrotic for partial
pressures less than 1mmHg. So, for example, in figure 8(b)
corresponding to vessel partial pressures of u0~16 (40mmHg) and
for a micro-vessel density of 50 vessels/mm2, typically 90% of the
tissue receives some level of oxygen, but for most of the tissue this
is at too low a level to be significant resulting in the fact that only
approximately 15% is oxygenated, 35% is hypoxic and the
remaining 50% is necrotic.
The computational cost of simulating multi-vessel distributions
to attain average quantities leads one to ask whether one could
predict the multi-vessel results just from the one-vessel results. In
particular, if the vessel density is low, one might expect the
oxygenated area of the multi-vessel distribution to simply be the
oxygenated area given by a single vessel multiplied by the number
of vessels, i.e.
Aox&NAoxs , ð18Þ
where N is the number of vessels and Aoxs is the oxygenated area
of a single vessel. Figure 9 shows the oxygenated area for two
different values of uh in more detail and compares the results with
a number of approximations. We focus on the value of scaled
vessel partial pressure u0~16 (P0~40mmHg for typical param-
eter values) since this is the most widely quoted value for the vessel
partial pressure in tumour tissue. For microvessel densities up to
around 50 mm{2, the vessels do not interact, and the approxi-
mation give by equation (18), the dashed line in the figure, works
well. That the vessels do not interact is further underlined by the
fact that up to a MVD of around 50, there is no difference in the
oxygenated area produced by a regular grid of vessels (shown by
the thick line in figure 9) and that produced by a random
arrangement of vessels.
2. Tracer
Having discussed some aspects of modelling oxygen diffusion in
tissue, we now consider the issues with trying to detect that oxygen
using a tracer. First we solve a model for tracer reaction and
diffusion that includes the spatial distribution of oxygen. We then
examine to what extent a compartment model for tracer dynamics
can accurately determine the level of oxygenation.
2.1 Modelling and non-dimensionalisation. The detection
of oxygenation via PET scanning techniques first requires a
radioactive tracer to be injected into the blood. The tracer is
transported by the blood: some is removed from the blood by the
kidneys and some diffuses into other body tissues. Once in the
tissue, some of the tracer will bind at a rate that is dependent on
the local oxygen concentration with the tracer being bound more
Table 1. Grid refinement check.
Grid spacing grid/vessel ratio Dirichlet DDuDD1 Source DDuDD1
1.0000 1 1089.671 818.8468
0.5000 2 1716.200 1270.952
0.2500 4 1641.403 1036.248
0.1250 8 1774.854 1146.761
0.0625 16 1808.991 1141.513
0.0400 25 1831.189 1147.694
The L1 norm as a function of grid size for two vessels separated by 5 units with
u0~40 and ePm~2:75.
doi:10.1371/journal.pone.0038597.t001
Figure 6. (a) DDuDD1 norm and (b) oxygenated area as a function of separation. Different vessel partial pressures are shown corresponding to,
uh~0:04,0:4,0:8,2 and 4 (typically corresponding to Ph~0:1,1,2,5 and 10 mmHg). The source term model for oxygen delivery has been used; the
behaviour for Dirichlet or flux boundary conditions is qualitatively similar. Each vessel has a scaled radius eR~0:55 and scaled permeability ePm~2:75.
The scaled vessel partial pressure is u0~16 (typically corresponding to P0~40 mmHg).
doi:10.1371/journal.pone.0038597.g006
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effectively at low oxygen levels. A detailed pharmacokinetic study
of the binding process for FMISO was carried out by Casciari et al
[6]. Although their compartment model did not allow for any
spatial variation, nevertheless they were able to show that the
model could replicate typical behaviour of TACs from both a
more complicated, but still spatially homogeneous, model and
clinically extracted TACs. They did find that including some
transport limitations into the compartments representing tracer in
the tissue was important.
In order to take account of the diffusion of tracer and the spatial
distribution of oxgyen, Kelly and Brady [9] suggest taking the
model for the partial pressure of oxgyen, equation (5) and coupling
it to a partial differential equation for the tracer,
LTf
Lt
~DT+2Tf{KtracerTfz
2PT
R
Tblood{Tf
 
:S,
LTb
Lt
~KtracerTf , ð19Þ
where Tf is tracer that is free to diffuse and Tb is bound tracer.
The parameter Ktracer is the rate at which the free tracer is bound
and is dependent on the oxygen partial pressure P,
Ktracer~
kmaxP1
PzP1
 
P
PzP2
 
:
The second term in brackets acts as a switch to turn off the
binding if tissue is necrotic. The concentration of tracer in the
blood, also known as the plasma input function, Tblood , is modelled
as the sum of two exponential decays,
Tblood~A e
{k0tzbe{kkt
 
: ð20Þ
The first term represents the dispersal of the tracer around the
body, the second the renal term representing the removal of tracer
by the kidneys. Typically, kk%k0. Implicit in modelling the tracer
in the blood in this way is that the tumour is a small volume
compared with the volume of the rest of the body. Consequently
the fact that some tracer flows into the tumour has a negligible
impact on Tblood .
Mo¨nnich et al use a similar model [10], but instead of using a
source term to model the entry of tracer from the blood they use
mixed boundary conditions. In section 1 we found that for oxygen
diffusion using a source term gave comparable results to the use of
mixed boundary conditions, and we would expect this to be the
same for the tracer. Kelly and Brady [9] show that this model can
reproduce typical TACs by considering random distributions of
vessels. Mo¨nnich et al do a similar comparison, but this time using
vascular maps that are obtained from tissue staining. Comparing
with experimentally determined TACs shows that the partial
differential equation model does mimic the behaviour that is seen
in practice. Our aim here is to examine to what extent the partial
differential equation (19) model is needed in order to accurately
model the behaviour that is seen and to what extent a
compartment model is adequate.
As for the oxygen problem, we first non-dimensionalise by
rescaling space by
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
DP50=Kmax
p
and the oxygen partial pressure
P~P50u and introducing Tf~Avf ,Tb~Avb,Tblood~Avblood ,
t~
DP50
DTKmax
t. This results in the model for the oxygen and tracer
as:
Figure 8. Mean of ten realisations of the oxygenated area versus vessel density (MVD). (a) u0~8 (b) u0~16 c) u0~40. In all cases,ePm~2:75 and the source model for oxygen entry from the blood vessels is used. The different lines on each plot represent different values of the
threshold, uh used to measure the level of oxygenation.
doi:10.1371/journal.pone.0038597.g008
Figure 7. Vascular grid versus computational grid. Blood vessels
are located randomly on a fixed coarse vascular grid (solid black lines)
allowing a refined computational grid (light grey lines).
doi:10.1371/journal.pone.0038597.g007
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+2u~
u
uz1
{
2ePmeR u0{uð Þ:S for (x,y)[(0,Lx)|(0,Ly), ð21Þ
and for free and bound tracer,
Lvf
Lt
~+2vf{
~k~P1
uz~P1
 !
u
uz~P2
 
vfz
2ePTeR vblood{vf :S,
Lvb
Lt
~
~k
uz~P1
 !
u
uz~P2
 
vf , ð22Þ
where the scaled plasma input function is
vblood~ e
{~k0tzbe{
~kkt
 
, ð23Þ
and
S~
1 for (x,y)[ vessel interior
0 for (x,y)[= vessel:
	
Since at the start there is no tracer in the tissue, only in the blood
plasma, both vf and vb are set to zero initially.
The scaled parameters for the tracer dynamics are
~PT~PT
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
P50D
KmaxD
2
T
s
,~kmax~
kmaxDP50
DTKmax
,~P1~
P1
P50
,~P2~
P2
P50
,~k0~
DP50
DTKmax
k0,~kk~
DP50
DTKmax
kk. The process of non-dimensionalisa-
tion reduces the original 17 parameters to 10.
2.2 Single vessel. Before considering how randomly distrib-
uted vessels within a piece of tissue behave, we first examine a
single vessel. Equations (21) are solved to find the steady-state
oxygen distribution as shown in figure 10(a). Then, equations (22)
are solved to give the concentrations of free and bound tracer as a
function of time and space. For these computations and for those
in the following sections we have chosen representative values
from the literature for the various parameter values. The
parameter ranges are given in in table S1 for the dimensioned
parameters and in table S2 for the corresponding non-dimensional
parameters.
Typical concentrations of the free and bound tracer as are
shown in 10(b) and (c) respectively for three different points in
time. These show how, initially, the dominant effect is the diffusion
of the tracer into the tissue–at t~10 there is essentially no bound
tracer but tracer has diffused a considerable distance from the
vessel (note the vessel radius is 0:55 in these non-dimensional
units). However, as time goes on the binding process becomes
important–by t~500 the way that the binding is dependent on the
oxygen level is apparent, with both the low binding rate at high
oxygen concentrations and the effect of the necrotic term resulting
in the shape of the bound oxygen profile in 10(c). In fact, the
maximal binding rate occurs when u~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
~P1~P2
p
which, for the
parameters we have used is u~0:38.
In order to further illustrate the behaviour, in figure 11(a) the
decay of the plasma input function, equation (23), as a function of
time is shown and, in figure 11(b) and (c), the concentration of free
and bound tracer respectively are shown for three different points
Figure 9. Mean tissue oxygenation and oxygenated area. (a) The mean oxygen level for three different values of the vessel partial pressure. (b)
and (c) The fraction of area that is oxygenated for u0~16 using uh~0:4 in the case of (b) and uh~2 in the case of (c).
doi:10.1371/journal.pone.0038597.g009
Figure 10. Oxygen and tracer distributions in space. (a) Oxygen partial pressure against r. (b) Free tracer against r for three different times. (c) Bound
tracer against r for three different times. The parameters are: u0~16,~R~0:55,ePm~2:75,~PT~4,~P1~0:6,~P2~0:24,kmax~0:01,~k0~5,~kk~0:01,b~0:5:
doi:10.1371/journal.pone.0038597.g010
Tumour Oxygenation
PLoS ONE | www.plosone.org 10 June 2012 | Volume 7 | Issue 6 | e38597
in space. For the parameters we have chosen the initial
concentration of the plasma in the blood vessel is 1:5. However
as ~k0%~kk this value rapidly drops, so fast that on the timescale
shown this is not visible, and in fact the blood plasma term is
dominated by the second term in equation (23). As time continues,
the free tracer diffuses from the blood vessels into the tissue, so that
at any particular location the free tracer concentration initially
increases with time, as seen in figure 11(b). The further from the
blood vessel, the longer it takes the tracer to diffuse, so the slower
this increase. At the same time as diffusing in space, the free tracer
binds at a rate dependent on the oxygen, and this ultimately leads
to the decay of the free tracer over time. In figure 11 (c) the growth
of the bound tracer as a function of time for three different points
are shown. At r~10, the bound tracer is zero because the oxygen
concentration is so low that the tissue is necrotic.
A TAC consists of the sum of signals from the plasma, free and
bound tracer,
TAC~
ðð
vblood :Sz vfzvb
 
:(1{S)
 
dxdy: ð24Þ
The general characteristics of TACs from normoxic, hypoxic
and necrotic tissue can be seen by considering the three points
r~1,r~5 and r~10 respectively, as shown in figure 11. For r~1,
the sum of the free and bound tracer will show a very rapid
increase from zero initially to a high level and then a slower but
still fairly rapid decline. Whereas, for r~10, the tissue is necrotic
and there is effectively no bound tracer. The only tracer
contribution to the TAC then comes from the free component,
which because of the distance of this point from the blood vessel,
shows only a gradual increase that is diffusion limited. The point
r~5 sits between these two extremes. That there is a cross-over
point, as mentioned by Wang et al [5], where both oxygenated and
hypoxic tissue would give the same image is clearly seen.
2.3 Multi-vessels. In section 1 it was seen that the
distribution of oxygen can be considered as a superposition of
the oxygen distribution from single vessels for low enough vessel
densities, or equivalently that the oxygen distribution from a
regular grid of vessels and that for a random arrangement of
vessels give similar oxygenation levels below a vessel density of
about 50 for a scaled partial pressure of u0~16 (equating to a
partial pressure of 40mmHg if typical parameter values are used).
Below, the analogous behaviour is considered for the TAC that
results from different microvessel density distributions. For each
microvessel density both random and regular vessel distributions
are considered. Having specified an arrangement of vessels, the
oxygen map is first calculated by solving equations (21). One
example of the resulting oxygen map is shown in figure 12 (a). The
tracer equations (22) are then solved as a function of time with the
plasma input function shown in figure 12(b). The resulting maps
for the free and bound tracer at a sequence of points in time are
shown in figure 12 (c),(e),(g) and (d),(f),(h) respectively. In
figure 12(b) and (c) it is seen how the initial phase is diffusion
dominated, with tracer only occuring close to the blood vessels and
the bound tracer at a rather lower level than the free tracer. Over
time, as seen in (d) and (e) and then in (f) and (g) the free tracer
continues to diffuse and is also gradually converted to bound
Figure 11. Plasma input function and tracer time evolution. (a) Plasma input function. (b) Free tracer against time for three different points in
space. (c) Bound tracer against time for three different points in space. (d) Tissue activity curve.
doi:10.1371/journal.pone.0038597.g011
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tracer, with highest levels of bound tracer occuring in the hypoxic
‘rings’ that form around blood vessels. These rings have a
maximum value at a distance of around five non-dimensional units
and are the two-dimensional manifestation of the maximum seen
in the tracer profile in figure 10(c). The corresponding TAC for
this square of tissue was then calculated by combining the plasma
input function, and the free and bound tracer using equation 24.
The resulting TACs for different vessel densities are shown in
figure 13. At the lowest vessel density of five vessels per mm2, as
shown in the top row, a regular arrangement of vessels would be
indistinguishable from a random arrangement of vessels. More
surprisingly, even at high vessel densities, the differences between
the random arrangement of vessels and the regular arrangements
are rather subtle. This suggests that it is in fact not the random
nature of the vessel distribution that is most critical, on the scale of
a millimetre.
2.4 Comparison with compartment models. Having
computed the oxygen map and the resulting TAC, one can ask
Figure 12. Oxygen map and contours of free and bound tracer as a function of time. A microvessel density of 100 mm{2 has been used.
(a) Oxygen concentration. (b) Plasma input function as a function of time. (c) vf at t~10. (d) vb at t~10. (e) vf at t~50. (f) vb at t~50. (g) vf at
t~500. (h) vb at t~500.
doi:10.1371/journal.pone.0038597.g012
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to what extent a compartment model can extract parameters such
as the mean level of oxygenation. Previous authors have compared
both compartment models and partial differential equation models
with real experimental data. The advantage of trying to fit a
compartment model with ‘experimental data’ generated from a
partial differential equation is that one has much greater
knowledge and control over the the exact parameter values that
are used. If fitting cannot work in this idealised scenario, then it
has little hope in the real world.
In order to compare the behaviour of compartment models with
a model that includes diffusion of the tracer and the spatial
dependence of the oxygen within the tissue we consider the
compartment model constructed by Thorwarth et al [7] and used
in [5,8,10]. This model considers three compartments, one for the
tracer in the blood, one for the free tracer and one for the bound
tracer. The tracer in the blood is modelled by equation (20), the
remaining two compartments are modelled by the coupled
ordinary differential equations,
dCf
dt
~k1Cblood{ k2zk3ð ÞCf ,
Figure 13. Mean levels of free and bound tracer and TACs computed from the PDE model. Each row corresponds to a different
microvessel density (5, 50, 100 and 150 per mm2 respectively). The first column shows the contribution to the TAC from the tracer in the blood
plasma and the free and bound tracer in the tissue. Ten different random vessel distributions were considered, so ten different sets of curves are
shown for each contribution. The central column shows the TACs that result from the ten different random vessel arrangements (solid line) and the
TAC as computed from a regular arrangement of vessels (dashed line). The final column shows the hypoxic fraction for each of the different random
realisations.
doi:10.1371/journal.pone.0038597.g013
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dCb
dt
~k3Cf : ð25Þ
Here, Cf represents the free tracer, Cb represents the bound
tracer. The constants k1 and k2 represent the rate at which tracer
enters/leaves the free compartment and is related to the
permeability of the vessels to the tracer. The constant k3 is the
net binding rate of the tracer in the tissue and is related to the level
of oxygenation of the tissue. Non-dimensionalising by letting
vblood~ATblood , wf~ACf ,wb~ACb and t~
DH
Dtq
t leads to the
equations
vblood~ e
{~k0tzbe{
~kkt
 
, ð26Þ
dwf
dt
~~k1vblood{ ~k2z~k3
 
wf ,
dwb
dt
~~k3wf : ð27Þ
Initially there is no free or bound tracer so that
wf (0)~wb(0)~0, leading to the analytical solution to equations
(27)
wf~
~k1
~k2z~k3{~k0
e{
~k0tz
~k1b
~k2z~k3{~kk
e{
~kkt ð28Þ
{~k1
1
~k2z~k3{~k0
z
b
~k2z~k3{~kk
 
e{(
~k2z
~k3)t, ð29Þ
wb~{
~k1~k3
~k0 ~k2z~k3{~k0
  e{~k0t{ ~k1~k3b
~kk ~k2z~k3{~kk
  e{~kkt ð30Þ
z
~k1~k3
~k2z~k3
1
~k2z~k3{~k0
z
b
~k2z~k3{~kk
 
e{(
~k2z
~k3)t ð31Þ
z
~k1~k3
~k2z~k3
1
~k0
z
b
~kk
 
: ð32Þ
Typical time tracers of vblood ,wf and wb are shown in figure 14.
There are three time scales that are important here corresponding
to the three different rates that appear in the exponential terms.
Typically kk%k0 and kkvk2zk3, but k2zk3 can be either
greater or less than k0 depending on the oxygenation level of the
tissue. It is the two timescales kk and k0 that are relevant for vblood ,
and the fact that ~kk%~k0 is seen by the very rapid decline in vblood
in the first few time units followed by a much slower decline
thereafter. For the free tracer, although all three timescales appear
in the solution, it is the influence of ~kk and ~k2z~k3 that are most
clearly seen in figure 14. The concentration of free tracer first
increases then decreases over time as tracer first diffuses from the
blood into the free compartment and then leaves to become
bound. However, the position and height of the consequent
maximum in the free tracer depends on how fast the free tracer is
converted to bound tracer relative to the dispersal of tracer around
the body as is shown by the two cases in figure 14. In 14(b)
~k2z~k3w~k0, and as soon as the tracer enters the free compartment
it is converted to bound tracer so the amount of free tracer remains
low.
The TAC consists of a signal with different weightings of the
three components, vblood , wb and wf . Fitting of the weights along
with the rate constant ~k3 are used to give some idea if tissue is
hypoxic or not: hypoxic tissue should have a relatively high value
for ~k3 and more bound tracer than normal tissue
Figure 14. Plasma input function and free and bound tracer concentrations computed from the compartment model. The parameters
~k0~5,~kk~0:01,~k1~0:5,~k2~~k3,b~0:5 are used in both cases and in (a) ~k2z~k3~0:1, (b) ~k2z~k3~4.
doi:10.1371/journal.pone.0038597.g014
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In each case, we first compute a TAC by solving the partial
differential equation model for a particular microvessel density.
This computed TAC is then fitted to the formula for the TAC
given by (33). We assume that the plasma input parameters, ~k0,~kk
and b, are known and fit for ~k1,~k2,~k3 and the weights a and b. A
sequence of calculations for increasing microvessel density was
carried out, for each of three vessel partial pressures–u0~8,
u0~16 and u0~40 respectively. The results are summarised in
figure 15 and figure 16. The parameters ~k1 and ~k2 in the
compartment model are the rates at which tracer enters and leaves
the free tracer compartment. As can be seen from figure 15, the
values of this parameter are dependent on both the vessel partial
pressure and the mean oxygenation level–or equivalently the
microvessel density. The parameter ~k3, as shown in figure 15(c) is
the rate at which oxygen binds to the tissue, and here the
nonlinear relationship between the amount of oxygen and the
mean value of oxygen is apparent with a binding rate that is
highest for hypoxic tissue and low both for very low levels of
oxygen, where tissue is predominantly necrotic, and low for high
values of oxygen. The parameters ~k1, ~k2 and b are strongly
correlated with each other, as demonstrated in figure 16.
Consequently, without knowing the vessel partial pressure it is
not possible to deduce information about the mean oxygen levels
or, equivalently, the microvessel density from these parameters
alone. Values for the parameter ~k3 do give a clear indication of
hypoxia, with the maximum value of ~k3 occuring for a non-
dimensional mean oxygen level of around 1 (corresponding to 2:5
mmHg). Low values of ~k3 can occur for one of two reasons, either
because tissue is necrotic or because tissue is normoxic. The
difference between these two cases can be deduced by considering
both ~k3 and ~k1: normoxic tissue would have a low value of ~k3 and
a high value of ~k1 wherease necrotic tissue would have a low value
of ~k3 and a low value of ~k1.
Figure 15. Fitted parameter values. The fitted values of (a) ~k1 , (b) ~k2 , (c) ~k3 and (d) b as a function of the mean oxygen level of the tissue. For the
computation of each point, first the MVD is fixed. The oxygen map is then computed from equation (21) and the mean oxygen level of the tissue
determined. The TAC from the PDE is then constructed by solving equations (22) and computing the expression given in (24). Finally, values of
~k1,~k2,~k3 and b are determined by fitting the TAC from the PDE to the compartment model TAC, equation (33). The circles, points and crosses are
calculations for different vessel partial pressures: circles represent calculations with u0~8; points represent calculations with u0~16, and crosses
represent calculations with u0~40.
doi:10.1371/journal.pone.0038597.g015
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The parameter ~k3 in the compartment model represents the
binding rate. This rate is dependent on the mean oxygenation level
in the free tracer compartment and should be directly related to
the binding rate in the partial differential equation model given in
equation (22),
~k3~
~k
uz~P1
 !
u
uz~P2
 
:
By assuming that the parameters ~k,~P1 and ~P2 are known, one can
invert this relationship and examine to what extent the value of k3
given by fitting the compartment model correlates to the actual
mean value of oxygen given by the partial differential equation
calculation, see figure 17.
Discussion
Modelling the distribution of tracer in the body is a difficult task.
There are a number of different levels of uncertainty and
inaccuracy. Firstly, in writing down a mathematical model various
modelling assumptions are made as to which processes may be
neglected and which cannot. Secondly, in most models there are
parameters which have to be determined. The value of these
parameters can affect both the qualitative and quantitative
behaviour of the model. Finally, there are computational errors
that are introduced when numerical methods are used to solve
equations. If a mathematical model is to be of use, these different
types of error need to be quantified and, ideally, an estimate of the
uncertainty of any result made.
In this paper we have sought to quantify the effect of some of
these sorts of error for the particular problem of oxygen diffusing
in a (two-dimensional) piece of tissue and the consequent tracer
dynamics. We have addressed two particular modelling issues:
firstly the consequence of using different kinds of boundary
condition to describe the flow of oxygen from blood vessel to tissue
and secondly the extent to which compartment models can be
used to describe tracer concentration in tissue where the oxygen
distribution is inhomogeneous. For typical vessel permeabilities
and partial pressures for tumour tissue, we have found that using a
Dirichlet type boundary would typically result in an overestimate
of the amount of oxygen by a factor of two, suggesting that either
mixed, or the source method should be used. The fact that the
source method gives good results, is significant as this is a method
that is likely to be easier to implement in three space dimensions
than modelling blood vessels as discrete entities with flux boundary
conditions. The second modelling assumption that we have
investigated is to what extent the heterogeneous nature of the
vascular supply is important/detectable by a TAC that averages
over a region of a square millimetre. In fact, the actual distribution
of the vessels does not significantly affect the form of the TAC:
TACs from both regular and randomly arranged blood vessels
Figure 16. Correlation of ~k1 with (a) ~k2, (b) ~k3and (c) b. The circles are computations with a vessel partial pressure u0~8; the points are for
u0~16, and the crosses are for u0~40.
doi:10.1371/journal.pone.0038597.g016
Figure 17. Predictions of the compartment model. (a) The value of the mean oxygen level as predicted by fitting the compartment model to
the TAC that is computed from the partial differential equation versus the actual mean oxygen level. (b) The predicted value of the parameter b
versus the actual value. The circles represent computations with a vessel partial pressure of u0~8; the dots represent computations with u0~16 and
the crosses represent computations with u0~40.
doi:10.1371/journal.pone.0038597.g017
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were strikingly similar with the qualitative and quantitative
features much more strongly dependent on the partial pressure
of the vessels and their number. In part, this is because after the
first few minutes, although one can still see the after-effects of the
position of the blood vessels in the spatial distribution of the tracer,
as shown in figure 12, the actual magnitude of the variation at any
point in time is relatively small. This is because typical diffusion
times for tracers, x2=2DT , are an order of magnitude shorter than
typical times associated with the binding for tracers, as given by
1=kmax. In real tissue, the vessels are not only highly heteroge-
neous in their position, but also in their size, vessel partial pressure
and vessel blood flow rates. However, the difference in timescales
between the diffusion and the chemical kinetics suggests that this
heterogeneity is averaged out by the diffusion process and is not
detectable on the timescale of the chemical kinetics. The
consequence is that fitting a TAC to a partial differential equation
model including the full heterogeneity in the distribution and the
characteristics of the vessels will result in essentially the same
prediction for mean oxygen partial pressure as fitting to a
compartment model. While the partial differential equation
models that include vascular structures are valuable for allowing
the investigation of how changes to the underlying physiological
parameters affect the results, this suggests that compartment
models will be sufficient in a clinical setting.
One of the difficulties in comparing with experiment is that
some of the parameters are hard to measure. The sensitivity results
of section 1.3 showed that a 10% error in the scaled permeability
~Pm or the scaled partial pressure u0 will result in a similar error in
the oxygenated area. Similarly the value of the oxygen threshold
used to define the oxygenated area, uh, has a significant effect on
the results.
Finally we note that one source of error is the computational
error: for the sake of computational time, many authors have used
a single point to represent a vessel. As we have seen, this in itself
can introduce an error of approximately 30%.
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Abstract
Knowledge of how a population of cancerous cells progress through the cell cycle is vital if the population is to be treated
effectively, as treatment outcome is dependent on the phase distributions of the population. Estimates on the phase
distribution may be obtained experimentally however the errors present in these estimates may effect treatment efficacy
and planning. If mathematical models are to be used to make accurate, quantitative predictions concerning treatments,
whose efficacy is phase dependent, knowledge of the phase distribution is crucial. In this paper it is shown that two
different transition rates at the G1-S checkpoint provide a good fit to a growth curve obtained experimentally. However, the
different transition functions predict a different phase distribution for the population, but both lying within the bounds of
experimental error. Since treatment outcome is effected by the phase distribution of the population this difference may be
critical in treatment planning. Using an age-structured population balance approach the cell cycle is modelled with
particular emphasis on the G1-S checkpoint. By considering the probability of cells transitioning at the G1-S checkpoint,
different transition functions are obtained. A suitable finite difference scheme for the numerical simulation of the model is
derived and shown to be stable. The model is then fitted using the different probability transition functions to experimental
data and the effects of the different probability transition functions on the model’s results are discussed.
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Introduction
The cell cycle is an ordered set of events that a cell undergoes
from its birth until it divides into two daughter cells [1]. In
eukaryotic cells the cell cycle may be broken down into four
distinct phases, namely G1, S, G2 and M. After birth, a cell enters
the longest of the phases, the G1 (Gap 1) phase, during which the
cell takes on nutrients needed to complete the rest of the cycle.
Once the cell has absorbed enough nutrients it may proceed round
the cell cycle leaving the G1 phase and entering the S (Synthesis)
phase. Not all cells leave the G1 phase to enter the S phase, a
number of cells enter a quiescent period where they remain viable
but leave the cell cycle for a short time, these cells enter the G0
(Gap 0) phase. During the S phase a cell replicates its DNA, at the
end of which they have effectively doubled their DNA content.
Once DNA synthesis is completed the cell enters the G2 (Gap 2)
phase. During the G2 a cell grows in size and prepares for mitosis.
Upon leaving G2 the final phaseM (Mitosis) is entered. It is during
the mitotic phase that the cell divides, producing two daughter
cells. Due to the processes involved in cell division, cells in the M
phase are especially vulnerable to radiotherapy. It should be noted
that the M phase may be broken down further into several sub
phases, however this is of no consequence for the model discussed
herein. The actual length of the cell cycle is variable, this
variability mainly occurs in the length of time cells spend in the G1
phase which is governed by the way in which cells ‘transition’ from
the G1 phase to the S phase [2]. Once a cell commits itself to DNA
synthesis (i.e. enters the S phase) it must continue the cell cycle
until division is complete, the ‘transition’ from the G1 phase to the
S phase is irreversible.
Chemotherapy drugs can be divided into several types, each of
which target a specific process within the cell cycle such as RNA
synthesis or cell division. Hence the efficacy of many chemother-
apy drugs (e.g. [3], [4] and [5]) is dependent on the cell cycle
phase. The radiosensitivity of cells is also phase dependent (e.g.
[6], [7] and [8]) with cells in the M (mitotic) phase having their
chromosomes arranged in a line prior to separation making them
particularly sensitive to ionising radiation. Due to the phase
dependent nature of chemotherapy drugs and radiotherapy
knowledge of how the cells progress through the different phases
is crucial.
There have been a number of mathematical models developed
for populations of cells progressing round the cell cycle. Systems of
ordinary differential equations may be used to model the growth
kinetics of populations of cells however these are too simplistic to
capture the intrinsic properties of the cell cycle, but are often an
invaluable first step in understanding the kinetics of a population
of cells. To adequately model crucial properties of a population of
cells such as age, mass or DNA distribution a system of partial
differential equations is needed.
Many partial differential equation models share the same
fundamental population balance structure as detailed in [9], [10]
and [11]. These models may broadly be grouped in terms of which
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property of the cell is used to structure the model, the main
properties used being DNA ([12], [13], [14], [15] and [16]), age
([17], [18], [19] and [20]) and mass ([17], [21], [19]).
There are advantages of using a DNA or mass structured model
in as much that these quantities may be easily determined
experimentally, however such a model contains no information
about the age of a particular cell and as such it is possible for cells
to remain in the cycle for an infinite amount of time. By use of an
age-structured model it is possible to control the length of time a
cell may remain in the cell cycle, in particular the G1 phase.
Another advantage of age structuring is that, if growth rates and
nutrient uptake rates for a given cell line are known, it is possible to
determine the mass and DNA content of a cell from its age,
however given the cells DNA content or mass it is not possible to
determine a cell’s age as there is not a one-to-one mapping
between age and DNA or mass.
Analysis has been undertaken to determine the existence and
stability of steady size/DNA distributions [22] which may occur
under specific circumstances using an age structured model.
Population balance models have been used not only on healthy,
unperturbed cell lines but also to model the effects of various
treatments to cancer cell populations [15], [18], [16] and [23].
In this paper, an age structured cell cycle model is considered
together with two different functions governing the movement
between the G1 and S phases. Whilst, different functions have
been used in the past [18], [20] and [24] little has been done to
study the effects of different functions on the phase distributions of
cells. It is shown that it is possible to obtain very similar growth
curves using different transition functions with the fundamental
difference being in the phase distributions for the cells. Although
the differences in the phase distributions lie within the range of
experimental error for many techniques such as conventional flow
cytometry it may be significant in terms of treatment optimisation.
The purpose of this paper is to understand how different transition
rules may effect the phase distribution of the cells and that whilst
the motivation for this analysis is the phase dependent nature of
certain treatments these have not been included within the model.
This paper is outlined as follows. The age structured model is
presented in Section 1 together with a brief overview of the
derivation of a generalised transition function in Section 2. Two
specific transition functions are then considered. In Section 3 the
numerical scheme used for computations is derived. Section 4 sees
the age structured model with different transition functions
compared with experimental data. The experimental data
concerns a batch experiment which was conducted using a
mouse-mouse hybridoma cell line (mm321) [25]. The findings of
this paper are then summarised together with ideas for future
work.
Model Outline
1 Age structured model
The model considered in this paper is divided into three, age-
structured sections, G1a, G1b and MAIN as depicted in Figure 1.
The MAIN compartment contains cells in the S, G2 and M
phases of the cell cycle, it is at the end of this compartment cell
division occurs.
The G1a section contains cells which have just undergone
division. Cells that are in G1a are not able to progress further
round the cell cycle until a fixed time period has elapsed, this
represents the minimum age a cell can start replicating its DNA.
This is biologically realistic as new cells are normally unable to
immediately start replicating their DNA. Once cells have
progressed to G1b they undergo transition to the MAIN
compartment at a rate h(v), which is often a function of how
long the cell has spent in G1b. It may also be a function of other
factors which effect a cell’s progression round the cell cycle such as
nutrient levels, the presence of certain drugs, temperature etc. The
MAIN compartment is of fixed duration and can be thought of as
merely a time delay from when a cell leaves G1b until cell division
and entry of the new daughter cells into G1a. All compartments
within this model are of a limited duration, the MAIN and G1a
compartments are of a fixed duration and the duration of G1b
varies from zero to some maximum value, TG1b . Biologically, any
cells remaining in G1b at the end of TG1b would either die or enter
a quiescent phase. Cells in a quiescent phase may be able to rejoin
the cycle at a later time. Neither of these scenarios is modelled
here.
In this model the non dimensionalised equations governing the
population density of cells n in each phase are given by
LnG1a
Lt
z
LnG1a
Lt
~0, ð1Þ
LnG1b
Lt
z
LnG1b
Lt
zh(v)nG1b~0, ð2Þ
LnMAIN
Lt
z
LnMAIN
Lt
~0: ð3Þ
With the corresponding boundary conditions
nG1a (t,0)~2nMAIN (t,TMAIN ),
nG1b (t,0)~nG1a (t,TG1a ),
nMAIN (t,0)~
ðTG1b
0
nG1a (t,t^)h(v(t^))d t^:
ð4Þ
To complete the model the cell distribution at time t~0 needs to
be specified, as we are concerned with the system once it has
reached exponential growth and steady ‘phase’ distribution this
Figure 1.Overview of a three compartment age structured
model.
doi:10.1371/journal.pone.0083477.g001
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condition is not important, however for completeness it may be
assumed there is a uniform feed of cells into the start of the cell
cycle for the first k hours,
nG1a (t,0)~c, tvk hours: ð5Þ
This model is of a similar structure to most population balance
age-structured models such as those presented in [18] and [20]
amongst others. In [20] the MAIN phase is split into three parts
S,G2 andM, but since our focus is on the total cell population and
the fraction of cells in G1, this difference has no impact. A further
difference is in the way that [20] model the transition from G1, and
this will be discussed in greater detail below. In [18], in addition,
the G1 phase is modelled as a single compartment rather than
divided into two, G1a and G1b.
2 G1-S Transition functions
The probability of a cell leaving the G1b phase and entering the
S phase via the transition rule is given by some probability
distribution function f (x) where x is the variable that determines
how likely cells are to undergo transition. Figure 2 gives a
graphical representation of such a probability distribution function
with phase age tG1b acting as the variable controlling the transition
probability. Note that phase age is the length of time a cell spends
in a particular phase, For the rest of this paper the subscripts have
been removed from the age variable for ease and only used in the
case of any ambiguity as to the phase referenced.
If t varies by a small amount, dt, then the probability of cells
whose age is between t and tzdt transitioning can be
approximated by f (t)dt. Assuming all cells are capable of
transitioning given enough nutrients, the total area under the
probability distribution curve is one. Therefore the probability that
a cell of age t has not yet transitioned is given by 1{
Ð
t
0
f (t’)dt’.
So the fraction of cells, who have not gone through transition, who
go through transition when their age changes from t to tzdt is
given by
f (t)dt
1{
Ð
t
0
f (t’)dt’
: ð6Þ
Another way of considering the number of cells going through
transition is via a transition rate h(t). If the fraction of cells who
leave in the time period t,tzdt)½ is given by h(t)dt, then by
definition this must be equal to equation (6). Therefore, in the limit
dt?0,
h(t)~
f (t)
1{
Ð
t
0
f (t’)dt’
dt
dt
: ð7Þ
since a cell ages at the same rate as time passes t(t)~t{c where c
is a constant therefore dt
dt
~1 hence equation (7) simplifies to
h(t)~
f (t)
1{
Ð
t
0
f (t’)dt’
: ð8Þ
If the cumulative probability of cells transitioning, F (t), is
considered then equation (8) may be expressed as
h(t)~
F ’(t)
1{F (t)
, ð9Þ
where the dash notation denotes the derivative with respect to t. It
is this form of the transition rate which will be used herein.
2.1 Specific transition rules. In this paper, we consider two
different transition functions, the first assumes that the transition
rate is constant, h~c, and is therefore independent of the time
spent in the G1b phase. Note the transition rate h~c corresponds
to a cumulative probability of transition given by 1{ect. This is
the same form of transition discussed in [18]. This transition rule is
not biologically realistic as it implies all cells in G1b have an equal
probability of progressing to the S phase regardless of how long
they have spent acquiring nutrients and preparing for DNA
synthesis.
The second form of transition function that we consider is a
sigmoidal transition function. This seems biologically reasonable
since this implies that the probability of cells progressing to the S
phase immediately after entering G1b is low due to the limited
amount of nutrients they have absorbed. Once the mass of
nutrients absorbed reaches some critical value then the probability
of transition is likely to increase considerably, however there will
always be a few cells which do not progress to the S phase
regardless of nutrient uptake, thus the sigmoidal function attains a
maximum value just under one. It should be noted that a
sigmoidal cumulative probability function is in keeping with the
phase transition seen in cell populations which have been
modelled using the kinetics and chemical processes within the
cell [26] and [27]. Here we propose a new sigmoidal transition
rule governing the probability of transition is proposed, which
unlike the one considered in [24] may be non-dimensionalised so
there is only one independent parameter, reducing the number of
parameters that need to be fitted.
Since a very small proportion of cells of G1 phase age zero it is
reasonable to expect that the cumulative distribution function
should be non-zero at tG1b~0. Furthermore, as discussed earlier,
some cells will not transition and enter a quiescent state so the
cumulative distribution for G1b remains less than one for all tG1b .
Therefore, the the cumulative distribution function given by
F (t,t)~1{
1
1ze
h(
Cc(t,t)
Cmax
{
1
2
)
, ð10Þ
is considered. Here, h is related to the maximum and minimum
values of the cumulative distribution function and Cmax is related
to the steepness of the sigmoidal function and Cc(t,t) represents
Figure 2. Probability distribution of transition, f (t) showing the
probability that a cell of age t has not yet transitioned (shaded
region) and the probability a cell of age t will transition in the
time interval t to tzdt (dark region).
doi:10.1371/journal.pone.0083477.g002
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the amount of glutamine a cell of age tG1b has absorbed at time t.
It then follows that, for h sufficiently large,
h(t,t)~
h
Cmax
LCc(t,t)
Lt
e
h(
Cc(t,t)
Cmax
{
1
2
)
1ze
h(
Cc(t,t)
Cmax
{
1
2
)
: ð11Þ
It is reasonable to assume that the rate of change of glutamine is
constant, provided there is a high amount of glutamine available.
By making this assumption then
LCc(t,t)
Lt
~R and Cc~tR (It is
assumed that the cell has not taken absorbed any glutamine prior
to entering the G1b phase, i.e. Cc~0 at t~0:). Hence,
h(t)~
Rh
Cmax
e
h( tR
Cmax
{
1
2
)
1ze
h( tR
Cmax
{
1
2
)
: ð12Þ
The corresponding non-dimensional form of this equation is given
by
h(t)~
e
(~t{h
2
)
1ze
(~t{h
2
)
, ð13Þ
which only has the single parameter h which needs to be fitted. In
[28] the following expression for the fraction of cells of age t
remaining in the G1b phase, n(t,t), for a given intra cellular
glutamine concentration CG1b(t,tG1b) is proposed
nG1b(t,tG1b)
nG1b(t{tG1b,0)
~
(CG1b(t,tG1b){SMax)
2
S2Max
, ð14Þ
where SMax is the maximum glutamine content a cell can have
before being forced to go through transition. This leads to the
transition function
h(t,tG1b)~
2
SMax{CG1b(t,tG1b)
LCG1b(t,tG1b)
LtG1b
: ð15Þ
Note
LCG1b(t,tG1b)
LtG1b
is assumed to always be §0 so that the
cumulative glutamine never decreases. It can be seen that when
CG1b(t,tG1b)?SMax, the probability of transition becomes infinite.
Despite this singularity at CG1b(t,tG1b)~SMax this transition
function still provides a very good fit to experimental data [20].
The reasons why this is the case are discussed below.
Numerical Methods
The system of differential equations governing the simplified
system described in Section 1 may be solved analytically for
specific initial conditions and short time intervals. However, in
order to be able to study and manipulate the model for different
transition functions for longer time intervals involving many cell
cycles it is necessary to use numerical techniques.
3 Derivation of Numerical scheme
In this section a finite difference scheme analogous to the Lax-
Wendroff scheme is derived. The Lax-Wendroff scheme was
chosen as it is a second order explicit method and as such yields
high accuracy for relatively large time steps where there is a rapid
change or discontinuity such as the initial flow of cells into the
main cycle.
For the G1b phase equation (2) may be written as
ntznt~{hn, ð16Þ
Note for ease the time and age dependence has been omitted
together with the phase subscript. Subscripts now denote the
partial derivatives. Also h is a function of t only, furthermore, if the
sigmoidal form of the transition rule given in equation (13) is used
then
ht~h{h
2
: ð17Þ
Rearranging and differentiating equation (16) gives
nt~{nt{hn, ð18aÞ
ntt~{ntt{hnt, ð18bÞ
ntt~{ntt{hnt{htn: ð18cÞ
Which, upon using the Taylor expansion together with (17) yields
n(tzdt,t)~n 1{dthz
(dt)2
2
h
 !
znt {dtz(dt)
2h
 
zntt
(dt)2
2
zO(dt3):
ð19Þ
Finally, standard formulae for the first and second derivatives of n
with respect to t are used, namely
dn
dt

i,j
~
ni,jz1{ni,j{1
2dt
, ð20Þ
d
2n
dt2

i,j
~
ni,j{1{2ni,jzni,jz1
(dt)2
, ð21Þ
where ni,j is the cell density of cells aged ½jts,(jz1)ts) in the time
interval ½its,(iz1)ts) where ts and ts are the length of the
discretised elements. This leads to the finite difference scheme
niz1,j~ni,j 1{
(dt)2
(dt)2
{dthi,jz
(dt)2
2
hi,j
 !
zni,jz1
(dt)2
2(dt)2
{
dt
2dt
z
(dt)2
2dt
hi,j
 !
zni,j{1
(dt)2
2(dt)2
z
dt
2dt
{
(dt)2
2dt
hi,j
 !
:
ð22Þ
Because of the ‘dispersive’ nature of any numerical difference
scheme if dt=dt additional errors are introduced at each time
step. For example if at t~0 all cells are age zero and the age step is
set to e and the time step set to e
2
, then after evolving the system for
one time step there would be cells whose age is e, this clearly makes
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no sense. Similarly if the time step is set to 2e after one step there
are no cells present whose age is 2e since tƒe for all cells. Hence,
additional interpolation is required if the age and time steps are
not equal. By setting dt~dt~a equation(24) becomes
niz1,j~ni,j
a
2
2
{a
 
hi,j
 
zni,jz1
a
2
hi,j
	 

zni,j{1 1{
a
2
hi,j
	 

: ð23Þ
3.1 Stability of the numerical system. For a numerical
scheme to produce accurate solutions to a partial differential
equation, not only must the error at each time step be small
enough, any errors must not grow exponentially, i.e. the numerical
scheme must also be stable. If the nutrient supply is unlimited and
uptake is uniform then the cell cycle may be simplified into two
‘phases’, G1b on it’s own and the remaining phases all put together.
A two compartment model is not suitable for analysing the
dynamics of a population of cells as too much information is lost
by combining the MAIN phase and G1a phases of the model
discussed in Section 1, in particular the timing of the cell division.
However, a two compartment model is sufficient for conducting a
stability analysis. Once the system has reached steady growth (i.e.
no further input from G1’) then it may be represented as shown in
Figure 3 where X and Y represent the two ‘phases’. To perform
the stability analysis the time step matrix is constructed, the norm
of which is shown to be bounded. It is helpful to start by defining
some notation.
Notation. If the numerical scheme is discretised into elements
of time of length ts and age elements of length ts then let cells in
phase X of age [½its,(iz1)ts) in the time interval [½jts,(jz1)ts) be
denoted by X ij . Also let all cells in phase X in the time interval
[½mts,(mz1)ts be denoted by Xm, where Xm is now a column
vector. Also assume the time line is moved such that at
t~t0, t’~0, where t’ is the time used for the purposes of the
subscript; for convenience the 0 notation is now dropped.
Construction of time step matrix. Let the maximum
durations of the X and Y phases be Nts and Kts respectively
then at time t~t0,
X 00 cells entering X ,
XN{10 cells in x dying due to old age at the next time step,
Y 00 cells entering Y ,
YK{10 cells leaving Y and doubling at the next time step:
ð24Þ
Clearly,
X 0a~2Y
K{1
a{1 : ð25Þ
Also the cells entering Y are a function of the cells who were in X
at the previous time step, therefore
Y 0a~h(Xa{1), ð26Þ
where h(v) is the probability of transition from X to Y . since
nothing happens to the cells during their time in Y , it can be
thought of as merely a time delay phase, therefore
Y ja~Y
j{1
a{1 for 1ƒjvK : ð27Þ
Note, the inequality is strictly less than K as cells of age Kts have
undergone division and the offspring are now in X 0a .
Assuming a finite central difference scheme is used for
calculating the cell densities in the X phase then
X ia~f (X
i{1
a{1,X
i
a{1,X
iz1
a{1) for 1ƒjvN, ð28Þ
and
XNa ~f (X
N{1
a{1 ,X
N
a{1): ð29Þ
From equations (25) and (27) it is clear that
X 0a~2Y
K{1
a{1 ~2Y
K{2
a{2 ~ . . .~2Y
0
a{K : ð30Þ
Now using equation (26) yields
X 0a~2h(X
0
a{K{1): ð31Þ
Equations (25–29) may be expressed in matrix notation as
X 0mz1
X 1::N{2mz1
XN{1mz1
Y 0mz1
Y 1::K{1mz1
2
6666664
3
7777775
~M
X 0m
X 1::N{2m
XN{1m
Y 0m
Y 1::K{1m
2
6666664
3
7777775
, ð32Þ
whereM is an (NzK)|(NzK) matrix. To prove the numerical
scheme is stable it is sufficient to show [29] that the norm of M in
equation (32) satisfies
Mk kƒ1zka, ð33Þ
where dt~dt~a and k is a constant independent of a. It can be
shown that if the trapezium rule is used for approximating
equation (26) then the norm of M is given by
Figure 3. Two Compartment Model.
doi:10.1371/journal.pone.0083477.g003
Table 1. Parameters from [20].
Parameter Notation Value
Maximum age in G1a phase TG1a 2.5 hours
Maximum age in G1b phase TG1b 10 hours
Maximum age in S phase TS 5 hours
Maximum age in G2zM phase TG2zM 4 hours
doi:10.1371/journal.pone.0083477.t001
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Mk k~supf2,a
XN{2
j~1
h(j)z
a
2
(h(0)zh(N{2))g: ð34Þ
For the transition functions considered h is monotonically
increasing so
a
XN{2
j~1
h(j)z
a
2
(h(0)zh(N{2))ƒa
ðXtmax
0
h(t)dt, ð35Þ
it is therefore sufficient to show a
ÐXtmax
0
h(t)dt remains bounded.
For the sigmoidal transition rule
ðXtmax
0
e
t{h
2
 
1ze
t{
h
2
  dt~ ln 1zet{h2	 
h iXtmax
0
, ð36Þ
which for typical h values this is approximately equal to
ln 1ze
Xtmax{
h
2
	 

. For Xtmaxƒ
h
2
then
ln 1ze
Xtmax{
h
2
	 

&1ze
Xtmax{
h
2ƒ2: ð37Þ
For Xtmaxw
h
2
then
Figure 4. Growth curves produced by using a constant transition rule (a) and a sigmoidal transition rule (b) fitted against
experimental batch data presented in [20].
doi:10.1371/journal.pone.0083477.g004
Figure 5. Proportions of cells in each phase using a constant transition rule (a) and a sigmoidal transition rule (b).
doi:10.1371/journal.pone.0083477.g005
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ln 1ze
Xtmax{
h
2
	 

&Xtmax{
h
2
: ð38Þ
Thus, in all cases Mk k remains bounded. In most cases
Xtmax{
h
2
 
av1, this leads to a stronger constraint on the bound
i.e. Mk kƒ2.
Results
In Section 4 it is shown that regardless of whether a constant or
a sigmoidal transition rule is used, it is possible to fit the model to a
growth curve from experimental data. It is then shown in Section 5
that whilst the different transition functions result in the same
growth curve, the fraction of cells in each phase differs.
4 Model validation
Experimental data from [25] was chosen and concerns a batch
experiment which was conducted using a mouse-mouse hybrid-
oma cell line (mm321). In this experiment 28% of the starting cell
population did not divide but remained viable, 36% of the starting
population were evenly distributed in the S phase of the cell cycle
and the remaining 36% were initially at the beginning of the G1b
phase. For the purposes of modelling it was assumed the cells
starting in the G1b phase were of a phase age between zero and
two hours. The numerical scheme described in Section 3, was
implemented using both sigmoidal and constant transition rules.
Parameters for the length of different phases were taken from [20],
and are stated in Table 1. The h and c parameters were allowed to
vary in the sigmoidal and constant transition rules respectively,
until a best fit had been obtained. Several starting values for h and
c were used in the optimizations of the fits to ensure the global best
fits had been found for each transition rule and that the results
were not a local minimum. Optimizations were carried out using
Matlab’s [30] least squares curve fitting algorithm lsqcurvefit. The
Matlab code for these optimizations is available from [31].
As can be seen in Figure 4, both the constant transition rule
(Figure 4a) and the sigmoidal rule (Figure 4b) provide a good fit to
the experimental data resulting in residual norm values of 0.1 and
0.2 respectively. The parameters in Table 1 were varied by
Figure 7. Sigmoidal transition function (a) with the corresponding cumulative probability of transition (b) as a function of G1b age.
doi:10.1371/journal.pone.0083477.g007
Figure 6. Constant transition function (a) with the corresponding cumulative probability of transition (b) as a function of G1b age.
doi:10.1371/journal.pone.0083477.g006
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+20%. Different values for the Table 1 parameters resulted in
different values for the fitted parameters (h and c) values but did
not significantly change the goodness of the fit shown in Figure 4
with no residual norms exceeding 0.2. Note that the model did not
impose any restrictions on the available nutrients, indicating
nutrients were not a limiting factor for cell growth over the course
of the experiment. This suggests, that if population growth is the
only concern, that a constant transition rule is sufficient.
5 The effect of the transition function
Although the effect of the different transition rules is not
apparent in the fitting to the experimental growth curve, here we
show that the transition rule does impact on the phase distribution
of cells.
In the experimental data used to fit the model the initial
population of cells was partially synchronised using a thymidine
double block. This partial synchronisation meant the initial
population of cells was situated in the S phase and the latter
part of the G1 phase, G1b. It therefore seems reasonable to assume
most cells will initially progress round the cycle in a group this
would result in the phase distribution being oscillatory. The
oscillations would be expected to decay slowly as the synchronicity
of the cell population was lost. Such oscillations may be one cause
for apparent ‘errors’ in phase distributions obtained from such
experiments as the timing of observations would need to occur at
known positions on the oscillation, the period of which may not
be known. To fully appreciate the differences these transition
functions have on the underlying model properties the percentages
of cells in each compartment may be compared once transient
oscillations have decayed and the system has reached a steady
state of phase distributions. The time scale required for the
transient oscillations to have decayed sufficiently is of the order of
500 hours and as such it is not feasible to obtain experimental
data.
In order to investigate this, the mathematical model was
numerically integrated using the same parameters and initial
conditions used in Section 4 for long enough that a steady phase
distribution had been obtained. The results are shown in Figure 5.
These two sets of results differ in two key ways. Firstly, both
simulations initially show an oscillation in the phase distribution,
however the rate of decay of the oscillations depends on the
transition function chosen, with the oscillations decaying much
more slowly for a sigmoidal transition function. The difference in
the decay rates may be appreciated by considering the area under
the cumulative probability function for the different transition
functions (Figures 6 and 7). For a steep sigmoidal probability
distribution function the area under the curve initially increases
slowly then has a rapid increase for a short time interval then
returns to a slow increase as shown in Figure 7. This rapid increase
would result in the majority of the population remaining in a
group as it progressed round the cycle, with each complete cycle
dispersing slightly due to the ages corresponding to a low
probability of transition. With the value of the constant transition
function used in this simulation the area under the corresponding
cumulative probability distribution function does not change as
rapidly as with the sigmoidal function as shown in Figure 6. This
results in the population of cells transitioning more evenly, leading
to a more rapid de-synchronisation. Secondly, once the transient
oscillations have decayed the percentages of cells in each of the
model’s ‘phases’ differ: in the sigmoidal transition rule there are
20.2%, 33.3% and 46.5% in the G1a, G1b and MAIN phases
respectively, whereas in the constant transition rule these change
to 22.6%, 24.4% and 53.0%.
Discussion
In this paper an age-structured cell cycle model has been
considered with particular emphasis on the G1-S checkpoint. By
considering the probability of cells transitioning at the G1-S
checkpoint, different transition functions have been obtained. A
suitable numerical scheme for the resulting PDEs has been derived
and shown to be numerically stable. This numerical scheme has
then been used to look at the effects of the different transition
functions on the phase distribution of the cell population.
The model shows there is a noticeable change in the proportion
of cells in each phase for the two different transition functions
considered. The sigmoidal transition function predicts 53.5% of
the cell population being in the G1 phase, whilst the constant
transition function places 47.0% of cells in the G1 phase.
As mentioned previously the efficacy of chemotherapy treat-
ments and the radiosensitivity of cells varies according to a cell’s
position in the cell cycle. Since the relationship between cell phase
and efficacy may be non-linear a small difference in phase
distribution may produce a large change in the efficacy of
treatments resulting in the model producing results outside
the bounds of experimental error. Therefore, the difference in
the phase distributions produced by this model, using the different
transition functions, will effect the model’s ability to accurately
represent the effects of a given treatment on a population of cells.
Consequently, it is important to ascertain the correct transition
function if such models are to be used to give a quantitative
prediction of the cell population’s response to treatments.
Improvements in techniques may reduce the level of potential
error in phase distributions obtained experimentally, this may
allow some transition functions to be discounted.
It may also be possible to rigorously derive the form of the
transition function for a population of cells by considering the
chemical kinetics of a single cell [26].
Whilst there is no consensus on the error on cell phase
distributions obtained using flow cytometry [32] the difference in
phase distributions produced by the model with the different
transition rules lie within the typical bounds of current experi-
mental error ([33], [34] and [32]). As noted in Section 5 the
difficulty of measuring the phase distribution may be compounded
by underlying oscillations induced by the blocking. Thus, the form
of the probability distribution function controlling the G1{S
checkpoint in an age structured population balance model has
little impact on the models ability to fit to experimental data. The
lack of effect of the form of the probability transition function
explains why the quadratic transition function used in [20] fitted
experimental data despite having a singularity. As such a
simplified transition function may be used to gain a qualitative
understanding of the dynamics of a population of cells.
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